Download THE CARDIOVASCULAR CENTER (CVC)

PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) Scientific Publications 2009-2014
Aalberts JJJ, Boonstra PW, van den Berg MP, Waterbolk TW. In-hospital mortality and
three-year survival after repaired acute type A aortic dissection. Netherlands Heart
Journal 2009;17(6):226-31.
Aalberts JJJ, Schuurman AG, Pals G, Hamel BJC, Bosman G, Hilhorst-Hofstee Y, et al.
Recurrent and founder mutations in the Netherlands Extensive clinical variability in
Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation.
Netherlands Heart Journal 2010;18(2):85-9.
Aalberts JJJ, Thio CHL, Schuurman AG, van Langen IM, van der Pol BAE, van Tintelen
JP, et al. Diagnostic yield in adults screened at the marfan outpatient clinic using the
1996 and 2010 ghent nosologies. American Journal of Medical Genetics Part A
2012;158A(5):982-8.
Aalberts JJJ, van Tintelen JP, Meijboom LJ, Polko A, Jongbloed JDH, van der Wal H, et
al. Relation between genotype and left-ventricular dilatation in patients with Marfan
syndrome. Gene 2014;534(1):40-3.
Aalberts JJJ, van Tintelen JP, Oomen T, Bergman JEH, Halley DJJ, Jongbloed JDH, et
al. Screening of TGFBR1, TGFBR2, and FLNA in Familial Mitral Valve Prolapse.
American Journal of Medical Genetics Part A 2014;164(1):113-9.
Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans ROB, et al.
Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic
Syndrome. Journal of Clinical Endocrinology & Metabolism 2010;95(9):E26-E31.
Abbasi A, Beulens JWJ, Snieder H, Bakker SJL. Commentary: both multiplicative and
additive components may contribute to parental transmission of type 2 diabetes - a
response to K. Hemminki and X. Li and J. Sundquist and K. Sundquist. Journal of
Internal Medicine 2011;270(3):291-2.
Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans ROB, et al.
Plasma procalcitonin and risk of type 2 diabetes in the general population. Diabetologia
2011;54(9):2463-5.
Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, de Jong PE, Gans ROB, et al.
External validation of the KORA S4/F4 prediction models for the risk of developing type
2 diabetes in older adults: the PREVEND study. European Journal of Epidemiology
2012;27(1):47-52.
Abbasi A, Bakker SJL, Corpeleijn E, van dA, Gansevoort RT, Gans ROB, et al. Liver
Function Tests and Risk Prediction of Incident Type 2 Diabetes: Evaluation in Two
Independent Cohorts. Plos One 2012;7(12).
Page 1 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Abbasi A, Corpeleijn E, Meijer E, Postmus D, Gansevoort RT, Gans ROB, et al. Sex
differences in the association between plasma copeptin and incident type 2 diabetes: the
Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia
2012;55(7):1963-70.
Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans ROB, et al.
Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of
Incident Cardiovascular Disease and All-Cause Mortality. Journal of the American Heart
Association 2012;1(5).
Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Hillege HL, Stolk RP, et al. Role of
HDL Cholesterol and Estimates of HDL Particle Composition in Future Development of
Type 2 Diabetes in the General Population: The PREVEND Study. Journal of Clinical
Endocrinology & Metabolism 2013;98(8):E1352-E1359.
Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Struck J, Schulte J, et al.
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and
Vascular Endstage Disease (PREVEND) study. Diabetologia 2014;57(9):1842-9.
Abdelmalek JA, Gansevoort RT, Heerspink HJL, Ix JH, Rifkin DE. Estimated Albumin
Excretion Rate Versus Urine Albumin-Creatinine Ratio for the Assessment of
Albuminuria: A Diagnostic Test Study From the Prevention of Renal and Vascular
Endstage Disease (PREVEND) Study. American Journal of Kidney Diseases
2014;63(3):415-21.
Adams KF, Ghali JK, Patterson JH, Stough WG, Butler J, Bauman JL, et al. A
perspective on re-evaluating digoxin's role in the current management of patients with
chronic systolic heart failure: targeting serum concentration to reduce hospitalization and
improve safety profile. European Journal of Heart Failure 2014;16(5):483-93.
Adamusiak T, Parkinson H, Muilu J, Roos E, van der Velde KJ, Thorisson GA, et al.
Observ-OM and Observ-TAB: Universal Syntax Solutions for the Integration, Search,
and Exchange of Phenotype And Genotype Information. Human Mutation
2012;33(5):867-73.
Agool A, Slart RHJA, Dierckx RAJO, Kluin PM, Visser L, Jager PL, et al. Somatostatin
receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with
multiple myeloma and plasmacytoma. European Journal of Nuclear Medicine and
Molecular Imaging 2010;37(1):124-30.
Agool A, Slart RHJA, Kluin PM, de Wolf JTM, Dierckx RAJO, Vellenga E. F-18 FLT PET:
A Noninvasive Diagnostic Tool for Visualization of the Bone Marrow Compartment in
Patients With Aplastic Anemia A Pilot Study. Clinical Nuclear Medicine
2011;36(4):286-9.
Agool A, Glaudemans AWJM, Boersma HH, Dierckx RAJO, Vellenga E, Slart RHJA.
Radionuclide imaging of bone marrow disorders. European Journal of Nuclear Medicine
and Molecular Imaging 2011;38(1):166-78.
Page 2 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Agool A, Slart RHJA, Thorp KK, Glaudemans AWJM, Cobben DCP, Been LB, et al.
Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET
study. Nuclear Medicine Communications 2011;32(1):17-22.
Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, et al. Digoxin Use and
Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart
Failure. American Journal of Medicine 2014;127(1):61-70.
Ahmed S, Ranchor AV, Crijns HJGM, Van Veldhuisen DJ, Van Gelder IC. Effect of
continuous versus episodic amiodarone treatment on quality of life in persistent atrial
fibrillation. Europace 2010;12(6):785-91.
Ahmed S, Van Gelder IC, Wiesfeld ACP, Van Veldhuisen DJ, Links TP. Determinants
and outcome of amiodarone-associated thyroid dysfunction. Clinical Endocrinology
2011;75(3):388-94.
Al-Ansari S, Zeebregts CJ, Slart RHJA, Peppelenbosch M, Tio RA. Galectins in
Atherosclerotic Disease. Trends in Cardiovascular Medicine 2009;19(5):164-9.
Albarwani S, Munoz ML, Voruganti VS, Jaju D, Al-Yahyaee VS, Rizvi SG, et al.
Heritability of Ambulatory and Beat-to-Beat Office Blood Pressure in Large
Multigenerational Arab Pedigrees: The 'Oman Family Study'. Twin Research and Human
Genetics 2012;15(6):753-8.
Alings M, Smit MD, Moes ML, Crijns HJGM, Tijssen JGP, Brugemann J, et al. Routine
versus aggressive upstream rhythm control for prevention of early atrial fibrillation in
heart failure: background, aims and design of the RACE 3 study. Netherlands Heart
Journal 2013;21(7-8):354-63.
Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PMJG, Slooff MJ, et al.
Immediate Postoperative Low Platelet Count is Associated With Delayed Liver Function
Recovery After Partial Liver Resection. Annals of Surgery 2010;251(2):300-6.
Alssema M, El-Harchaoui K, Schindhelm RK, Diamant M, Nijpels G, Kostense PJ, et al.
Fasting cholesteryl ester transfer protein concentration is independently associated with
the postprandial decrease in high-density lipoprotein cholesterol concentration after
fat-rich meals: the Hoorn prandial study. Metabolism-Clinical and Experimental
2010;59(6):854-60.
Alssema M, Newson RS, Bakker SJL, Stehouwer CDA, Heymans MW, Nijpels G, et al.
One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic
Kidney Disease. Diabetes Care 2012;35(4):741-8.
Altena R, Perik PJ, Van Veldhuisen DJ, de Vries EGE, Gietema JA. Cardiovascular
toxicity caused by cancer treatment: strategies for early detection. Lancet Oncology
2009;10(4):391-9.
Altena R, de Haas EC, Nuver J, Brouwer CAJ, van den Berg MP, Smit AJ, et al.
Evaluation of sub-acute changes in cardiac function after cisplatin-based combination
chemotherapy for testicular cancer. British Journal of Cancer 2009;100(12):1861-6.
Page 3 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Altena R, Hummel YM, Nuver J, Smit AJ, Lefrandt JD, de Boer RA, et al. Longitudinal
changes in cardiac function after cisplatin-based chemotherapy for testicular cancer.
Annals of Oncology 2011;22(10):2286-93.
Altena R, Gietema JA, Van Veldhuisen DJ, Reyners AKL. Pregnancy unbosoms the
heart of breast cancer survivors. Annals of Oncology 2012;23(8):2206-8.
Ambrosio G, Flather MD, Bohm M, Cohen-Solal A, Murrone A, Mascagni F, et al.
beta-blockade with nebivolol for prevention of acute ischaemic events in elderly patients
with heart failure. Heart 2011;97(3):209-14.
Ambrosio G, Flather MD, Bohm M, Cohen-Solal A, Murrone A, Mascagni F, et al.
beta-blockade with nebivolol for prevention of acute ischaemic events in elderly patients
with heart failure. Cardiovascular Therapy and Prevention 2011;10(4):69-76.
Ambrosy AP, Butler J, Ahmed A, Vaduganathan M, Van Veldhuisen DJ, Colucci WS, et
al. The Use of Digoxin in Patients With Worsening Chronic Heart Failure Reconsidering
an Old Drug to Reduce Hospital Admissions. Journal of the American College of
Cardiology 2014;63(18):1823-32.
Amin N, Byrne E, Johnson J, Chenevix-Trench G, Walter S, Nolte IM, et al.
Genome-wide association analysis of coffee drinking suggests association with
CYP1A1/CYP1A2 and NRCAM. Molecular Psychiatry 2012;17(11):1116-29.
Anker SD, Voors AA, Okonko D, Clark AL, James MK, von Haehling S, et al.
Prevalence, incidence, and prognostic value of anaemia in patients after an acute
myocardial infarction: data from the OPTIMAAL trial. European Heart Journal
2009;30(11):1331-9.
Annema C, Luttik ML, Jaarsma T. Do Patients With Heart Failure Need a Case
Manager? Journal of Cardiovascular Nursing 2009;24(2):127-31.
Annema C, Luttik ML, Jaarsma T. Reasons for readmission in heart failure: Perspectives
of patients, caregivers, cardiologists, and heart failure nurses. Heart & Lung
2009;38(5):427-34.
Arking DE, Pulit SL, Crotti L, van der Harst P, Munroe PB, Koopmann TT, et al. Genetic
association study of QT interval highlights role for calcium signaling pathways in
myocardial repolarization. Nature Genetics 2014;46(8):826-36.
Assa S, Dasselaar JJ, Slart RHJA, de Jong PE, Voors AA, Tio RA, et al. Comparison of
Cardiac Positron Emission Tomography Perfusion Defects During Stress Induced by
Hemodialysis Versus Adenosine. American Journal of Kidney Diseases
2012;59(6):862-4.
Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, de Jong PE, et al.
Hemodialysis-Induced Regional Left Ventricular Systolic Dysfunction: Prevalence,
Patient and Dialysis Treatment-Related Factors, and Prognostic Significance. Clinical
Journal of the American Society of Nephrology 2012;7(10):1615-23.
Page 4 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Assa S, Hummel YM, Voors AA, Kuipers J, Groen H, de Jong PE, et al. Changes in Left
Ventricular Diastolic Function During Hemodialysis Sessions. American Journal of
Kidney Diseases 2013;62(3):549-56.
Assa S, Gansevoort RT, Westerhuis R, Kobold ACM, Voors AA, de Jong PE, et al.
Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I
measured by sensitive assay in hemodialysis patients. Clinical Research in Cardiology
2013;102(6):439-45.
Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, Groen H, et al.
Hemodialysis-Induced Regional Left Ventricular Systolic Dysfunction and Inflammation:
A Cross-sectional Study. American Journal of Kidney Diseases 2014;64(2):265-73.
Asselbergs FW, Guo YR, van Iperen EPA, Sivapalaratnam S, Tragante V, Lanktree MB,
et al. Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid
Loci. American Journal of Human Genetics 2012;91(5):823-38.
Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et
al. Lower estimated glomerular filtration rate and higher albuminuria are associated with
mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease
population cohorts. Kidney International 2011;79(12):1331-40.
Baardman ME, Kerstjens-Frederikse WS, Corpeleijn E, de Walle HEK, Hofstra RMW,
Berger RMF, et al. Combined adverse effects of maternal smoking and high body mass
index on heart development in offspring: evidence for interaction? Heart
2012;98(6):474-9.
Baardman ME, Erwich JJHM, Berger RMF, Hofstra RMW, Kerstjens-Frederikse WS,
Lutjohann D, et al. The origin of fetal sterols in second-trimester amniotic fluid:
endogenous synthesis or maternal-fetal transport? American Journal of Obstetrics and
Gynecology 2012;207(3).
Baardman ME, Kerstjens-Frederikse WS, Berger RMF, Bakker MK, Hofstra RMW,
Plosch T. The Role of Maternal-Fetal Cholesterol Transport in Early Fetal Life: Current
Insights. Biology of Reproduction 2013;88(1).
Baardman ME, Sarvaas GJD, de Walle HEK, Fleurke-Rozema H, Snijders R, Ebels T, et
al. Impact of introduction of 20-week ultrasound scan on prevalence and fetal and
neonatal outcomes in cases of selected severe congenital heart defects in The
Netherlands. Ultrasound in Obstetrics & Gynecology 2014;44(1):58-63.
Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular Epigenetics Basic Concepts and
Results From Animal and Human Studies. Circulation-Cardiovascular Genetics
2010;3(6):567-73.
Backlund M, Paukku K, Daviet L, de Boer RA, Valo E, Hautaniemi S, et al.
Posttranscriptional regulation of angiotensin II type 1 receptor expression by
glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Research
2009;37(7):2346-58.
Page 5 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Badar AA, Perez-Moreno AC, Jhund PS, Wong CM, Hawkins NM, Cleland JGF, et al.
Relationship between angina pectoris and outcomes in patients with heart failure and
reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial
in Heart Failure (CORONA). European Heart Journal 2014;35(48):3426-33.
Bakker SJL, Gansevoort RT, de Zeeuw D. Albuminuria: What can we expect from the
determination of nonimmunoreactive albumin? Current Hypertension Reports
2009;11(2):111-7.
Balci A, Sollie KM, Mulder BJM, de Laat MWM, Roos-Hesselink JW, van Dijk APJ, et al.
Associations between cardiovascular parameters and uteroplacental Doppler (blood)
flow patterns during pregnancy in women with congenital heart disease: Rationale and
design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. American
Heart Journal 2011;161(2):269-U449.
Balci A, Drenthen W, Mulder BJM, Roos-Hesselink JW, Voors AA, Vliegen HW, et al.
Pregnancy in women with corrected tetralogy of Fallot: Occurrence and predictors of
adverse events. American Heart Journal 2011;161(2):307-13.
Balci A, Sollie-Szarynska KM, van der Bijl AGL, Ruys TPE, Mulder BJM, Roos-Hesselink
JW, et al. Prospective validation and assessment of cardiovascular and offspring risk
models for pregnant women with congenital heart disease. Heart 2014;100(17):1373-81.
Balder JW, Staels B, Kuivenhoven JA. Pharmacological interventions in human HDL
metabolism. Current Opinion in Lipidology 2013;24(6):500-9.
Barbareschi G, Sanderman R, Leegte IL, Van Veldhuisen DJ, Jaarsma T. Educational
Level and the Quality of Life of Heart Failure Patients: A Longitudinal Study. Journal of
Cardiac Failure 2011;17(1):47-53.
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An Entirely
Subcutaneous Implantable Cardioverter-Defibrillator. New England Journal of Medicine
2010;363(1):36-44.
Bartelds B, Borgdorff MA, Oosten A, Takens J, Boersma B, Nederhoff MG, et al.
Differential responses of the right ventricle to abnormal loading conditions in mice:
pressure vs. volume load. European Journal of Heart Failure 2011;13(12):1275-82.
Bartelds B, van Loon RLE, Mohaupt S, Wijnberg H, Dickinson MG, Boersma B, et al.
Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary
Hypertension. Chest 2012;141(3):651-60.
Bartels AL, Zeebregts CJ, Bijl M, Tio RA, Slart RHJA. Fused FDG-PET and MRI imaging
of Takayasu arteritis in vertebral arteries. Annals of Nuclear Medicine 2009;23(8):753-6.
Bartuzi P, Wijshake T, Dekker DC, Fedoseienko A, Kloosterhuis NJ, Youssef SA, et al. A
cell-type-specific role for murine Commd1 in liver inflammation. Biochimica et Biophysica
Acta-Molecular Basis of Disease 2014;1842(11):2257-65.
Batty JA, Hall AS, White HL, Wikstrand J, de Boer RA, Van Veldhuisen DJ, et al. An
Investigation of CYP2D6 Genotype and Response to Metoprolol CR/XL During Dose
Page 6 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Titration in Patients With Heart Failure: A MERIT-HF Substudy. Clinical Pharmacology &
Therapeutics 2014;95(3):321-30.
Beghetti M, Haworth SG, Bonnet D, Barst RJ, Acar P, Fraisse A, et al. Pharmacokinetic
and clinical profile of a novel formulation of bosentan in children with pulmonary arterial
hypertension: the FUTURE-1 study. British Journal of Clinical Pharmacology
2009;68(6):948-55.
Beghetti M, Berger RMF, Schulze-Neick I, Day RW, Pulido T, Feinstein J, et al.
Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice.
European Respiratory Journal 2013;42(3):689-700.
Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, et al.
Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein
Lipase. Arteriosclerosis Thrombosis and Vascular Biology 2009;29(6):956-U447.
Belonje AMS, Westenbrink BD, Voors AA, von Haehling S, Ponikowski P, Anker SD, et
al. Erythropoietin levels in heart failure after an acute myocardial infarction:
Determinants, prognostic value, and the effects of captopril versus losartan. American
Heart Journal 2009;157(1):91-6.
Belonje AMS, Voors AA, van der Meer P, Jaarsma T, Van Veldhuisen DJ, van Gilst WH.
Response to Letter Regarding Article, "Endogenous Erythropoietin and Outcome in
Heart Failure". Circulation 2010;122(10):E450.
Belonje AMS, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, Van Veldhuisen DJ.
Endogenous Erythropoietin and Outcome in Heart Failure. Circulation
2010;121(2):245-51.
Bentley JP, Asselbergs FW, Coffey CS, Hebert PR, Moore JH, Hillege HL, et al.
Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from
the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems. Plos One 2010;5(9).
Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, et al. Novel
loci affecting iron homeostasis and their effects in individuals at risk for
hemochromatosis. Nature Communications 2014;5.
Berger RMF, Beghetti M, Galie N, Gatzoulis MA, Granton J, Lauer A, et al. Atrial septal
defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of
pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup
analysis. International Journal of Cardiology 2010;144(3):373-8.
Berger RMF, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing ZC, et al. Clinical features
of paediatric pulmonary hypertension: a registry study. Lancet 2012;379(9815):537-46.
Berger RMF. Pulmonary hypertension: smaller kids, smaller steps. Lancet Respiratory
Medicine 2014;2(5):348-50.
Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa MF, et al. Genome-wide
meta-analysis identifies 11 new loci for anthropometric traits and provides insights into
genetic architecture. Nature Genetics 2013;45(5):501-U69.
Page 7 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Beyan H, Riese H, Hawa MI, Beretta G, Davidson HW, Hutton JC, et al. Glycotoxin and
Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
A Twin and Population Study. Diabetes 2012;61(5):1192-8.
Beyer AR, Fasolo B, Phillips LD, de Graeff PA, Hillege HL. Risk Perception of
Prescription Drugs: Results of a Survey Among Experts in the European Regulatory
Network. Medical Decision Making 2013;33(4):579-92.
Bhuiyan ZA, Jongbloed JDH, van der Smagt J, Lombardi PM, Wiesfeld ACP, Nelen M,
et al. Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right
Ventricular Dysplasia/Cardiomypathy Patients Results From a Multicenter Study.
Circulation-Cardiovascular Genetics 2009;2(5):418-U22.
Biere-Rafi S, Zwiers M, Peters M, van der Meer J, Rosendaal FR, Buller HR, et al. The
effect of haemophilia and von Willebrand disease on arterial thrombosis: a systematic
review. Netherlands Journal of Medicine 2010;68(5):207-14.
Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A, et al. Statin
treatment and the risk of recurrent pulmonary embolism. European Heart Journal
2013;34(24):1800-6.
Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, linga-Thie GM, Motazacker MM, et
al. High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a
study in individuals with low plasma HDL-C. Journal of Lipid Research
2013;54(6):1698-704.
Bochem AE, Kuivenhoven A, Stroes ESG. The Promise of Cholesteryl Ester Transfer
Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease. Current
Pharmaceutical Design 2013;19(17):3143-9.
Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, Dallinga GM, Motazacker MM, et
al. Adrenal Function in Females with Low Plasma HDL-C Due to Mutations in ABCA1
and LCAT. Plos One 2014;9(5).
Boerman LM, Berendsen AJ, van der Meer P, Maduro JH, Berger MY, de Bock GH.
Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy
for breast cancer in an unselected population. Supportive Care in Cancer
2014;22(7):1949-58.
Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FFJ, de Jong-van
den Berg L, et al. Screen-and-Treat Strategies for Albuminuria to Prevent
Cardiovascular and Renal Disease: Cost-Effectiveness of Nationwide and Targeted
Interventions Based on Analysis of Cohort Data From the Netherlands. Clinical
Therapeutics 2010;32(6):1103-21.
Boersma C, Voors AA, Visser ST, de Jong-van den Berg L, Postma MJ. Cost
Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with
Hypertension in the Netherlands A Comparative Analysis Using Clinical Trial and Drug
Utilization Data. American Journal of Cardiovascular Drugs 2010;10(1):49-54.
Page 8 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, et al.
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline
in subjects with autosomal dominant polycystic kidney disease. Nephrology Dialysis
Transplantation 2012;27(11):4131-7.
Boertien WE, Meijer E, Gansevoort RT. Urinary biomarkers in autosomal dominant
polycystic kidney disease: is there no prognostic value? Kidney International
2012;82(3):361.
Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, et al. Relationship of
Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney
Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results
From the CRISP Cohort. American Journal of Kidney Diseases 2013;61(3):420-9.
Boertien WE, Meijer E, de Jong PE, Bakker SJL, Czerwiec FS, Struck J, et al.
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant
polycystic kidney disease at various stages of chronic kidney disease. Kidney
International 2013;84(6):1278-86.
Boertien WE, Riphagen IJ, Drion I, Alkhalaf A, Bakker SJL, Groenier KH, et al. Copeptin,
a surrogate marker for arginine vasopressin, is associated with declining glomerular
filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia 2013;56(8):1680-8.
Bogale N, Priori S, Cleland JGF, Brugada J, Linde C, Auricchio A, et al. The European
CRT Survey: 1 year (9-15 months) follow-up results. European Journal of Heart Failure
2012;14(1):61-73.
Boger CA, Chen MH, Tin A, Olden M, Koettgen A, de Boer IH, et al. CUBN Is a Gene
Locus for Albuminuria. Journal of the American Society of Nephrology
2011;22(3):555-70.
Bohm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, et al.
Biomarkers: optimizing treatment guidance in heart failure. Clinical Research in
Cardiology 2011;100(11):973-81.
Bolling MC, Pas HH, de Visser M, Aronica E, Pfendner EG, van den Berg MP, et al.
PLEC1 Mutations Underlie Adult-Onset Dilated Cardiomyopathy in Epidermolysis
Bullosa Simplex with Muscular Dystrophy. Journal of Investigative Dermatology
2010;130(4):1178-81.
Bolling MC, Jongbloed JDH, Boven LG, Diercks GFH, Smith FJD, Mclean WHI, et al.
Plectin Mutations Underlie Epidermolysis Bullosa Simplex in 8% of Patients. Journal of
Investigative Dermatology 2014;134(1):273-6.
Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, et al. Genome Wide
Association Identifies Common Variants at the SERPINA6/SERPINA1 Locus Influencing
Plasma Cortisol and Corticosteroid Binding Globulin. Plos Genetics 2014;10(7).
Boraska V, Jeroncic A, Colonna V, Southam L, Nyholt DR, Rayner NW, et al.
Genome-wide meta-analysis of common variant differences between men and women.
Human Molecular Genetics 2012;21(21):4805-15.
Page 9 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Borgdorff MA, Bartelds B, Dickinson MG, Steendijk P, Berger RMF. A cornerstone of
heart failure treatment is not effective in experimental right ventricular failure.
International Journal of Cardiology 2013;169(3):183-9.
Borgdorff MA, Bartelds B, Dickinson MG, van Wiechen MPH, Steendijk P, de Vroomen
M, et al. Sildenafil treatment in established right ventricular dysfunction improves
diastolic function and attenuates interstitial fibrosis independent from afterload. American
Journal of Physiology-Heart and Circulatory Physiology 2014;307(3):H361-H369.
Borgdorff MAJ, Bartelds B, Dickinson MG, Boersma B, Weij M, Zandvoort A, et al.
Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the
pressure-loaded right ventricle. European Journal of Heart Failure 2012;14(9):1067-74.
Borgdorff MAJ, Bartelds B, Dickinson MG, Steendijk P, de Vroomen M, Berger RMF.
Distinct loading conditions reveal various patterns of right ventricular adaptation.
American Journal of Physiology-Heart and Circulatory Physiology
2013;305(3):H354-H364.
Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, et al. Poor
replication of candidate genes for major depressive disorder using genome-wide
association data. Molecular Psychiatry 2011;16(5):516-32.
Bosker FJ, Wu T, Gladkevich A, Ge D, Treiber FA, Snieder H. Urinary norepinephrine
and epinephrine excretion rates are heritable, but not associated with office and
ambulatory blood pressure. Hypertension Research 2012;35(12):1164-70.
Bosma OH, Vermeulen KM, Verschuuren EA, Erasmus ME, van der Bij W. Adherence to
immunosuppression in adult lung transplant recipients: Prevalence and risk factors.
Journal of Heart and Lung Transplantation 2011;30(11):1275-80.
Bouma W, van der Horst ICC, Wijdh-den Hamer IJ, Erasmus ME, Zijlstra F, Mariani MA,
et al. Chronic ischaemic mitral regurgitation. Current treatment results and new
mechanism-based surgical approaches. European Journal of Cardio-Thoracic Surgery
2010;37(1):170-85.
Bouma W, Klinkenberg TJ, van der Horst ICC, Wijdh-den Hamer IJ, Erasmus ME, Bijl M,
et al. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis:
a report of four cases and a systematic review of the literature. Journal of Cardiothoracic
Surgery 2010;5.
Bouma W, Lexis CPH, Willems TP, Suurmeijer AJH, van der Horst ICC, Ebels T, et al.
Successful surgical excision of primary right atrial angiosarcoma. Journal of
Cardiothoracic Surgery 2011;6.
Bouma W, Brugemann J, Wijdh-den Hamer IJ, Klinkenberg TJ, Koene BM, Kuijpers M,
et al. Mitral valve repair and redo repair for mitral regurgitation in a heart transplant
recipient. Journal of Cardiothoracic Surgery 2012;7.
Bouma W, Wijdh-den Hamer IJ, Klinkenberg TJ, Kuijpers M, Bijleveld A, van der Horst
ICC, et al. Mitral valve repair for post-myocardial infarction papillary muscle rupture.
European Journal of Cardio-Thoracic Surgery 2013;44(6):1063-9.
Page 10 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Bouma W, Hamer IJWD, Koene BM, Kuijpers M, Natour E, Erasmus ME, et al.
Predictors of in-hospital mortality after mitral valve surgery for post-myocardial infarction
papillary muscle rupture. Journal of Cardiothoracic Surgery 2014;9.
Bourge RC, Fleg JL, Fonarow GC, Cleland JGF, McMurray JJV, Van Veldhuisen DJ, et
al. Digoxin Reduces 30-day All-cause Hospital Admission in Older Patients with Chronic
Systolic Heart Failure. American Journal of Medicine 2013;126(8):701-8.
Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal
Relationship Between Subclinical Atrial Fibrillation and Embolic Events. Circulation
2014;129(21):2094-9.
Breithardt G, Ravens U, Kirchhof P, Van Gelder IC. Atrial fibrillation and bleeding
complication - risk factors and risk marker. Nervenheilkunde 2012;31(11):791-5.
Broers CJM, Sinclair N, van der Ploeg TJ, Jaarsma T, Van Veldhuisen DJ, Umans
VAWM. The post-infarction nurse practitioner project A prospective study comparing
nurse intervention with conventional care in a non-high-risk myocardial infarction
population. Netherlands Heart Journal 2009;17(2):61-7.
Brouwer CAJ, Postma A, Vonk JM, Zwart N, van den Berg MP, Bink-Boelkens MTE, et
al. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.
European Journal of Cancer 2011;47(16):2453-62.
Brouwer CAJ, Postma A, Hooimeijer HLH, Smit AJ, Vonk JM, van Roon AM, et al.
Endothelial Damage in Long-Term Survivors of Childhood Cancer. Journal of Clinical
Oncology 2013;31(31):3906-+.
Brouwers FP, Asselbergs FW, Hillege HL, de Boer RA, Gansevoort RT, Van Veldhuisen
DJ, et al. Long-term effects of fosinopril and pravastatin on cardiovascular events in
subjects with microalbuminuria: Ten years of follow-up of Prevention of Renal and
Vascular End-stage Disease Intervention Trial (PREVEND IT). American Heart Journal
2011;161(6):1171-8.
Brouwers FP, de Boer RA, van der Harst P, Struck J, de Jong PE, de Zeeuw D, et al.
Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the
general population. Heart 2012;98(18):1348-53.
Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, et al.
Incidence and epidemiology of new onset heart failure with preserved vs. reduced
ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
European Heart Journal 2013;34(19):1424-31.
Brouwers FP, van Gilst WH, Damman K, van den Berg MP, Gansevoort RT, Bakker
SJL, et al. Clinical Risk Stratification Optimizes Value of Biomarkers to Predict
New-Onset Heart Failure in a Community-Based Cohort. Circulation-Heart Failure
2014;7(5):723-U73.
Brugemann J, Kampinga GA, Riezebos-Brilman A, Stek CJ, Edel JP, van der Bij W, et
al. Two donor-related infections in a heart transplant recipient: One common, the other a
tropical surprise. Journal of Heart and Lung Transplantation 2010;29(12):1433-7.
Page 11 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Bruggink JLM, Meerwaldt R, van Dam GM, Lefrandt JD, Slart RHJA, Tio RA, et al.
Spectroscopy to improve identification of vulnerable plaques in cardiovascular disease.
International Journal of Cardiovascular Imaging 2010;26(1):111-9.
Bruggink JLM, Slart RHJA, Pol JA, Reijnen MMPJ, Zeebregts CJ. Current Role of
Imaging in Diagnosing Aortic Graft Infections. Seminars in Vascular Surgery
2011;24(4):182-90.
Buck S, Maass AH, Van Veldhuisen DJ, Van Gelder IC. Cardiac resynchronisation
therapy and the role of optimal device utilisation. Netherlands Heart Journal
2009;17(9):354-7.
Buijs RVC, Willems TP, Tio RA, Boersma HH, Tielliu IFJ, Slart RHJA, et al. Current state
of experimental imaging modalities for risk assessment of abdominal aortic aneurysm.
Journal of Vascular Surgery 2013;57(3):851-9.
Buijs RVC, Willems TP, Tio RA, Boersma HH, Tielliu IFJ, Slart RHJA, et al. Calcification
as a Risk Factor for Rupture of Abdominal Aortic Aneurysm. European Journal of
Vascular and Endovascular Surgery 2013;46(5):542-8.
Buikema JW, van der Meer P, Sluijter JPG, Domian IJ. Concise Review: Engineering
Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue Engineering
Technology. Stem Cells 2013;31(12):2587-98.
Buller HR, Prins MH, Lensing AWA, Decousus H, Jacobson BF, Minar E, et al. Oral
Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. New England
Journal of Medicine 2012;366(14):1287-97.
Burzotta F, De Vita M, Gu YLL, Isshiki T, Lefevre T, Kaltoft A, et al. Clinical impact of
thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data
pooled analysis of 11 trials. European Heart Journal 2009;30(18):2193-203.
Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, de Boer RA, et al.
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis. Arteriosclerosis Thrombosis
and Vascular Biology 2013;33(1):67-+.
Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for
the management of atrial fibrillation The Task Force for the Management of Atrial
Fibrillation of the European Society of Cardiology (ESC). European Heart Journal
2010;31(19):2369-429.
Camm AJ, Capucci A, Hohnloser SH, Torp-Pedersen C, Van Gelder IC, Mangal B, et al.
A Randomized Active-Controlled Study Comparing the Efficacy and Safety of
Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation. Journal of the American
College of Cardiology 2011;57(3):313-21.
Candini C, Schimmel AW, Peter J, Bochem AE, Holleboom AG, Vergeer M, et al.
Identification and characterization of novel loss of function mutations in ATP-binding
cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
Atherosclerosis 2010;213(2):492-8.
Page 12 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Cao Q, Postmus D, Hillege HL, Buskens E. Probability Elicitation to Inform Early Health
Economic Evaluations of New Medical Technologies: A Case Study in Heart Failure
Disease Management. Value in Health 2013;16(4):529-35.
Caplin B, Wang Z, Slaviero A, Tomlinson J, Dowsett L, Delahaye M, et al.
Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines,
Regulates NO, and Controls Blood Pressure. Arteriosclerosis Thrombosis and Vascular
Biology 2012;32(12):2892-+.
Carballo S, Robinson P, Otway R, Fatkin D, Jongbloed JDH, de Jonge N, et al.
Identification and Functional Characterization of Cardiac Troponin I As a Novel Disease
Gene in Autosomal Dominant Dilated Cardiomyopathy. Circulation Research
2009;105(4):375-U116.
Carter CE, Gansevoort RT, Scheven L, Lambers Heerspink HJ, Shlipak MG, de Jong
PE, et al. Influence of Urine Creatinine on the Relationship between the
Albumin-to-Creatinine Ratio and Cardiovascular Events. Clinical Journal of the American
Society of Nephrology 2012;7(4):595-603.
Casteleijn NF, de Jager RL, Neeleman MP, Blankestijn PJ, Gansevoort RT. Chronic
Kidney Pain in Autosomal Dominant Polycystic Kidney Disease: A Case Report of
Successful Treatment by Catheter-Based Renal Denervation. American Journal of
Kidney Diseases 2014;63(6):1019-21.
Casteleijn NF, Blankestijn PJ, Gansevoort RT. In Reply to 'Catheter-Based Renal
Denervation in ADPKD: Just for Pain Control?'. American Journal of Kidney Diseases
2014;64(6):999-1000.
Casteleijn NF, Visser FW, Drenth JPH, Gevers TJG, Groen GJ, Hogan MC, et al. A
stepwise approach for effective management of chronic pain in autosomal-dominant
polycystic kidney disease. Nephrology Dialysis Transplantation 2014;29:142-53.
Chambers JC, Zhang WH, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, et al.
Genetic loci influencing kidney function and chronic kidney disease. Nature Genetics
2010;42(5):373-5.
Chambers JC, Zhang WH, Sehmi J, Li XZ, Wass MN, van der Harst P, et al.
Genome-wide association study identifies loci influencing concentrations of liver
enzymes in plasma. Nature Genetics 2011;43(11):1131-U129.
Cheng JM, Akkerhuis KM, Battes LC, van Vark LC, Hillege HL, Paulus WJ, et al.
Biomarkers of heart failure with normal ejection fraction: a systematic review. European
Journal of Heart Failure 2013;15(12):1350-62.
Christiaans I, Nannenberg EA, Dooijes D, Jongbloed RJE, Michels M, Postema PG, et
al. Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands.
Netherlands Heart Journal 2010;18(5):248-54.
Christiaans I, Birnie E, van Langen IM, van Spaendonck-Zwarts KY, van Tintelen JP,
van den Berg MP, et al. The yield of risk stratification for sudden cardiac death in
Page 13 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on
predictive screening. European Heart Journal 2010;31(7):842-8.
Christiaans I, Birnie E, Bonsel GJ, Mannens MMAM, Michels M, Majoor-Krakauer D, et
al. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large
nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers:
determining the best cardiological screening strategy. European Heart Journal
2011;32(9):1161-70.
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al.
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study.
Circulation 2014;129(8):837-47.
Cleland JG, Chiswell K, Teerlink JR, Stevens S, Fiuzat M, Givertz MM, et al. Predictors
of Postdischarge Outcomes From Information Acquired Shortly After Admission for
Acute Heart Failure A Report From the Placebo-Controlled Randomized Study of the
Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With
Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect
on Congestion and Renal Function (PROTECT) Study. Circulation-Heart Failure
2014;7(1):76-87.
Cleland JGF, McMurray JJV, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, et al.
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart
Failure: Prediction of Cardiovascular Events and Interaction With the Effects of
Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in
Heart Failure). Journal of the American College of Cardiology 2009;54(20):1850-9.
Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, et al. Identification of
seven loci affecting mean telomere length and their association with disease. Nature
Genetics 2013;45(4):422-7.
Cohen-Solal A, Kotecha D, Van Veldhuisen DJ, Babalis D, Bohm M, Coats AJ, et al.
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal
function: insights from the SENIORS trial. European Journal of Heart Failure
2009;11(9):872-80.
Cohn DM, Hermanides J, DeVries JH, Kamphuisen PW, Kuhls S, Homering M, et al.
Stress-induced hyperglycaemia and venous thromboembolism following total hip or total
knee arthroplasty Analysis from the RECORD trials. Thrombosis and Haemostasis
2012;107(2):225-31.
Colin S, Fanchon M, Belloy L, Bochem AE, Copin C, Derudas B, et al. HDL does not
influence the polarization of human monocytes toward an alternative phenotype.
International Journal of Cardiology 2014;172(1):179-84.
Collier TJ, Pocock SJ, McMurray JJV, Zannad F, Krum H, Van Veldhuisen DJ, et al. The
impact of eplerenone at different levels of risk in patients with systolic heart failure and
mild symptoms: insight from a novel risk score for prognosis derived from the
EMPHASIS-HF trial. European Heart Journal 2013;34(36):2823-9.
Page 14 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Conraads VM, Spruit MA, Braunschweig F, Cowie MR, Tavazzi L, Borggrefe M, et al.
Physical Activity Measured With Implanted Devices Predicts Patient Outcome in Chronic
Heart Failure. Circulation-Heart Failure 2014;7(2):279-87.
Constantinides A, van Pelt LJ, van Leeuwen JJJ, de Vries R, Tio RA, van der Horst ICC,
et al. Carotid intima media thickness is associated with plasma lipoprotein-associated
phospholipase A(2) mass in nondiabetic subjects but not in patients with type 2 diabetes.
European Journal of Clinical Investigation 2011;41(8):820-7.
Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in
Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease
and Mortality. Jama-Journal of the American Medical Association 2014;311(24):2518-31.
Corsetti JP, Gansevoort RT, Sparks CE, Dullaart RPF. Inflammation reduces HDL
protection against primary cardiac risk. European Journal of Clinical Investigation
2010;40(6):483-9.
Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RPF. LPL polymorphism
(D9N) predicts cardiovascular disease risk directly and through interaction with CETP
polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis
2011;214(2):373-6.
Corsetti JP, Gansevoort RT, Bakker SJL, Navis G, Sparks CE, Dullaart RPF.
Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men
with concurrently high levels of high-density lipoprotein cholesterol and C-reactive
protein. Metabolism-Clinical and Experimental 2012;61(7):996-1002.
Corsetti JP, Gansevoort RT, Bakker SJL, Sparks CE, Vart P, Dullaart RPF.
Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in
Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants. Journal
of the American Society of Nephrology 2014;25(12):2906-15.
Costanzo MR, Heywood JT, Massie BM, Iwashita J, Henderson L, Mamatsashvili M, et
al. A double-blind, randomized, parallel, placebo-controlled study examining the effect of
cross-linked polyelectrolyte in heart failure patients with chronic kidney disease.
European Journal of Heart Failure 2012;14(8):922-30.
Cotter G, Voors AA, Weatherley BD, Pang PS, Teerlink JR, Filippatos G, et al. Acute
Heart Failure Clinical Drug Development: From Planning to Proof of Activity to Phase III.
Cardiology 2010;116(4):292-301.
Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JGF, et al. Worsening
heart failure, a critical event during hospital admission for acute heart failure: results
from the VERITAS study. European Journal of Heart Failure 2014;16(12):1362-71.
Covel CL, Albert CM, Andreotti F, Badimon L, Van Gelder IC, Hylek EM. Female sex as
an independent risk factor for stroke in atrial fibrillation: Possible mechanisms.
Thrombosis and Haemostasis 2014;111(3):385-91.
Page 15 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Cox MGPJ, van der Smagt JJ, Wilde AAM, Wiesfeld ACP, Atsma DE, Nelen MR, et al.
New ECG Criteria in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Circulation-Arrhythmia and Electrophysiology 2009;2(5):524-30.
Cox MGPJ, van der Smagt JJ, Noorman M, Wiesfeld AC, Volders PGA, van Langen IM,
et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task
Force Criteria Impact of New Task Force Criteria. Circulation-Arrhythmia and
Electrophysiology 2010;3(2):126-33.
Cox MGPJ, van der Zwaag PA, van der Werf C, van der Smagt JJ, Noorman M, Bhuiyan
ZA, et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Pathogenic
Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype
Follow-Up Study. Circulation 2011;123(23):2690-U87.
Coyne JC, Jaarsma T, Luttik ML, Van Sonderen E, Van Veldhuisen DJ, Sanderman R.
Lack of Prognostic Value of Type D Personality for Mortality in a Large Sample of Heart
Failure Patients. Psychosomatic Medicine 2011;73(7):557-62.
Crews DC, Boulware LE, Gansevoort RT, Jaar BG. Albuminuria: Is it Time to Screen the
General Population? Advances in Chronic Kidney Disease 2011;18(4):249-57.
Crul T, Toth N, Piotto S, Literati-Nagy P, Tory K, Haldimann P, et al. Hydroximic Acid
Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness.
Current Pharmaceutical Design 2013;19(3):309-46.
Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al.
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to
improve detection and clinical management. A position paper from the Consensus Panel
on Familial Hypercholesterolaemia of the European Atherosclerosis Society. European
Heart Journal 2014;35(32):2146-U100.
Cvejic A, Haer-Wigman L, Stephens JC, Kostadima M, Smethurst PA, Frontini M, et al.
SMIM1 underlies the Vel blood group and influences red blood cell traits. Nature
Genetics 2013;45(5):542-U115.
Damman J, Daha MR, Leuvenink HG, van Goor H, Hillebrands JL, van Dijk MC, et al.
Association of Complement C3 Gene Variants with Renal Transplant Outcome of
Deceased Cardiac Dead Donor Kidneys. American Journal of Transplantation
2012;12(3):660-8.
Damman J, Kok JL, Snieder H, Leuvenink HG, van Goor H, Hillebrands JL, et al. Lectin
complement pathway gene profile of the donor and recipient does not influence graft
outcome after kidney transplantation. Molecular Immunology 2012;50(1-2):1-8.
Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, Van Veldhuisen DJ. Both inand out-hospital worsening of renal function predict outcome in patients with heart
failure: results from the Coordinating Study Evaluating Outcome of Advising and
Counseling in Heart Failure (COACH). European Journal of Heart Failure
2009;11(9):847-54.
Page 16 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Damman K, Hillege HL, Van Veldhuisen DJ. Albuminuria in heart failure: a CHARMing
new risk factor? Lancet 2009;374(9689):506-8.
Damman K, Van Veldhuisen DJ, Hillege HL. Cardiac Resynchronization Therapy
Improves Renal Function: Importance of Forward and Backward Failure. Journal of
Cardiac Failure 2009;15(1):78-9.
Damman K, van Deursen VM, Navis G, Voors AA, Van Veldhuisen DJ, Hillege HL.
Increased Central Venous Pressure Is Associated With Impaired Renal Function and
Mortality in a Broad Spectrum of Patients With Cardiovascular Disease. Journal of the
American College of Cardiology 2009;53(7):582-8.
Damman K, Voors AA, Hillege HL, Navis G, Lechat P, Van Veldhuisen DJ, et al.
Congestion in chronic systolic heart failure is related to renal dysfunction and increased
mortality. European Journal of Heart Failure 2010;12(9):974-82.
Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TDJ, Westenbrink BD, et
al. Tubular damage in chronic systolic heart failure is associated with reduced survival
independent of glomerular filtration rate. Heart 2010;96(16):1297-302.
Damman K, Chuen MJNK, MacFadyen RJ, Lip GYH, Gaze D, Collinson PO, et al.
Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early
Abnormalities in Renal and Tubular Function. Journal of the American College of
Cardiology 2011;57(22):2233-41.
Damman K, Maass AH, van der Meer P. Heart failure highlights in 2010. European
Journal of Heart Failure 2011;13(4):358-63.
Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, et al. Clinical
outcome of renal tubular damage in chronic heart failure. European Heart Journal
2011;32(21):2705-12.
Damman K, Voors AA, Navis G, Van Veldhuisen DJ, Hillege HL. The Cardiorenal
Syndrome in Heart Failure. Progress in Cardiovascular Diseases 2011;54(2):144-53.
Damman K, Voors AA, Navis G, Van Veldhuisen DJ, Hillege HL. Current and novel renal
biomarkers in heart failure. Heart Failure Reviews 2012;17(2):241-50.
Damman K, van der Harst P, Smilde TDJ, Voors AA, Navis G, Van Veldhuisen DJ, et al.
Use of cystatin C levels in estimating renal function and prognosis in patients with
chronic systolic heart failure. Heart 2012;98(4):319-24.
Damman K, Valente MA, Voors AA, O'Connor CM, Van Veldhuisen DJ, Hillege HL.
Renal impairment, worsening renal function, and outcome in patients with heart failure:
an updated meta-analysis. European Heart Journal 2014;35(7):455-+.
Damman P, Kampinga MA, van der Horst ICC, Woudstra P, Grundeken MJ, Kuijt WJ, et
al. Multiple biomarkers for the prediction of short and long-term mortality after
ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration.
Journal of Thrombosis and Thrombolysis 2013;36(1):42-6.
Page 17 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Dasselaar JJ, Slart RHJA, Knip M, Pruim J, Tio RA, McIntyre CW, et al. Haemodialysis
is associated with a pronounced fall in myocardial perfusion. Nephrology Dialysis
Transplantation 2009;24(2):604-10.
Davenport A, Anker SD, Mebazaa A, Palazzuoli A, Vescovo G, Bellomo R, et al. ADQI 7:
the clinical management of the Cardio-Renal syndromes: work group statements from
the 7th ADQI consensus conference. Nephrology Dialysis Transplantation
2010;25(7):2077-89.
Davison BA, Cotter G, Sun HR, Chen L, Teerlink JR, Metra M, et al. Permutation criteria
to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from
Pre-RELAX-AHF. Clinical Research in Cardiology 2011;100(9):745-53.
de Azambuja E, Procter MJ, Van Veldhuisen DJ, gbor-Tarh D, Metzger-Filho O,
Steinseifer J, et al. Trastuzumab-Associated Cardiac Events at 8 Years of Median
Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01). Journal of Clinical Oncology
2014;32(20):2159-+.
de Boer MJ, Ottervanger JP, Suryapranata H, Hoorntje JCA, Dambrink JHE, Gosselink
ATM, et al. Old Age and Outcome After Primary Angioplasty for Acute Myocardial
Infarction. Journal of the American Geriatrics Society 2010;58(5):867-72.
de Boer RA, Voors AA, Muntendam P, van Gilst WH, Van Veldhuisen DJ. Galectin-3: a
novel mediator of heart failure development and progression. European Journal of Heart
Failure 2009;11(9):811-7.
de Boer RA, van der Harst P, Van Veldhuisen DJ, van den Berg MP. Pharmacogenetics
in heart failure: promises and challenges. Expert Opinion on Pharmacotherapy
2009;10(11):1713-25.
de Boer RA, Doehner W, van der Horst ICC, Anker SD, Babalis D, Roughton M, et al.
Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients >= 70 Years
Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of
Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure
[SENIORS]). American Journal of Cardiology 2010;106(1):78-86.
de Boer RA, Lok DJA, Jaarsma T, van der Meer P, Voors AA, Hillege HL, et al.
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved
ejection fraction. Annals of Medicine 2011;43(1):60-8.
de Boer RA, Verweij N, Van Veldhuisen DJ, Westra HJ, Bakker SJL, Gansevoort RT, et
al. A Genome-Wide Association Study of Circulating Galectin-3. Plos One 2012;7(10).
de Boer RA, Schroten NF, Bakker SJL, Mahmud H, Szymanski MK, van der Harst P, et
al. Plasma renin and outcome in the community: data from PREVEND. European Heart
Journal 2012;33(18):2351-9.
de Boer RA, Azizi M, Danser AHJ, Nguyen G, Nussberger J, Ruilope LM, et al. Dual
RAAS suppression: recent developments and implications in light of the ALTITUDE
study. Journal of the Renin-Angiotensin-Aldosterone System 2012;13(3):409-12.
Page 18 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
de Boer RA, Van Veldhuisen DJ, Gansevoort RT, Kobold ACM, van Gilst WH, Hillege
HL, et al. The fibrosis marker galectin-3 and outcome in the general population. Journal
of Internal Medicine 2012;272(1):55-64.
de Boer RA, Edelmann F, Cohen-Solal A, Mamas MA, Maisel A, Pieske B. Galectin-3 in
heart failure with preserved ejection fraction. European Journal of Heart Failure
2013;15(10):1095-101.
de Boer RA, van der Velde AR. Galectin-3: a new biomarker for heart failure progression
and prognosis. Laboratoriumsmedizin-Journal of Laboratory Medicine
2013;37(5):251-60.
de Boer RA, van der Velde AR, Mueller C, Van Veldhuisen DJ, Anker SD, Peacock WF,
et al. Galectin-3: A Modifiable Risk Factor in Heart Failure. Cardiovascular Drugs and
Therapy 2014;28(3):237-46.
de Boer RA. Clinical evaluation of heart failure patients: what good are biomarkers
bringing us? Netherlands Heart Journal 2014;22(3):113-4.
de Boer SPM, Westerhout CM, Simes RJ, Granger CB, Zijlstra F, Boersma E. Mortality
and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent
of the Patient's Age. Jacc-Cardiovascular Interventions 2010;3(3):324-31.
de Borst MH, de Boer RA, Stolk RP, Slaets JPJ, Wolffenbuttel BHR, Navis G. Vitamin D
Deficiency: Universal Risk Factor for Multifactorial Diseases? Current Drug Targets
2011;12(1):97-106.
de Borst MH, Nauta FL, Vogt L, Laverman GD, Gansevoort RT, Navis G. Indomethacin
Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in
Chronic Kidney Disease Patients: A Post-Hoc Analysis. Plos One 2012;7(5).
de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, et al. Patch:
platelet transfusion in cerebral haemorrhage: study protocol for a multicentre,
randomised, controlled trial. Bmc Neurology 2010;10.
de Groot MJ, Hoeksma M, van Rijn M, Slart RHJA, van Spronsen FJ. Relationships
between lumbar bone mineral density and biochemical parameters in phenylketonuria
patients. Molecular Genetics and Metabolism 2012;105(4):566-70.
de Groot NMS, Kirchhof CJ, Van Gelder IC, Meeder JG, Balk AHMM, Wilde AA, et al.
Dronedarone in patients with atrial fibrillation. Netherlands Heart Journal
2010;18(7-8):370-3.
de Haas HJ, van den Borne SW, Boersma HH, Slart RHJA, Fuster V, Narula J. Evolving
role of molecular imaging for new understanding: targeting myofibroblasts to predict
remodeling. OXFORD: BLACKWELL SCIENCE PUBL; 2012.
de Jager CM, Hoekstra M, Nijsten MWN, Lansink AO, Ismael F. Metabolic and
Neurologic Sequelae in a Patient with Long-Standing Anorexia Nervosa Who Presented
with Septic Shock and Deep Hypoglycemia. International Journal of Eating Disorders
2011;44(8):756-9.
Page 19 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, van Gilst WH, Van
Gelder IC. Mechanisms of atrial structural changes caused by stretch occurring before
and during early atrial fibrillation. Cardiovascular Research 2011;89(4):754-65.
De Jong AM, Van Gelder IC, Vreeswijk-Baudoin I, Cannon MV, van Gilst WH, Maass
AH. Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a
Mouse Model of Ventricular Pressure Overload. Plos One 2013;8(9).
De Jong AM, Maass AH, Oberdorf-Maass SU, de Boer RA, van Gilst WH, Van Gelder
IC. Cyclical stretch induces structural changes in atrial myocytes. Journal of Cellular and
Molecular Medicine 2013;17(6):743-53.
de Jong JS, van Ginkel RJ, Slart RHJA, Lemstra CL, Paans AMJ, Mulder NH, et al.
FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor
recurrences. Ejso 2010;36(11):1092-5.
de Jong JS, Beukema JC, van Dam GM, Slart R, Lemstra C, Wiggers T. Limited Value
of Staging Squamous Cell Carcinoma of the Anal Margin and Canal Using the Sentinel
Lymph Node Procedure: A Prospective Study with Long-Term Follow-Up. Annals of
Surgical Oncology 2010;17(10):2656-62.
de Jong PE, Gansevoort RT. Focus on Microalbuminuria to Improve Cardiac and Renal
Protection. Nephron Clinical Practice 2009;111(3):C204-C210.
de Jong PE, Gansevoort RT. Albuminuria in non-primary renal disease: risk marker
rather than risk factor. Nephrology Dialysis Transplantation 2010;25(3):656-8.
de Jong PE, Bakker SJL, Gansevoort RT. What to Measure-Albuminuria or Total
Proteinuria? American Journal of Kidney Diseases 2011;57(1):1-2.
de Jong PE, Gansevoort RT. Is Cystatin C the Answer to Detecting Progression in CKD?
Journal of the American Society of Nephrology 2011;22(1):9-11.
de Jong RM, Tio RA, van der Harst P, Voors AA, Koning PM, Zeebregts CJAM, et al.
Ischemic patterns assessed by positron emission tomography predict adverse outcome
in patients with idiopathic dilated cardiomyopathy. Journal of Nuclear Cardiology
2009;16(5):769-74.
de Jonge GJ, van der Vleuten PA, Overbosch J, Lubbers DD, Jansen-van der Weide M,
Zijlstra F, et al. Semi-automatic measurement of left ventricular function on dual source
computed tomography using five different software tools in comparison with magnetic
resonance imaging. European Journal of Radiology 2011;80(3):755-66.
de Klerk OL, Nolte IM, Bet PM, Bosker FJ, Snieder H, den Boer JA, et al. ABCB1 gene
variants influence tolerance to selective serotonin reuptake inhibitors in a large sample
of Dutch cases with major depressive disorder. Pharmacogenomics Journal
2013;13(4):349-53.
de Laat MWM, Pieper PG, Oudijk MA, Mulder BJM, Christoffels VM, Afink GB, et al. The
Clinical and Molecular Relations Between Idiopathic Preterm Labor and Maternal
Congenital Heart Defects. Reproductive Sciences 2013;20(2):190-201.
Page 20 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
de Leeuw K, Meertens JHJM, van der Horst ICC, van der Berg AP, Ligtenberg JJM,
Tulleken JE, et al. "Acute Liver Failure": the Heart May be the Matter. Acta Clinica
Belgica 2011;66(3):236-9.
de Leeuw K, Goorhuis JF, Tielliu IFJ, Symoens S, Malfait F, de Paepe A, et al. Superior
mesenteric artery aneurysm in a 9-year-old boy with classical Ehlers-Danlos syndrome.
American Journal of Medical Genetics Part A 2012;158A(3):626-9.
De Maat GE, Van Gelder IC, Rienstra M, Quast AFBE, Tan ES, Wiesfeld ACP, et al.
Surgical vs. transcatheter pulmonary vein isolation as first invasive treatment in patients
with atrial fibrillation: a matched group comparison. Europace 2014;16(1):33-9.
de Peuter OR, Lussana F, Peters RJG, Buller HR, Kamphuisen PW. A systematic
review of selective and non-selective beta blockers for prevention of vascular events in
patients with acute coronary syndrome or heart failure. Netherlands Journal of Medicine
2009;67(9):284-94.
de Peuter OR, Kok WEM, Torp-Pedersen C, Buller HR, Kamphuisen PW. Systolic Heart
Failure: A Prothrombotic State. Seminars in Thrombosis and Hemostasis
2009;35(5):497-504.
de Peuter OR, Verberne HJ, Kok WE, van den Bogaard B, Schaap MC, Nieuwland R, et
al. Differential Effects of Nonselective Versus Selective beta-Blockers on Cardiac
Sympathetic Activity and Hemostasis in Patients with Heart Failure. Journal of Nuclear
Medicine 2013;54(10):1733-9.
De Smedt RH, Jaarsma T, Ranchor AV, van der Meer K, Groenier KH, Haaijer-Ruskamp
FM, et al. Coping with adverse drug events in patients with heart failure: Exploring the
role of medication beliefs and perceptions. Psychology & Health 2012;27(5):570-87.
De Smedt RHE, Denig P, Haaijer-Ruskamp FM, Jaarsma T. Perceived medication
adverse effects and coping strategies reported by chronic heart failure patients.
International Journal of Clinical Practice 2009;63(2):233-42.
De Smedt RHE, Jaarsma T, Haaijer-Ruskamp FM, Denig P. The Impact of Perceived
Adverse Effects on Medication Changes in Heart Failure Patients. Journal of Cardiac
Failure 2010;16(2):135-41.
De Smedt RHE, Haaijer-Ruskamp FM, Groenier KH, van der Meer K, Jaarsma T.
Perceived Adverse Drug Events in Heart Failure Patients' Perception and Related
Factors. Journal of Cardiovascular Nursing 2011;26(3):250-60.
De Smedt RHE, Denig P, van der Meer K, Haaijer-Ruskamp FM, Jaarsma T.
Self-reported adverse drug events and the role of illness perception and medication
beliefs in ambulatory heart failure patients: A cross-sectional survey. International
Journal of Nursing Studies 2011;48(12):1540-50.
de Smet B, Pundziute G. How Would I Treat? the Invited Experts' Opinion.
Eurointervention 2012;8(2):284.
Page 21 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
de Vetten L, Bergman KA, Elzenga NJ, van Melle JP, Timmer A, Bartelds B. Neonatal
Myocardial Infarction or Myocarditis? Pediatric Cardiology 2011;32(4):492-7.
de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RPF, et al. Skin
Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is
Elevated in Peripheral Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology
2013;33(1):131-8.
de Vos LC, Mulder DJ, Smit AJ, Dullaart RPF, Kleefstra N, Lijfering WM, et al. Skin
Autofluorescence Is Associated With 5-Year Mortality and Cardiovascular Events in
Patients With Peripheral Artery Disease. Arteriosclerosis Thrombosis and Vascular
Biology 2014;34(4):933-8.
de Vries AE, de Jong RM, Van der Wal MHL, Jaarsma T, van Dijk RB, Hillege HL. The
value of INnovative ICT guided disease management combined with Telemonitoring in
OUtpatient clinics for Chronic Heart failure patients. Design and methodology of the IN
TOUCH study: a multicenter randomised trial. Bmc Health Services Research 2011;11.
de Vries AE, Van der Wal MHL, Bedijn W, de Jong RM, van Dijk RB, Hillege HL, et al.
Follow-up and treatment of an instable patient with heart failure using telemonitoring and
a computerised disease management system: a case report. European Journal of
Cardiovascular Nursing 2012;11(4):432-8.
de Vries AE, Van der Wal MHL, Nieuwenhuis MMW, de Jong RM, van Dijk RB, Jaarsma
T, et al. Health Professionals' Expectations Versus Experiences of Internet-Based
Telemonitoring: Survey Among Heart Failure Clinics. Journal of Medical Internet
Research 2013;15(1):73-83.
de Vries AE, Van der Wal MHL, Nieuwenhuis MMW, de Jong RM, van Dijk RB, Jaarsma
T, et al. Perceived barriers of heart failure nurses and cardiologists in using clinical
decision support systems in the treatment of heart failure patients. Bmc Medical
Informatics and Decision Making 2013;13.
de Vries BMW, Hillebrands JL, van Dam GM, Tio RA, de Jong JS, Slart RHJA, et al.
Multispectral Near-Infrared Fluorescence Molecular Imaging of Matrix
Metalloproteinases in a Human Carotid Plaque Using a Matrix-Degrading
Metalloproteinase-Sensitive Activatable Fluorescent Probe. Circulation
2009;119(20):E534-E536.
de Waal EGM, Slart RHJA, Vellenga E. Is FDG PET a Better Imaging Tool Than
Somatostatin Receptor Scintigraphy in Patients With Relapsing Multiple Myeloma?
Clinical Nuclear Medicine 2012;37(10):939-42.
de Wee EM, Fijnvandraat K, de Goede-Bolder A, Mauser-Bunschoten EP, Eikenboom
JCJ, Brons PP, et al. Impact of von Willebrand disease on health-related quality of life in
a pediatric population. Journal of Thrombosis and Haemostasis 2011;9(3):502-9.
de Witte P, Aalberts JJJ, Radonic T, Timmermans J, Scholte AJ, Zwinderman AH, et al.
Intrinsic biventricular dysfunction in Marfan syndrome. Heart 2011;97(24):2063-8.
Page 22 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, et al.
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs. New
England Journal of Medicine 2010;363(13):1222-32.
Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Meta-Analysis of
Genome-Wide Association Studies in > 80 000 Subjects Identifies Multiple Loci for
C-Reactive Protein Levels. Circulation 2011;123(7):731-U151.
Den Exter PL, van Es J, Klok FA, Kroft LJ, Kruip MJHA, Kamphuisen PW, et al. Risk
profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism.
Blood 2013;122(7):1144-9.
Den Exter PL, van Es J, Erkens PMG, van Roosmalen MJG, van den Hoven P, Hovens
MMC, et al. Impact of Delay in Clinical Presentation on the Diagnostic Management and
Prognosis of Patients with Suspected Pulmonary Embolism. American Journal of
Respiratory and Critical Care Medicine 2013;187(12):1369-73.
den Hartog AW, Franken R, de Witte P, Radonic T, Marquering HA, van der Steen WE,
et al. Aortic Disease in Patients with Marfan Syndrome: Aortic Volume Assessment for
Surveillance. Radiology 2013;269(2):369-76.
den Hoed M, Eijgelsheim M, Esko T, Brundel BJJM, Peal DS, Evans DM, et al.
Identification of heart rate-associated loci and their effects on cardiac conduction and
rhythm disorders. Nature Genetics 2013;45(6):621-+.
Deuling JHH, Smit MD, Maass AH, van den Heuvel AFM, Nieuwland W, Zijlstra F, et al.
The value and limitations of a wound inspection clinic after cardiac device implantation.
European Journal of Cardiovascular Nursing 2009;8(4):288-92.
Deuling JHH, Vermeulen RP, Smit MD, van der Maaten JMAA, Boersema HM, van den
Heuvel AFM, et al. Planning and monitoring of patients for electrical cardioversion for
atrial fibrillation. Netherlands Heart Journal 2012;20(4):148-54.
Devuyst O, Antignac C, Bindels RJM, Chauveau D, Emma F, Gansevoort R, et al. The
ERA-EDTA Working Group on inherited kidney disorders. Nephrology Dialysis
Transplantation 2012;27(1):67-9.
Dewilde WJM, Oirbans T, Verheugt FWA, Kelder JC, De Smet BJGL, Herrman JP, et al.
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy
and undergoing percutaneous coronary intervention: an open-label, randomised,
controlled trial. Lancet 2013;381(9872):1107-15.
Di Angelantonio E, Gao P, Danesh J. Cardiovascular Disease Risk Prediction Factors
Reply. Jama-Journal of the American Medical Association 2012;308(19):1970-1.
Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, et al.
Lipid-Related Markers and Cardiovascular Disease Prediction. Jama-Journal of the
American Medical Association 2012;307(23):2499-506.
Dickinson MG, Scholvinck EH, Boonstra A, Vonk-Noordegraaf A, Snijder RJ, Berger
RMF. Low Complication Rates With Totally Implantable Access Port Use in
Page 23 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Epoprostenol Treatment of Pulmonary Hypertension. Journal of Heart and Lung
Transplantation 2009;28(3):273-9.
Dickinson MG, Bartelds B, Molema G, Borgdorff MA, Boersma B, Takens J, et al. Egr-1
Expression During Neointimal Development in Flow-Associated Pulmonary
Hypertension. American Journal of Pathology 2011;179(5):2199-209.
Dickinson MG, Bartelds B, Borgdorff MAJ, Berger RMF. The role of disturbed blood flow
in the development of pulmonary arterial hypertension: lessons from preclinical animal
models. American Journal of Physiology-Lung Cellular and Molecular Physiology
2013;305(1):L1-L14.
Dickinson MG, Kowalski PS, Bartelds B, Borgdorff MAJ, van der Feen D, Sietsma H, et
al. A critical role for Egr-1 during vascular remodelling in pulmonary arterial
hypertension. Cardiovascular Research 2014;103(4):573-84.
Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, et al. The European
cardiac resynchronization therapy survey. European Heart Journal 2009;30(20):2450-60.
Dieperink W, Weelink EEM, van der Horst ICC, de Vos R, Jaarsma T, Aarts LPHJ, et al.
Treatment of presumed acute cardiogenic pulmonary oedema in an ambulance system
by nurses using Boussignac continuous positive airway pressure. Emergency Medicine
Journal 2009;26(2):141-4.
Dieplinger B, Egger M, Haltmayer M, Kleber ME, Scharnagl H, Silbernagel G, et al.
Increased Soluble ST2 Predicts Long-term Mortality in Patients with Stable Coronary
Artery Disease: Results from the Ludwigshafen Risk and Cardiovascular Health Study.
Clinical Chemistry 2014;60(3):530-40.
Djurabi RK, Klok FA, Nijkeuter M, Kaasjager K, Kamphuisen PW, Kramer MHH, et al.
Comparison of the clinical usefulness of two quantitative D-Dimer tests in patients with a
low clinical probability of Pulmonary Embolism. Thrombosis Research
2009;123(5):771-4.
Dobre D, Rossignol P, Murin J, Parkhomenko A, Lamiral Z, Krum H, et al. Statin therapy
and clinical outcomes in myocardial infarction patients complicated by acute heart
failure: insights from the EPHESUS trial. European Journal of Heart Failure
2013;15(2):221-7.
Dontje ML, Van der Wal MHL, Stolk RP, Brugemann J, Jaarsma T, Wijtvliet PEPJ, et al.
Daily Physical Activity in Stable Heart Failure Patients. Journal of Cardiovascular
Nursing 2014;29(3):218-26.
Douma RA, Kamphuisen PW, Rijnders AJM, Ten Wolde M, Buller HR. An alternative
diagnostic strategy in young women with suspected pulmonary embolism. Journal of
Thrombosis and Haemostasis 2009;7(4):725-7.
Douma RA, Kamphuisen PW, Buller HR. Acute pulmonary embolism. Part 1:
epidemiology and diagnosis. Nature Reviews Cardiology 2010;7(10):585-96.
Page 24 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Douma RA, van Sluis GL, Kamphuisen PW, Sohne M, Leebeek FWG, Bossuyt PMM, et
al. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary
embolism in cancer patients Explanations and potential ameliorations. Thrombosis and
Haemostasis 2010;104(4):831-6.
Douma RA, Hofstee HMA, Schaefer-Prokop C, van Waesberghe JHTM, Lely RJ,
Kamphuisen PW, et al. Comparison of 4-and 64-slice CT scanning in the diagnosis of
pulmonary embolism. Thrombosis and Haemostasis 2010;103(1):242-6.
Douma RA, Kok MGM, Verberne LM, Kamphuisen PW, Buller HR. Incidental venous
thromboembolism in cancer patients: prevalence and consequence. Thrombosis
Research 2010;125(6):E306-E309.
Douma RA, Le Gal G, Sohne M, Righini M, Kamphuisen PW, Perrier A, et al. Potential of
an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism
in older patients: a retrospective analysis of three large cohorts. British Medical Journal
2010;340.
Douma RA, Tan M, Schutgens REG, Bates SM, Perrier A, Legnani C, et al. Using an
age-dependent D-dimer cut-off value increases the number of older patients in whom
deep vein thrombosis can be safely excluded. Haematologica-the Hematology Journal
2012;97(10):1507-13.
Douwes JM, Berger RMF. The Maze of Vasodilator Response Criteria. Pediatric
Cardiology 2011;32(2):245-6.
Douwes JM, van Loon RLE, Hoendermis ES, Vonk-Noordegraaf A, Roofthooft MTR,
Talsma MD, et al. Acute pulmonary vasodilator response in paediatric and adult
pulmonary arterial hypertension: occurrence and prognostic value when comparing three
response criteria. European Heart Journal 2011;32(24):3137-46.
Douwes JM, Roofthooft MTR, Bartelds B, Talsma MD, Hillege HL, Berger RMF. Pulsatile
haemodynamic parameters are predictors of survival in paediatric pulmonary arterial
hypertension. International Journal of Cardiology 2013;168(2):1370-7.
Douwes JM, Roofthooft MTR, van Loon RLE, Ploegstra MJ, Bartelds B, Hillege HL, et al.
Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a
national referral centre. Heart 2014;100(3):224-30.
Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJM, et al.
Predictors of pregnancy complications in women with congenital heart disease.
European Heart Journal 2010;31(17):2124-32.
Driessen MMP, Baggen VJM, Freling HG, Pieper PG, van Dijk AP, Doevendans PA, et
al. Pressure overloaded right ventricles: a multicenter study on the importance of
trabeculae in RV function measured by CMR. International Journal of Cardiovascular
Imaging 2014;30(3):599-608.
Duffels MGJ, van der Plas MN, Surie S, Winter MM, Bouma BJ, Groenink M, et al.
Bosentan in pulmonary arterial hypertension: a comparison between congenital heart
disease and chronic pulmonary embolism. Netherlands Heart Journal 2009;17(9):334-+.
Page 25 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Duffels MGJ, Vis JC, van Loon RLE, Berger RMF, Hoendermis ES, van Dijk APJ, et al.
Down patients with Eisenmenger syndrome: Is bosentan treatment an option?
International Journal of Cardiology 2009;134(3):378-83.
Duffels MGJ, Vis JC, van Loon RLE, Nieuwkerk PT, van Dijk APJ, Hoendermis ES, et al.
Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary
Arterial Hypertension Associated With Congenital Heart Disease With and Without
Down's Syndrome. American Journal of Cardiology 2009;103(9):1309-15.
Duffels MGJ, Hardziyenka M, Surie S, de Bruin-Bon RHAC, Hoendermis ES, van Dijk
APJ, et al. Duration of right ventricular contraction predicts the efficacy of bosentan
treatment in patients with pulmonary hypertension. European Journal of
Echocardiography 2009;10(3):433-8.
Duffels MGJ, Mulder KM, Trip MD, de Groot E, Gort J, van Dijk APJ, et al.
Atherosclerosis in Patients With Cyanotic Congenital Heart Disease. Circulation Journal
2010;74(7):1436-41.
Ebels T, van Slooten YJ, Elzenga NJ, Waterbolk TW, Berger RMF. Quantification of
Ventricular Volume Load in the Context of a Bidirectional Cavopulmonary Shunt: A
Theoretical Treatise. Annals of Thoracic Surgery 2012;93(6):2022-7.
Eckhardt CL, Kamphuisen PW, Fijnvandraat K. Inhibitors of Factor VIII in Hemophilia.
New England Journal of Medicine 2009;361(3):309.
Eckhardt CL, Menke LA, van Ommen CH, van der Lee JH, Geskus RB, Kamphuisen
PW, et al. Intensive peri-operative use of factor VIII and the Arg593 -> Cys mutation are
risk factors for inhibitor development in mild/moderate hemophilia A. Journal of
Thrombosis and Haemostasis 2009;7(6):930-7.
Eckhardt CL, van Velzen AS, Peters M, Astermark J, Brons PP, Castaman G, et al.
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia
A. Blood 2013;122(11):1954-62.
Eerenberg ES, Sijpkens MK, Meijers JCM, Buller HR, Levi M, Kamphuisen PW.
Response to Letters Regarding Article, "Reversal of Rivaroxaban and Dabigatran by
Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover
Study in Healthy Subjects". Circulation 2012;125(16):E616.
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic
variants in novel pathways influence blood pressure and cardiovascular disease risk.
Nature 2011;478(7367):103-9.
Eijgelsheim M, Newton-Cheh C, Sotoodehnia N, de Bakker PIW, Muller M, Morrison AC,
et al. Genome-wide association analysis identifies multiple loci related to resting heart
rate. Human Molecular Genetics 2010;19(19):3885-94.
El Harchaoui K, Franssen R, Hovingh GK, Bisoendial RJ, Stellaard F, Kuipers F, et al.
Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia.
Atherosclerosis 2009;207(2):614-6.
Page 26 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
El Messaoudi S, Rongen GA, de Boer RA, Riksen NP. The cardioprotective effects of
metformin. Current Opinion in Lipidology 2011;22(6):445-53.
Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis
identifies six new susceptibility loci for atrial fibrillation. Nature Genetics
2012;44(6):670-U88.
Elsenberg EHAM, Versteeg D, Sels JW, Vlaar PJJ, Hobbelink MGG, Cramer MJM, et al.
Inducible cardiac ischaemia is related to a decrease in the whole-blood Toll-like receptor
2 and 4 response. Clinical Science 2012;122(11-12):527-33.
Emans ME, van der Putten K, Velthuis BK, de Vries JJJ, Cramer MJ, America YGCJ, et
al. Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not
associated with left ventricular function and myocardial fibrosis as assessed by cardiac
magnetic resonance imaging. Bmc Cardiovascular Disorders 2012;12.
Engels GE, Gu YJ, van Oeveren W, Rakhorst G, Mariani MA, Erasmus ME. The utility of
lung epithelium specific biomarkers in cardiac surgery: a comparison of biomarker
profiles in on- and off-pump coronary bypass surgery. Journal of Cardiothoracic Surgery
2013;8.
Enjuanes C, Klip IT, Bruguera J, Cladellas M, Ponikowski P, Banasiak W, et al. Iron
deficiency and health-related quality of life in chronic heart failure: Results from a
multicenter European study. International Journal of Cardiology 2014;174(2):268-75.
Eny KM, Lutgers HL, Maynard J, Klein BEK, Lee KE, Atzmon G, et al. GWAS identifies
an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for
skin fluorescence. Diabetologia 2014;57(8):1623-34.
Erasmus ME, Verschuuren EAM, Nijkamp DM, Vermeyden JW, van der Bij W. Lung
Transplantation from Nonheparinized Category III Non-Heart-Beating Donors. A
Single-Centre Report. Transplantation 2010;89(4):452-7.
Erqou S, Lee CTC, Suffoletto M, Echouffo-Tcheugui JB, de Boer RA, van Melle JP, et al.
Association between glycated haemoglobin and the risk of congestive heart failure in
diabetes mellitus: systematic review and meta-analysis. European Journal of Heart
Failure 2013;15(2):185-93.
Es J, Douma RA, Kamphuisen PW, Gerdes VEA, Verhamme P, Wells PS, et al. Clot
resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison
of computed tomography and perfusion scintigraphy. Journal of Thrombosis and
Haemostasis 2013;11(4):679-85.
Eschalier R, McMurray JJV, Swedberg K, Van Veldhuisen DJ, Krum H, Pocock SJ, et al.
Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or
Worsening Renal Function Analyses of the EMPHASIS-HF Study Subgroups
(Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
Journal of the American College of Cardiology 2013;62(17):1585-93.
Eshuis SA, Dierckx RAJO, van Snick PJH, Slart RHJA, Glaudemans AWJM.
Manifestation of lymphoma expansion following lymphatic drainage on F-18-FDG
Page 27 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
PET/CT. European Journal of Nuclear Medicine and Molecular Imaging
2011;38(11):2100-1.
Ettema EM, Zittema D, Kuipers J, Gansevoort RT, Vart P, de Jong PE, et al. Dialysis
Hypotension: A Role for Inadequate Increase in Arginine Vasopressin Levels? A
Systematic Literature Review and Meta-Analysis. American Journal of Nephrology
2014;39(2):100-9.
Fairley JA, Mitchell LE, Berg T, Kenneth NS, von Schubert C, Sillje HHW, et al. Direct
Regulation of tRNA and 5S rRNA Gene Transcription by Polo-like Kinase 1. Molecular
Cell 2012;45(4):541-52.
Felker GM, Hasselblad V, Tang WHW, Hernandez AF, Armstrong PW, Fonarow GC, et
al. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF
study. European Journal of Heart Failure 2012;14(11):1257-64.
Felker GM, Teerlink JR, Butler J, Hernandez AF, Miller AB, Cotter G, et al. Effect of
Serelaxin on Mode of Death in Acute Heart Failure Results From the RELAX-AHF Study.
Journal of the American College of Cardiology 2014;64(15):1591-8.
Fens N, Douma RA, Sterk PJ, Kamphuisen PW. Breathomics as a diagnostic tool for
pulmonary embolism. Journal of Thrombosis and Haemostasis 2010;8(12):2831-3.
Filippatos G, Teerlink JR, Farmakis D, Cotter G, Davison BA, Felker GM, et al. Serelaxin
in acute heart failure patients with preserved left ventricular ejection fraction: results from
the RELAX-AHF trial. European Heart Journal 2014;35(16):1041-50.
Fiuzat M, O'Connor CM, Gueyffier F, Mascette AM, Geller NL, Mebazaa A, et al.
Biomarker-Guided Therapies in Heart Failure: A Forum for Unified Strategies. Journal of
Cardiac Failure 2013;19(8):592-9.
Fokkema ML, Vlaar PJ, Vogelzang M, Gu YL, Kampinga MA, de Smet BJ, et al. Effect of
High-Dose Intracoronary Adenosine Administration During Primary Percutaneous
Coronary Intervention in Acute Myocardial Infarction A Randomized Controlled Trial.
Circulation-Cardiovascular Interventions 2009;2(4):323-9.
Fokkema ML, van der Vleuten R, Vlaar PJ, Svilaas T, Zijlstra F. Incidence, Predictors,
and Outcome of Reinfarction and Stent Thrombosis Within One Year After Primary
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
Catheterization and Cardiovascular Interventions 2009;73(5):627-34.
Fokkema ML, Vlaar PJ, Svilaas T, Vogelzang M, Amo D, Diercks GFH, et al. Incidence
and clinical consequences of distal embolization on the coronary angiogram after
percutaneous coronary intervention for ST-elevation myocardial infarction. European
Heart Journal 2009;30(8):908-15.
Fokkema ML, Wieringa WG, van der Horst IC, Boersma E, Zijlstra F, de Smet BJ.
Quantitative Analysis of the Impact of Total Ischemic Time on Myocardial Perfusion and
Clinical Outcome in Patients With ST-Elevation Myocardial Infarction. American Journal
of Cardiology 2011;108(11):1536-41.
Page 28 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Fokkema ML, Kleijn L, van der Meer P, Belonje AM, Achterhof SK, Hillege HL, et al.
Long Term Effects of Epoetin Alfa in Patients with ST- Elevation Myocardial Infarction.
Cardiovascular Drugs and Therapy 2013;27(5):433-9.
Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, et al.
Population Trends in Percutaneous Coronary Intervention 20-Year Results From the
SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Journal of the
American College of Cardiology 2013;61(12):1222-30.
Fokkema ML, van der Meer P, Rao SV, Belonje AM, Ferrario M, Hillege HL, et al. Safety
and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation
myocardial infarction: A meta-analysis of individual patient data. American Heart Journal
2014;168(3):354-U154.
Folmes KD, Chan AYM, Koonen DPY, Pulinilkunnil TC, Baczko I, Hunter BE, et al.
Distinct Early Signaling Events Resulting From the Expression of the PRKAG2 R302Q
Mutant of AMPK Contribute to Increased Myocardial Glycogen.
Circulation-Cardiovascular Genetics 2009;2(5):457-66.
Fontes JD, Lyass A, Massaro JM, Rienstra M, Dallmeier D, Schnabel RB, et al. Insulin
Resistance and Atrial Fibrillation (from the Framingham Heart Study). American Journal
of Cardiology 2012;109(1):87-90.
Fontes JD, Yamamoto JF, Larson MG, Wang N, Dallmeier D, Rienstra M, et al. Clinical
correlates of change in inflammatory biomarkers: The Framingham Heart Study.
Atherosclerosis 2013;228(1):217-23.
Forman JP, Scheven L, de Jong PE, Bakker SJL, Curhan GC, Gansevoort RT.
Association Between Sodium Intake and Change in Uric Acid, Urine Albumin Excretion,
and the Risk of Developing Hypertension. Circulation 2012;125(25):3108-16.
Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality, quantity
and harmony: the DataSHaPER approach to integrating data across bioclinical studies.
International Journal of Epidemiology 2010;39(5):1383-93.
Fox ER, Young JH, Li YL, Dreisbach AW, Keating BJ, Musani SK, et al. Association of
genetic variation with systolic and diastolic blood pressure among African Americans:
the Candidate Gene Association Resource study. Human Molecular Genetics
2011;20(11):2273-84.
Franceschini N, Van Rooij FJA, Prins BP, Feitosa MF, Karakas M, Eckfeldt JH, et al.
Discovery and Fine Mapping of Serum Protein Loci through Transethnic Meta-analysis.
American Journal of Human Genetics 2012;91(4):744-53.
Franken R, den Hartog AW, van de Riet L, Timmermans J, Scholte AJ, van den Berg
MP, et al. Clinical Features Differ Substantially Between Caucasian and Asian
Populations of Marfan Syndrome. Circulation Journal 2013;77(11):2793-8.
Franken R, den Hartog AW, de Waard V, Engele L, Radonic T, Lutter R, et al.
Circulating transforming growth factor-beta as a prognostic biomarker in Marfan
syndrome. International Journal of Cardiology 2013;168(3):2441-6.
Page 29 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Freling HG, van Slooten YJ, van Melle JP, Mulder BJM, van Dijk APJ, Hillege HL, et al.
Prosthetic valves in adult patients with congenital heart disease: Rationale and design of
the Dutch PROSTAVA study. Netherlands Heart Journal 2012;20(10):419-24.
Freling HG, Pieper PG, Vermeulen KM, van Swieten JM, Sijens PE, Van Veldhuisen DJ,
et al. Improved Cardiac MRI Volume Measurements in Patients with Tetralogy of Fallot
by Independent End-Systolic and End-Diastolic Phase Selection. Plos One 2013;8(1).
Freling HG, van Wijk K, Jaspers K, Pieper PG, Vermeulen KM, van Swieten JM, et al.
Impact of right ventricular endocardial trabeculae on volumes and function assessed by
CMR in patients with tetralogy of Fallot. International Journal of Cardiovascular Imaging
2013;29(3):625-31.
Freling HG, Willems TP, van Melle JP, van Slooten YJ, Bartelds B, Berger RMF, et al.
Effect of Right Ventricular Outflow Tract Obstruction On Right Ventricular Volumes and
Exercise Capacity in Patients With Repaired Tetralogy of Fallot. American Journal of
Cardiology 2014;113(4):719-23.
Frenay ARS, Ruifrok WPT, Bulthuis M, Huitema S, de Boer RA, van Goor H. Renal
effects of long-term darbepoetin alpha treatment in hypertensive TGR(mRen2)27 rats.
Journal of the Renin-Angiotensin-Aldosterone System 2012;13(2):232-8.
Fu JY, Wolfs MGM, Deelen P, Westra HJ, Fehrmann RSN, Meerman GJT, et al.
Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation
of Gene Expression. Plos Genetics 2012;8(1).
Funck-Brentano C, Van Veldhuisen DJ, van de Ven LLM, Follath F, Goulder M,
Willenheimer R. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome
and adverse events in patients with chronic heart failure: a post hoc analysis of the
CIBIS-III trial. European Journal of Heart Failure 2011;13(7):765-72.
Funke A, Schreurs M, paricio-Vergara M, Sheedfar F, Gruben N, Kloosterhuis NJ, et al.
Cholesterol-induced hepatic inflammation does not contribute to the development of
insulin resistance in male LDL receptor knockout mice. Atherosclerosis
2014;232(2):390-6.
Gallagher R, Luttik ML, Jaarsma T. Social Support and Self-care in Heart Failure.
Journal of Cardiovascular Nursing 2011;26(6):439-45.
Ganesh SK, Tragante V, Guo W, Guo YR, Lanktree MB, Smith EN, et al. Loci
influencing blood pressure identified using a cardiovascular gene-centric array. Human
Molecular Genetics 2013;22(8):1663-78.
Gansevoort RT, Ritz E. Hermann Senator and albuminuria-025EFforgotten pioneering
work in the 19th century. Nephrology Dialysis Transplantation 2009;24(3):1057-62.
Gansevoort RT, de Jong PE. The Case for Using Albuminuria in Staging Chronic Kidney
Disease. Journal of the American Society of Nephrology 2009;20(3):465-8.
Page 30 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Gansevoort RT, Nauta FL, Bakker SJL. Albuminuria: all you need to predict outcomes in
chronic kidney disease? Current Opinion in Nephrology and Hypertension
2010;19(6):513-8.
Gansevoort RT, de Jong PE. Challenges for the present CKD classification system.
Current Opinion in Nephrology and Hypertension 2010;19(3):308-14.
Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et
al. Lower estimated GFR and higher albuminuria are associated with adverse kidney
outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
Kidney International 2011;80(1):93-104.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF,
et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and
prevention. Lancet 2013;382(9889):339-52.
Gardner M, Bann D, Wiley L, Cooper R, Hardy R, Nitsch D, et al. Gender and telomere
length: Systematic review and meta-analysis. Experimental Gerontology 2014;51:15-27.
Ge DL, Su SY, Zhu HD, Dong YB, Wang XL, Harshfield GA, et al. Stress-Induced
Sodium Excretion A New Intermediate Phenotype to Study the Early Genetic Etiology of
Hypertension? Hypertension 2009;53(2):262-9.
Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JEA, Cleland JG, et al.
Assessing and grading congestion in acute heart failure: a scientific statement from the
Acute Heart Failure Committee of the Heart Failure Association of the European Society
of Cardiology and endorsed by the European Society of Intensive Care Medicine.
European Journal of Heart Failure 2010;12(5):423-33.
Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, Bohm M, et al. Soluble
guanylate cyclase: a potential therapeutic target for heart failure. Heart Failure Reviews
2013;18(2):123-34.
Gheorghiade M, Vaduganathan M, Fonarow GC, Greene SJ, Greenberg BH, Liu PP, et
al. Anticoagulation in heart failure: current status and future direction. Heart Failure
Reviews 2013;18(6):797-813.
Gheorghiade M, Fonarow GC, Van Veldhuisen DJ, Cleland JGF, Butler J, Epstein AE, et
al. Lack of evidence of increased mortality among patients with atrial fibrillation taking
digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
European Heart Journal 2013;34(20):1489-+.
Gheorghiade M, Patel K, Filippatos G, Anker SD, Van Veldhuisen DJ, Cleland JGF, et
al. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup
analysis of the DIG trial. European Journal of Heart Failure 2013;15(5):551-9.
Gheorghiade M, Vaduganathan M, Greene SJ, Mentz RJ, Adams KF, Anker SD, et al.
Site selection in global clinical trials in patients hospitalized for heart failure: perceived
problems and potential solutions. Heart Failure Reviews 2014;19(2):135-52.
Page 31 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Ghobadi G, Bartelds B, van der Veen SJ, Dickinson MG, Brandenburg S, Berger RMF,
et al. Lung irradiation induces pulmonary vascular remodelling resembling pulmonary
arterial hypertension. Thorax 2012;67(4):334-41.
Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, et al.
Physiological Interaction of Heart and Lung in Thoracic Irradiation. International Journal
of Radiation Oncology Biology Physics 2012;84(5):E639-E646.
Gieger C, Radhakrishnan A, Cvejic A, Tang WH, Porcu E, Pistis G, et al. New gene
functions in megakaryopoiesis and platelet formation. Nature 2011;480(7376):201-8.
Givertz MM, Postmus D, Hillege HL, Mansoor GA, Massie BM, Davison BA, et al. Renal
Function Trajectories and Clinical Outcomes in Acute Heart Failure. Circulation-Heart
Failure 2014;7(1):59-67.
Glaudemans A, Bonanno E, Galli F, Zeebregts C, Vries E, Koole M, et al. In vivo and in
vitro evidence that Tc-99m-HYNIC-interleukin-2 is able to detect T lymphocytes in
vulnerable atherosclerotic plaques of the carotid artery. European Journal of Nuclear
Medicine and Molecular Imaging 2014;41(9):1710-9.
Glaudemans AWJM, Slart RHJA, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BPC,
et al. Nuclear imaging in cardiac amyloidosis. European Journal of Nuclear Medicine and
Molecular Imaging 2009;36(4):702-14.
Glaudemans AWJM, Slart RHJA, Bozzao A, Bonanno E, Arca M, Dierckx RAJO, et al.
Molecular imaging in atherosclerosis. European Journal of Nuclear Medicine and
Molecular Imaging 2010;37(12):2381-97.
Glaudemans AWJM, Slart RHJA, Pruim J. Panniculitis-like T-cell lymphoma detected by
positron emission tomography/computed tomography scanning in a patient with
haemophagocytic syndrome. European Journal of Haematology 2011;87(4):379.
Glaudemans AWJM, Enting RH, Heesters MAAM, Dierckx RAJO, van Rheenen RWJ,
Walenkamp AME, et al. Value of C-11-methionine PET in imaging brain tumours and
metastases. European Journal of Nuclear Medicine and Molecular Imaging
2013;40(4):615-35.
Glaudemans AWJM, de Vries EFJ, Vermeulen LEM, Slart RHJA, Dierckx RAJO, Signore
A. A large retrospective single-centre study to define the best image acquisition
protocols and interpretation criteria for white blood cell scintigraphy with
Tc-99m-HMPAO-labelled leucocytes in musculoskeletal infections. European Journal of
Nuclear Medicine and Molecular Imaging 2013;40(11):1760-9.
Glaudemans AWJM, Slart RHJA, Noordzij W, Dierckx RAJO, Hazenberg BPC. Utility of
F-18-FDG PET(/CT) in patients with systemic and localized amyloidosis. European
Journal of Nuclear Medicine and Molecular Imaging 2013;40(7):1095-101.
Glaudemans AWJM, de Vries EFJ, Galli F, Dierckx RAJO, Slart RHJA, Signore A. The
Use of F-18-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and
Infectious Diseases. Clinical & Developmental Immunology 2013.
Page 32 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Glaudemans AWJM, de Vries EFJ, Slart RHJA, Dierckx RAJO, Signore A. Reply to
comment by Koranda: Tc-99m-HMPAO-labelled leucocytes in musculoskeletal
infections-the choice of reference tissue for a semiquantitative analysis. European
Journal of Nuclear Medicine and Molecular Imaging 2014;41(5):1030-2.
Glaudemans AWJM, van Rheenen RWJ, van den Berg MP, Noordzij W, Koole M,
Blokzijl H, et al. Bone scintigraphy with (99m)technetium-hydroxymethylene
diphosphonate allows early diagnosis of cardiac involvement in patients with
transthyretin-derived systemic amyloidosis. Amyloid-Journal of Protein Folding Disorders
2014;21(1):35-44.
Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, et al. Early Beneficial
Effects of Bone Marrow-Derived Mesenchymal Stem Cells Overexpressing Akt on
Cardiac Metabolism After Myocardial Infarction. Stem Cells 2009;27(4):971-9.
Golestani R, Tio RA, Zeebregts CJ, Zeilstra A, Dierckx RA, Boersma HH, et al.
Abdominal aortic calcification detected by dual X-ray absorptiometry: A strong predictor
for cardiovascular events. Annals of Medicine 2010;42(7):539-45.
Golestani R, Wu C, Tio RA, Zeebregts CJ, Petrov AD, Beekman FJ, et al. Small-animal
SPECT and SPECT/CT: application in cardiovascular research. European Journal of
Nuclear Medicine and Molecular Imaging 2010;37(9):1766-77.
Golestani R, Slart RHJA, Dullaart RPF, Glaudemans AWJM, Zeebregts CJ, Boersma
HH, et al. Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging.
European Journal of Clinical Investigation 2012;42(7):795-803.
Gomaraschi M, Ossoli A, Pozzi S, Nilsson P, Cefalu AB, Averna M, et al. eNOS
Activation by HDL Is Impaired in Genetic CETP Deficiency. Plos One 2014;9(5).
Gori M, Lam CSP, Gupta DK, Santos ABS, Cheng S, Shah AM, et al. Sex-specific
cardiovascular structure and function in heart failure with preserved ejection fraction.
European Journal of Heart Failure 2014;16(5):535-42.
Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, et al.
Association between renal function and cardiovascular structure and function in heart
failure with preserved ejection fraction. European Heart Journal 2014;35(48):3442-51.
Gorter TM, van Melle JP, Hillege HL, Pieper PG, Ebels T, Hoendermis ES, et al.
Ventricular remodelling after pulmonary valve replacement: comparison between
pressure-loaded and volume-loaded right ventricles. Interactive Cardiovascular and
Thoracic Surgery 2014;19(1):95-101.
Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, et al. Effects
of Nesiritide and Predictors of Urine Output in Acute Decompensated Heart Failure
Results From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and
Decompensated Heart Failure). Journal of the American College of Cardiology
2013;62(13):1177-83.
Page 33 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Grimshaw KEC, Allen K, Edwards CA, Beyer K, Boulay A, van der Aa LB, et al. Infant
feeding and allergy prevention: a review of current knowledge and recommendations. A
EuroPrevall state of the art paper. Allergy 2009;64(10):1407-16.
Groen JM, van der Vleuten PA, Greuter MJW, Zijlstra F, Oudkerk M. Comparison of
MRI, 64-slice MDCT and DSCT in assessing functional cardiac parameters of a moving
heart phantom. European Radiology 2009;19(3):577-83.
Groeneweg JA, van der Zwaag PA, Nordkamp LRAO, Bikker H, Jongbloed JDH,
Jongbloed R, et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal
Phospholamban Mutation Carriers. American Journal of Cardiology
2013;112(8):1197-206.
Groeneweg JA, van der Zwaag PA, Jongbloed JDH, Cox MGPJ, Vreeker A, de Boer RA,
et al. Left-dominant arrhythmogenic cardiomyopathy in a large family: Associated
desmosomal or nondesmosomal genotype? Heart Rhythm 2013;10(4):548-59.
Groeneweg JA, van der Heijden JF, Dooijes D, van Veen TAB, van Tintelen JP, Hauer
RN. Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk
management. Netherlands Heart Journal 2014;22(7-8):316-25.
Groeneweg JA, Ummels A, Mulder M, Bikker H, van der Smagt JJ, van Mil AM, et al.
Functional assessment of potential splice site variants in arrhythmogenic right ventricular
dysplasia/cardiomyopathy. Heart Rhythm 2014;11(11):2010-7.
Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J, et al.
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized
controlled trial. European Heart Journal 2013;34(45):3491-500.
Groenveld HF, Crijns HJGM, Rienstra M, van den Berg MP, Van Veldhuisen DJ, Van
Gelder IC. Does intensity of rate control influence outcome in persistent atrial
fibrillation?: Data of the RACE study. American Heart Journal 2009;158(5):785-91.
Groenveld HF, Crijns HJGM, van den Berg MP, Van Sonderen E, Alings AM, Tijssen
JGP, et al. The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial
Fibrillation Data From the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation
II) Study. Journal of the American College of Cardiology 2011;58(17):1795-803.
Groenveld HF, Tijssen JGP, Crijns HJGM, van den Berg MP, Hillege HL, Alings M, et al.
Rate Control Efficacy in Permanent Atrial Fibrillation: Successful and Failed Strict Rate
Control Against a Background of Lenient Rate Control. Journal of the American College
of Cardiology 2013;61(7):741-8.
Grootendorst DC, Elliott EG, Michels WM, Gansevoort RT, Halbesma N. Lead and CKD.
Nephrology Dialysis Transplantation 2013;28(8):E7.
Gruben N, Vergara MA, Kloosterhuis NJ, van der Molen H, Stoelwinder S, Youssef S, et
al. Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin
Resistance and Nonalcoholic Fatty Liver Disease in Mice. Plos One 2014;9(4).
Page 34 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Gruben N, Shiri-Sverdlov R, Koonen DPY, Hofker MH. Nonalcoholic fatty liver disease:
A main driver of insulin resistance or a dangerous liaison? Biochimica et Biophysica
Acta-Molecular Basis of Disease 2014;1842(11):2329-43.
Gu YL, Fokkema ML, Kampinga MA, De Smet BJGL, Tan ES, van den Heuvel AFM, et
al. Intracoronary versus intravenous abciximab in ST-segment elevation myocardial
infarction: rationale and design of the CICERO trial in patients undergoing primary
percutaneous coronary intervention with thrombus aspiration. Trials 2009;10.
Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, et al.
Intracoronary Versus Intravenous Administration of Abciximab in Patients With
ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous
Coronary Intervention With Thrombus Aspiration The Comparison of Intracoronary
Versus Intravenous Abciximab Administration During Emergency Reperfusion of
ST-Segment Elevation Myocardial Infarction (CICERO) Trial. Circulation
2010;122(25):2709-17.
Gu YL, van der Horst ICC, Douglas YL, Svilaas T, Mariani MA, Zijlstra F. Role of
coronary artery bypass grafting during the acute and subacute phase of ST-elevation
myocardial infarction. Netherlands Heart Journal 2010;18(7-8):348-54.
Gu YLL, Haeck JDE, Vogelzang M, Bilodeau L, Krucoff MW, Tijssen JGP, et al.
Computer-Assisted Quantification of Myocardial Reperfusion After Primary
Percutaneous Coronary Intervention Predicts Functional and Contrast-Enhanced
Cardiovascular Magnetic Resonance Outcomes in Patients With ST-Segment Elevation
Myocardial Infarction. Catheterization and Cardiovascular Interventions
2011;77(2):174-81.
Gu YLL, Voors AA, Zijlstra F, Hillege HL, Struck J, Masson S, et al. Comparison of the
temporal release pattern of copeptin with conventional biomarkers in acute myocardial
infarction. Clinical Research in Cardiology 2011;100(12):1069-76.
Gu YLL, Kampinga MA, Wieringa WG, Fokkema ML, Hillege HL, van den Heuvel AFM,
et al. Response to Letter Regarding Article, "Intracoronary Versus Intravenous
Administration of Abciximab in Patients With ST-Segment Elevation Myocardial
Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus
Aspiration: The Comparison of Intracoronary Versus Intravenous Abciximab
Administration During Emergency Reperfusion of ST-Segment Elevation Myocardial
Infarction (CICERO) Trial". Circulation 2011;124(8):E231.
Gui J, Moore JH, Williams SM, Andrews P, Hillege HL, van der Harst P, et al. A Simple
and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis
of Gene-Gene Interactions for Quantitative Traits. Plos One 2013;8(6).
Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, et al. Galectin-3
predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in
Heart Failure (CORONA). European Heart Journal 2012;33(18):2290-6.
Guo DH, Parikh SJ, Chao JL, Pollock NK, Wang XL, Snieder H, et al. Urinary prostasin
excretion is associated with adiposity in nonhypertensive African-American adolescents.
Pediatric Research 2013;74(2):206-10.
Page 35 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Haeck JDE, Koch KT, Gu YL, Bilodeau L, Kuijt WJ, Sjauw KD, et al. Proximal embolic
protection in patients undergoing primary angioplasty for acute myocardial infarction
(PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled
trial. Netherlands Heart Journal 2010;18(11):531-6.
Haeck JDE, Gu YL, Vogelzang M, Bilodeau L, Krucoff MW, Tijssen JGP, et al. Feasibility
and Applicability of Computer-Assisted Myocardial Blush Quantification After Primary
Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
Catheterization and Cardiovascular Interventions 2010;75(5):701-6.
Halbersma WB, Arrigoni SC, Mecozzi G, Grandjean JG, Kappetein AP, van der Palen J,
et al. Four-Year Outcome of OPCAB No-Touch With Total Arterial Y-Graft: Making the
Best Treatment a Daily Practice. Annals of Thoracic Surgery 2009;88(3):796-801.
Halbesma N, Bakker SJL, Jansen DF, Stolk RP, de Zeeuw D, de Jong PE, et al. High
Protein Intake Associates with Cardiovascular Events but not with Loss of Renal
Function. Journal of the American Society of Nephrology 2009;20(8):1797-804.
Halbesma N, Jansen DF, Stolk RP, de Jong PE, Gansevoort RT. Changes in renal risk
factors versus renal function outcome during follow-up in a population-based cohort
study. Nephrology Dialysis Transplantation 2010;25(6):1846-53.
Halbesma N, Jansen DF, Heymans MW, Stolk RP, de Jong PE, Gansevoort RT.
Development and Validation of a General Population Renal Risk Score. Clinical Journal
of the American Society of Nephrology 2011;6(7):1731-8.
Hallan SI, Matsushita K, Sang YY, Mahmoodi BK, Black C, Ishani A, et al. Age and
Association of Kidney Measures With Mortality and End-stage Renal Disease.
Jama-Journal of the American Medical Association 2012;308(22):2349-60.
Hallan SI, Gansevoort RT. Moderator's View: Should we diagnose CKD using the
'one-size fits all' KDIGO 2012 guideline or do we need a more complex age-specific
classification system? Nephrology Dialysis Transplantation 2014;29(4):780-2.
Hartog JWL, Willemsen S, Voors AA. Letter by Hartog et al Regarding Article,
"Advanced Glycation End Products Accumulate in Vascular Smooth Muscle and Modify
Vascular but Not Ventricular Properties in Elderly Hypertensive Canines". Circulation
2009;119(10):E233.
Hartog JWL, van de Wal RM, Schalkwijk CG, Miyata T, Jaarsma W, Plokker HWT, et al.
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in
patients with hypertension and diastolic dysfunction. European Journal of Heart Failure
2010;12(4):397-403.
Hartog JWL, Willemsen S, Van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, et
al. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise
tolerance and cardiac function in patients with chronic heart failure. European Journal of
Heart Failure 2011;13(8):899-908.
Hartong DT, Mcgee TL, Sandberg MA, Berson EL, Asselbergs FW, van der Harst P, et
al. Search for a correlation between telomere length and severity of retinitis pigmentosa
Page 36 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
due to the dominant rhodopsin Pro23His mutation. Molecular Vision
2009;15(60-62):592-7.
Hassan MO, Bayoumi RA, Lopez-Alvarenga JC, Snieder H, Jaju D, Al-Yahyaee S, et al.
Heritability of Hemodynamic Reactivity to Laboratory Stressors in a Homogenous Arab
Population: 'Oman Family Study'. Twin Research and Human Genetics
2009;12(6):541-8.
Hassan MO, Jaju D, Voruganti VS, Bayoumi RA, Albarwani S, Al-Yahyaee S, et al.
Genome-Wide Linkage Analysis of Hemodynamic Parameters Under Mental and
Physical Stress in Extended Omani Arab Pedigrees: The Oman Family Study. Twin
Research and Human Genetics 2011;14(3):257-67.
Hattasch R, Spethmann S, de Boer RA, Ruifrok WPT, Schattke S, Wagner M, et al.
Galectin-3 increase in endurance athletes. European Journal of Preventive Cardiology
2014;21(10):1192-9.
Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, Starling RC, et
al. Rationale and study design of the INcrease Of Vagal TonE in Heart Failure study:
INOVATE-HF. American Heart Journal 2012;163(6):954-+.
Haver VG, Slart RHJA, Zeebregts CJ, Peppelenbosch MP, Tio RA. Rupture of
Vulnerable Atherosclerotic Plaques: MicroRNAs Conducting the Orchestra? Trends in
Cardiovascular Medicine 2010;20(2):65-71.
Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al.
Subclinical Atrial Fibrillation and the Risk of Stroke. New England Journal of Medicine
2012;366(2):120-9.
Healey JS, Israel CW, Connolly SJ, Hohnloser SH, Nair GM, Divakaramenon S, et al.
Relevance of Electrical Remodeling in Human Atrial Fibrillation Results of the
Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the
Atrial Fibrillation Reduction Atrial Pacing Trial Mechanisms of Atrial Fibrillation Study.
Circulation-Arrhythmia and Electrophysiology 2012;5(4):626-31.
Heerspink HJL, Gaillard CJAM, Gansevoort RT. Screening, Monitoring, and Treatment
of Stage 1 to 3 Chronic Kidney Disease. Annals of Internal Medicine 2014;161(1):82-3.
Heerspink HJL, Weldegiorgis M, Inker LA, Gansevoort R, Parving HH, Dwyer JP, et al.
Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc
Analysis From the Reduction of End Points in Non-Insulin-Dependent Diabetes With the
Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic
Nephropathy Trial (IDNT). American Journal of Kidney Diseases 2014;63(2):244-50.
Heestermans T, van't Hof AWJ, ten Berg JM, van Werkum JW, Boersma E, Mosterd A,
et al. The golden hour of prehospital reperfusion with triple antiplatelet therapy: A
sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial
early initiation of triple antiplatelet therapy. American Heart Journal
2010;160(6):1079-84.
Page 37 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Heestermans T, Suryapranata H, ten Berg JM, Mosterd A, Gosselink ATM, Kochman W,
et al. Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of
complete ST-segment resolution before primary percutaneous coronary intervention in
the On-TIME 2 trial Correlates of reperfusion before primary PCI. Journal of
Electrocardiology 2011;44(1):42-8.
Heestermans T, de Boer MJ, van Werkum JW, Mosterd A, Gosselink ATM, Dambrink
JHE, et al. Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to
primary PCI: protection for the negative impact of time delay. Eurointervention
2011;7(4):442-8.
Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M,
et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis,
and management. Lancet Diabetes & Endocrinology 2014;2(8):655-66.
Hellemons ME, Agarwal PK, van der Bij W, Verschuuren EAM, Postmus D, Erasmus
ME, et al. Former Smoking Is a Risk Factor for Chronic Kidney Disease After Lung
Transplantation. American Journal of Transplantation 2011;11(11):2490-8.
Hellemons ME, Bakker SJL, Postmus D, Verschuuren EAM, Erasmus ME, Navis G, et
al. Incidence of impaired renal function after lung transplantation. Journal of Heart and
Lung Transplantation 2012;31(3):238-43.
Hellemons ME, Mazagova M, Gansevoort RT, Henning RH, de Zeeuw D, Bakker SJL, et
al. Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in PatientsWith
Type 2 Diabetes. Diabetes Care 2012;35(11):2340-6.
Hellemons ME, Heerspink HJL, Gansevoort RT, de Zeeuw D, Bakker SJL.
High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a
nested case-control study with confirmation in diabetes. Journal of Hypertension
2013;31(4):805-12.
Hemels MEW, Hoendermis ES, van Melle JP, Pieper PG. Therapy refractory
hypertension in adults: aortic coarctation has to be ruled out. Netherlands Heart Journal
2011;19(3):107-11.
Hermanides J, Cohn DM, DeVries JH, Kamphuisen PW, Huijgen R, Meijers JCM, et al.
Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study.
Journal of Thrombosis and Haemostasis 2009;7(6):945-9.
Hermus L, Schuitemaker JHN, Tio RA, Breek JC, Slart RHJA, de Boef E, et al. Novel
serum biomarkers in carotid artery stenosis: Useful to identify the vulnerable plaque?
Clinical Biochemistry 2011;44(16):1292-8.
Hernandez-Madrid A, Svendsen JH, Lip GYH, Van Gelder IC, Dobreanu D,
Blomstrom-Lundqvist C. Cardioversion for atrial fibrillation in current European practice:
results of the European Heart Rhythm Association survey. Europace 2013;15(6):915-8.
Hesselink ENK, Hesselink MSK, de Bock GH, Gansevoort RT, Bakker SJL, Vredeveld
EJ, et al. Long-Term Cardiovascular Mortality in Patients With Differentiated Thyroid
Carcinoma: An Observational Study. Journal of Clinical Oncology 2013;31(32):4046-53.
Page 38 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Hesstermans AACM, van Werkum JW, Zwart B, van der Heyden JA, Kelder JC, Breet
NJ, et al. Acute and subacute stent thrombosis after primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction: incidence, predictors and
clinical outcome. Journal of Thrombosis and Haemostasis 2010;8(11):2385-93.
Heuvelman HJ, Arabkhani B, Cornette JMJ, Pieper PG, Bogers AJJC, Takkenberg JJM,
et al. Pregnancy Outcomes in Women With Aortic Valve Substitutes. American Journal
of Cardiology 2013;111(3):382-7.
Hirsch-Reinshagen V, Donkin J, Stukas S, Chan J, Wilkinson A, Fan JJ, et al. LCAT
synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins.
Journal of Lipid Research 2009;50(5):885-93.
Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JGP, van der Giessen WJ, Tio RA, et
al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood
compared with standard therapy in patients after acute myocardial infarction treated by
primary percutaneous coronary intervention: results of the randomized controlled HEBE
trial. European Heart Journal 2011;32(14):1736-47.
Hobbs RP, Han SY, van der Zwaag PA, Bolling MC, Jongbloed JDH, Jonkman MF, et al.
Insights from a Desmoplakin Mutation Identified in Lethal Acantholytic Epidermolysis
Bullosa. Journal of Investigative Dermatology 2010;130(11):2680-3.
Hoekstra M, Vogelzang M, Verbitskiy E, Nijsten MWN. Health technology assessment
review: Computerized glucose regulation in the intensive care unit - how to create
artificial control. Critical Care 2009;13(5).
Hoekstra M, Schoorl MA, van der Horst ICC, Vogelzang M, Wietasch JKG, Zijlstra F, et
al. Computer-Assisted Glucose Regulation During Rapid Step-Wise Increases of
Parenteral Nutrition in Critically Ill Patients: A Proof of Concept Study. Journal of
Parenteral and Enteral Nutrition 2010;34(5):549-53.
Hoekstra M, Vogelzang M, Drost JT, Janse M, Loef BG, van der Horst ICC, et al.
Implementation and evaluation of a nurse-centered computerized potassium regulation
protocol in the intensive care unit - a before and after analysis. Bmc Medical Informatics
and Decision Making 2010;10.
Hoekstra M, Yeh L, Lansink AO, Vogelzang M, Stegeman CA, Rodgers MGG, et al.
Determinants of renal potassium excretion in critically ill patients: The role of insulin
therapy. Critical Care Medicine 2012;40(3):762-5.
Hoekstra M, Korporaal SJA, van der Sluis RJ, Hirsch-Reinshagen V, Bochem AE,
Wellington CL, et al. LCAT deficiency in mice is associated with a diminished adrenal
glucocorticoid function. Journal of Lipid Research 2013;54(2):358-64.
Hoekstra T, Lesman-Leegte I, van der Wal M, Luttik ML, Jaarsma T. Nurse-led
interventions in heart failure care Patient and nurse perspectives. European Journal of
Cardiovascular Nursing 2010;9(4):226-32.
Page 39 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Hoekstra T, Lesman-Leegte I, Van Veldhuisen DJ, Sanderman R, Jaarsma T. Quality of
life is impaired similarly in heart failure patients with preserved and reduced ejection
fraction. European Journal of Heart Failure 2011;13(9):1013-8.
Hoekstra T, Jaarsma T, Sanderman R, Van Veldhuisen DJ, Lesman-Leegte I. Perceived
sexual difficulties and associated factors in patients with heart failure. American Heart
Journal 2012;163(2):246-51.
Hoekstra T, Lesman-Leegte I, Luttik ML, Sanderman R, Van Veldhuisen DJ, Jaarsma T.
Sexual problems in elderly male and female patients with heart failure. Heart
2012;98(22):1647-52.
Hoekstra T, Jaarsma T, Van Veldhuisen DJ, Hillege HL, Sanderman R, Lesman-Leegte
I. Quality of life and survival in patients with heart failure. European Journal of Heart
Failure 2013;15(1):94-102.
Hoen PW, Rosmalen JGM, Schoevers RA, Huzen J, van der Harst P, de Jonge P.
Association between anxiety but not depressive disorders and leukocyte telomere length
after 2 years of follow-up in a population-based sample. Psychological Medicine
2013;43(4):689-97.
Hoes MF, van Hagen I, Russo F, Van Veldhuisen DJ, van den Berg MP, Roos-Hesselink
J, et al. Peripartum cardiomyopathy: Euro Observational Research Program.
Netherlands Heart Journal 2014;22(9):396-400.
Hof MJ, Maass AH. Leads for cardiac resynchronization therapy: where and how many?
European Journal of Heart Failure 2012;14(5):459-60.
Hohnloser SH, Healey JS, Gold MR, Israel CW, Yang S, van Gelder I, et al. Atrial
overdrive pacing to prevent atrial fibrillation: Insights from ASSERT. Heart Rhythm
2012;9(10):1667-73.
Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN, Wareham NJ,
et al. Plasma levels of lecithin: cholesterol acyltransferase and risk of future coronary
artery disease in apparently healthy men and women: a prospective case-control
analysis nested in the EPIC-Norfolk population study. Journal of Lipid Research
2010;51(2):416-21.
Holleboom AG, Karlsson H, Lin RS, Beres TM, Sierts JA, Herman DS, et al.
Heterozygosity for a Loss-of-Function Mutation in GALNT2 Improves Plasma
Triglyceride Clearance in Man. Cell Metabolism 2011;14(6):811-8.
Holleboom AG, Daniil G, Fu XM, Zhang RL, Hovingh GK, Schimmel AW, et al. Lipid
Oxidation in Carriers of Lecithin: Cholesterol Acyltransferase Gene Mutations.
Arteriosclerosis Thrombosis and Vascular Biology 2012;32(12):3066-+.
Holleboom AG, Jakulj L, Franssen R, Decaris J, Vergeer M, Koetsveld J, et al. In vivo
tissue cholesterol efflux is reduced in carriers of a mutation in APOA1. Journal of Lipid
Research 2013;54(7):1964-71.
Page 40 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Holm PW, Slart RHJA, Zeebregts CJ, Hillebrands JL, Tio RA. Atherosclerotic plaque
development and instability: A dual role for VEGF. Annals of Medicine
2009;41(4):257-64.
Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M, et al.
Secretory Phospholipase A(2)-IIA and Cardiovascular Disease. Journal of the American
College of Cardiology 2013;62(21):1966-76.
Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association
between alcohol and cardiovascular disease: Mendelian randomisation analysis based
on individual participant data. Bmj-British Medical Journal 2014;349.
Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJL, et al.
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts
a slower decrease in long-term renal function. Kidney International 2011;80(3):282-7.
Hoogstra-Berends F, Meijering RAM, Zhang DL, Heeres A, Loen L, Seerden JP, et al.
Heat Shock Protein-Inducing Compounds as Therapeutics to Restore Proteostasis in
Atrial Fibrillation. Trends in Cardiovascular Medicine 2012;22(3):62-8.
Hooisma GA, Balink H, Houtman PM, Slart RHJA, Lensen KDF. Parameters related to a
positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter
retrospective study. Clinical Rheumatology 2012;31(5):861-71.
Hospers IC, van der Laan JG, Zeebregts CJ, Nieboer P, Wolffenbuttel BHR, Dierckx RA,
et al. Vertebral Fracture Assessment in Supine Position: Comparison by Using
Conventional Semiquantitative Radiography and Visual Radiography. Radiology
2009;251(3):822-8.
House AA, Anand I, Bellomo R, Cruz D, Bobek I, Anker SD, et al. Definition and
classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI
Consensus Conference. Nephrology Dialysis Transplantation 2010;25(5):1416-20.
Hovens IB, Schoemaker RG, van der Zee EA, Heineman E, Izaks GJ, van Leeuwen BL.
Thinking through postoperative cognitive dysfunction: How to bridge the gap between
clinical and pre-clinical perspectives. Brain Behavior and Immunity 2012;26(7):1169-79.
Hovens IB, Schoemaker RG, van der Zee EA, Heineman E, Nyakas C, van Leeuwen
BL. Surgery-induced behavioral changes in aged rats. Experimental Gerontology
2013;48(11):1204-11.
Hovens IB, Schoemaker RG, van der Zee EA, Absalom AR, Heineman E, van Leeuwen
BL. Postoperative cognitive dysfunction: Involvement of neuroinflammation and neuronal
functioning. Brain Behavior and Immunity 2014;38:202-10.
Huang J, Sabater-Lleal M, Asselbergs FW, Tregouet D, Shin SY, Ding JZ, et al.
Genome-wide association study for circulating levels of PAI-1 provides novel insights
into its regulation. Blood 2012;120(24):4873-81.
Huang J, Huffman JE, Yamkauchi M, Trompet S, Asselbergs FW, Sabater-Lleal M, et al.
Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels
Page 41 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
and Functional Follow-Up Implicates Endothelial STXBP5 and STX2. Arteriosclerosis
Thrombosis and Vascular Biology 2014;34(5):1093-101.
Huijskes RVHP, Hoogenberg K, Wiesfeld ACP, Pijl MEJ, Van Gelder IC. Phlebotomies
as a treatment of serious heart failure due to haemochromatosis: a case report.
Netherlands Heart Journal 2009;17(11):438-41.
Hummel YM, Klip IJT, de Jong RM, Pieper PG, Van Veldhuisen DJ, Voors AA. Diastolic
function measurements and diagnostic consequences: a comparison of pulsed waveand color-coded tissue Doppler imaging. Clinical Research in Cardiology
2010;99(7):453-8.
Hummel YM, Bugatti S, Damman K, Willemsen S, Hartog JWL, Metra M, et al.
Functional and Hemodynamic Cardiac Determinants of Exercise Capacity in Patients
With Systolic Heart Failure. American Journal of Cardiology 2012;110(9):1336-41.
Hummel YM, Wilde AAM, Voors AA, Bugatti S, Hillege HL, van den Berg MP. Ventricular
dysfunction in a family with long QT syndrome type 3. Europace 2013;15(10):1516-21.
Huzen J, van der Harst P, de Boer RA, Lesman-Leegte I, Voors AA, van Gilst WH, et al.
Telomere length and psychological well-being in patients with chronic heart failure. Age
and Ageing 2010;39(2):223-7.
Huzen J, de Boer RA, Van Veldhuisen DJ, van Gilst WH, van der Harst P. The emerging
role of telomere biology in cardiovascular disease. Frontiers in Bioscience-Landmark
2010;15:35-45.
Huzen J, Peeters W, de Boer RA, Moll FL, Wong LSM, Codd V, et al. Circulating
Leukocyte and Carotid Atherosclerotic Plaque Telomere Length Interrelation,
Association With Plaque Characteristics, and Restenosis After Endarterectomy.
Arteriosclerosis Thrombosis and Vascular Biology 2011;31(5):1219-U708.
Huzen J, Wong LSM, Van Veldhuisen DJ, Samani NJ, Zwinderman AH, Codd V, et al.
Telomere length loss due to smoking and metabolic traits. Journal of Internal Medicine
2014;275(2):155-63.
Hwang B, Luttik ML, Dracup K, Jaarsma T. Family Caregiving for Patients With Heart
Failure: Types of Care Provided and Gender Differences. Journal of Cardiac Failure
2010;16(5):398-403.
Inglis SC, McMurray JJV, Bohm M, Schaufelberger M, Van Veldhuisen DJ, Lindberg M,
et al. Intermittent claudication as a predictor of outcome in patients with ischaemic
systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart
Failure trial (CORONA). European Journal of Heart Failure 2010;12(7):698-705.
Ipema KJR, Westerhuis R, van der Schans CP, de Jong PE, Gaillard CAJM, Krijnen WP,
et al. Effect of Nocturnal Haemodialysis on Body Composition. Nephron Clinical Practice
2014;128(1-2):171-7.
Page 42 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Ivy DD, Abman SH, Barst RJ, Berger RMF, Bonnet D, Fleming TR, et al. Pediatric
Pulmonary Hypertension. Journal of the American College of Cardiology
2013;62(25):D117-D126.
Izaks GJ, Joosten H, Koerts J, Gansevoort RT, Slaets JP. Reference Data for the Ruff
Figural Fluency Test Stratified by Age and Educational Level. Plos One 2011;6(2).
Izaks GJ, Gansevoort RT, van der Knaap AM, Navis G, Dullaart RPF, Slaets JPJ. The
Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or
Older. Plos One 2011;6(11).
Izaks GJ, van der Knaap AM, Gansevoort RT, Navis G, Slaets JPJ, Dullaart RPF.
Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons
aged 35 years or older. Neurobiology of Aging 2012;33(8).
Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, et al. Palliative
care in heart failure: a position statement from the palliative care workshop of the Heart
Failure Association of the European Society of Cardiology. European Journal of Heart
Failure 2009;11(5):433-43.
Jaarsma T, Arestedt KF, Martensson J, Dracup K, Stromberg A. The European Heart
Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable
and valid international instrument. European Journal of Heart Failure 2009;11(1):99-105.
Jaarsma T, Lesman-Leegte I, Hillege HL, Veeger NJ, Sanderman R, Van Veldhuisen
DJ. Depression and the Usefulness of a Disease Management Program in Heart Failure
Insights From the COACH (Coordinating study evaluating Outcomes of Advising and
Counseling in Heart failure) Study. Journal of the American College of Cardiology
2010;55(17):1837-43.
Jacobs RL, Zhao Y, Koonen DPY, Sletten T, Su B, Lingrell S, et al. Impaired de Novo
Choline Synthesis Explains Why Phosphatidylethanolamine
N-Methyltransferase-deficient Mice Are Protected from Diet-induced Obesity. Journal of
Biological Chemistry 2010;285(29):22403-13.
Jager NA, Westra J, van Dam GM, Teteloshvili N, Tio RA, Breek JC, et al. Targeted
Folate Receptor beta Fluorescence Imaging as a Measure of Inflammation to Estimate
Vulnerability Within Human Atherosclerotic Carotid Plaque. Journal of Nuclear Medicine
2012;53(8):1222-9.
Jager NA, Westra J, Golestani R, van Dam GM, Low PS, Tio RA, et al. Folate
Receptor-beta Imaging Using Tc-99m-Folate to Explore Distribution of Polarized
Macrophage Populations in Human Atherosclerotic Plaque. Journal of Nuclear Medicine
2014;55(12):1945-51.
Jager PL, Slart RHJA, Webber CL, Adachi JD, Papaioannou AL, Gulenchyn KY.
Combined Vertebral Fracture Assessment and Bone Mineral Density Measurement: A
Patient-friendly New Tool with an Important Impact on the Canadian Risk Fracture
Classification. Canadian Association of Radiologists Journal-Journal de l Association
Canadienne des Radiologistes 2010;61(4):194-200.
Page 43 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Jager PL, Jonkman S, Koolhaas W, Stiekema A, Wolffenbuttel BHR, Slart RHJA.
Combined vertebral fracture assessment and bone mineral density measurement: a new
standard in the diagnosis of osteoporosis in academic populations. Osteoporosis
International 2011;22(4):1059-68.
Jamshidi Y, Nolte IM, Dalageorgou C, Zheng DL, Johnson T, Bastiaenen R, et al.
Common Variation in the NOS1AP Gene Is Associated With Drug-Induced QT
Prolongation and Ventricular Arrhythmia. Journal of the American College of Cardiology
2012;60(9):841-50.
Jankauskas A, Zaveckiene J, Pundziute G, Slapikas R, Basevicius A, Zaliunas R. Image
quality of 16-slice computed tomography coronary angiography in patients with complete
left bundle branch block. Medicina-Lithuania 2009;45(1):14-20.
Jansen H, Stolk RP, Nolte IM, Kema IP, Wolffenbuttel BHR, Snieder H. Determinants of
HbA1c in nondiabetic Dutch adults: genetic loci and clinical and lifestyle parameters, and
their interactions in the lifelines cohort study. Journal of Internal Medicine
2013;273(3):283-93.
Jayakumar C, Nauta FL, Bakker SJL, Bilo H, Gansevoort RT, Johnson MH, et al.
Netrin-1, a urinary proximal tubular injury marker, is elevated early in the time course of
human diabetes. Journal of Nephrology 2014;27(2):151-7.
Jhund PS, Claggett B, Packer M, Zile MR, Voors AA, Pieske B, et al. Independence of
the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin
inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an
analysis of the PARAMOUNT trial. European Journal of Heart Failure 2014;16(6):671-7.
Jhund PS, Claggett BL, Voors AA, Zile MR, Packer M, Pieske BM, et al. Elevation in
High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and
Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696.
Circulation-Heart Failure 2014;7(6):953-U129.
Johansson P, Lesman-Leegte I, Svensson E, Voors A, Van Veldhuisen DJ, Jaarsma T.
Depressive symptoms and inflammation in patients hospitalized for heart failure.
American Heart Journal 2011;161(6):1053-9.
Johansson P, Nieuwenhuis M, Lesman-Leegte I, Van Veldhuisen DJ, Jaarsma T.
Depression and the delay between symptom onset and hospitalization in heart failure
patients. European Journal of Heart Failure 2011;13(2):214-9.
Johansson P, van der Wal M, Van Veldhuisen DJ, Jaarsma T. Association Between
Prehospital Delay and Subsequent Clinical Course in Patients With/Hospitalized for
Heart Failure. Journal of Cardiac Failure 2012;18(3):202-7.
Johansson P, Lesman-Leegte I, Lundgren J, Hillege HL, Hoes A, Sanderman R, et al.
Time-course of depressive symptoms in patients with heart failure. Journal of
Psychosomatic Research 2013;74(3):238-43.
Page 44 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Johnson T, Gaunt TR, Newhouse SJ, Padmanabhan S, Tomaszewski M, Kumari M, et
al. Blood Pressure Loci Identified with a Gene-Centric Array. American Journal of
Human Genetics 2011;89(6):688-700.
Joosten H, Izaks GJ, Slaets JPJ, de Jong PE, Visser ST, Bilo HJG, et al. Association of
Cognitive Function with Albuminuria and eGFR in the General Population. Clinical
Journal of the American Society of Nephrology 2011;6(6):1400-9.
Joosten H, van Eersel MEA, Gansevoort RT, Bilo HJG, Slaets JPJ, Izaks GJ.
Cardiovascular Risk Profile and Cognitive Function in Young, Middle-Aged, and Elderly
Subjects. Stroke 2013;44(6):1543-+.
Joosten H, Visser ST, van Eersel ME, Gansevoort RT, Bilo HJG, Slaets JP, et al. Statin
Use and Cognitive Function: Population-Based Observational Study with Long-Term
Follow-Up. Plos One 2014;9(12).
Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens
EJM, et al. Urinary and plasma magnesium and risk of ischemic heart disease. American
Journal of Clinical Nutrition 2013;97(6):1299-306.
Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJM, Geleijnse
JM, et al. Urinary Magnesium Excretion and Risk of Hypertension The Prevention of
Renal and Vascular End-Stage Disease Study. Hypertension 2013;61(6):1161-+.
Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJM, Geleijnse
JM, et al. Response to Lowered Magnesium in Hypertension. Hypertension
2013;62(4):E20.
Joosten MM, Pai JK, Bertoia ML, Gansevoort RT, Bakker SJL, Cooke JP, et al. beta
2-Microglobulin, Cystatin C, and Creatinine and Risk of Symptomatic Peripheral Artery
Disease. Journal of the American Heart Association 2014;3(4).
Joosten MM, Gansevoort RT, Mukamal KJ, Heerspink HJL, Geleijnse JM, Feskens EJM,
et al. Sodium Excretion and Risk of Developing Coronary Heart Disease. Circulation
2014;129(10):1121-U132.
Juarez-Orozco LE, Glauche J, Alexanderson E, Zeebregts CJ, Boersma HH,
Glaudemans AWJM, et al. Myocardial perfusion reserve in spared myocardium:
correlation with infarct size and left ventricular ejection fraction. European Journal of
Nuclear Medicine and Molecular Imaging 2013;40(8):1148-54.
Kaab S, Crawford DC, Sinner MF, Behr ER, Kannankeril PJ, Wilde AAM, et al. A Large
Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible
Modulator of Drug-Induced Torsades de Pointes. Circulation-Cardiovascular Genetics
2012;5(1):91-9.
Kalogeropoulos AP, Tang WHW, Hsu A, Felker GM, Hernandez AF, Troughton RW, et
al. High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the
ASCEND-HF Trial. Journal of Cardiac Failure 2014;20(5):319-26.
Page 45 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Kamphuisen PW, Lee AYY. Catheter-related thrombosis: lifeline or a pain in the neck?
Hematology-American Society Hematology Education Program 2012;638-44.
Kamphuisen PW, Beyer-Westendorf J. Bleeding complications during anticoagulant
treatment in patients with cancer. Thrombosis Research 2014;133:S49-S55.
Kamphuisen PW, Ten Cate H. Cardiovascular risk in patients with hemophilia. Blood
2014;123(9):1297-301.
Kamphuisen PW. Gaining experience with the NOACs. Blood 2014;124(6):836.
Kampinga MA, Vlaar PJ, Fokkema ML, Gu YL, Zijlstra F. Thrombus Aspiration during
Percutaneous coronary intervention in Acute non-ST-elevation myocardial infarction
Study (TAPAS II)-Study design. Netherlands Heart Journal 2009;17(11):409-13.
Kampinga MA, Nijsten MWN, Gu YLL, Dijk WA, De Smet BJGL, van den Heuvel AFM, et
al. Is the Myocardial Blush Grade Scored by the Operator During Primary Percutaneous
Coronary Intervention of Prognostic Value in Patients With ST-Elevation Myocardial
Infarction in Routine Clinical Practice? Circulation-Cardiovascular Interventions
2010;3(3):216-U35.
Kampinga MA, Damman P, van der Horst ICC, Woudstra P, Kuijt WJ, Nijsten MWN, et
al. Survival of Patients after ST-Elevation Myocardial Infarction: External Validation of a
Predictive Biomarker Model. Clinical Chemistry 2012;58(6):1063-4.
Kampman MAM, Balci A, Van Veldhuisen DJ, van Dijk APJ, Roos-Hesselink JW,
Sollie-Szarynska KM, et al. N-terminal pro-B-type natriuretic peptide predicts
cardiovascular complications in pregnant women with congenital heart disease.
European Heart Journal 2014;35(11):708-15.
Kappelle PJWH, Perton F, Hillege HL, linga-Thie GM, Dullaart RPF. High plasma
cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: A
nested case control study. Atherosclerosis 2011;217(1):249-52.
Kappelle PJWH, Gansevoort RT, Hillege JL, Wolffenbuttel BHR, Dullaart RPF.
Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both
predict cardiovascular events in the general population independently of nonlipid risk
factors, albuminuria and C-reactive protein. Journal of Internal Medicine
2011;269(2):232-42.
Kappelle PJWH, Dullaart RPF, van Beek AP, Hillege HL, Wolffenbuttel BHR. The
plasma leptin/adiponectin ratio predicts first cardiovascular event in men: A prospective
nested case-control study. European Journal of Internal Medicine 2012;23(8):755-9.
Kappelle PJWH, Gansevoort RT, Hillege HJ, Wolffenbuttel BHR, Dullaart RPF. Common
variation in Cholesteryl Ester Transfer Protein: Relationship of first major adverse
cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total
cholesterol/high-density lipoprotein cholesterol ratio. Journal of Clinical Lipidology
2013;7(1):56-64.
Page 46 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, et al.
Distinguishing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia-Associated
Mutations From Background Genetic Noise. Journal of the American College of
Cardiology 2011;57(23):2317-27.
Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-Reactive
Protein, Fibrinogen, and Cardiovascular Disease Prediction. New England Journal of
Medicine 2012;367(14):1310-20.
Kaufmann SG, Westenbroek RE, Zechner C, Maass AH, Bischoff S, Muck J, et al.
Functional protein expression of multiple sodium channel alpha- and beta-subunit
isoforms in neonatal cardiomyocytes. Journal of Molecular and Cellular Cardiology
2010;48(1):261-9.
Kaufmann SG, Westenbroek RE, Maass AH, Lange V, Renner A, Wischmeyer E, et al.
Distribution and function of sodium channel subtypes in human atrial myocardium.
Journal of Molecular and Cellular Cardiology 2013;61:133-41.
Ke L, Meijering RAM, Hoogstra-Berends F, Mackovicova K, Vos MJ, Van Gelder IC, et
al. Hspb1, Hspb6, Hspb7 and Hspb8 Protect Against Rhoa Gtpase-Induced Remodeling
in Tachypaced Atrial Myocytes. Plos One 2011;6(6).
Kerstens MN, de Vries R, Plukker JTM, Slart RHJA, Dullaart RPF. Multiple skeletal
lesions on FDG PET in severe primary hyperparathyroidism. European Journal of
Nuclear Medicine and Molecular Imaging 2014;41(1):182-3.
Kerstjens-Frederikse WS, Sarvaas GJD, Ruiter JS, Van den Akker PC, Temmerman
AM, van Melle JP, et al. Left ventricular outflow tract obstruction: should cardiac
screening be offered to first-degree relatives? Heart 2011;97(15):1228-32.
Kerstjens-Frederikse WS, Bongers EMHF, Roofthooft MTR, Leter EM, Douwes JM, Van
Dijk A, et al. TBX4 mutations (small patella syndrome) are associated with
childhood-onset pulmonary arterial hypertension. Journal of Medical Genetics
2013;50(8):500-6.
Kieneker LM, Gansevoort RT, Mukamal KJ, de Boer RA, Navis G, Bakker SJL, et al.
Urinary Potassium Excretion and Risk of Developing Hypertension The Prevention of
Renal and Vascular End-Stage Disease Study. Hypertension 2014;64(4):769-+.
Kilpelaeinen TO, den Hoed M, Ong KK, Grontved A, Brage S, Jameson K, et al.
Obesity-susceptibility loci have a limited influence on birth weight: a meta-analysis of up
to 28,219 individuals. American Journal of Clinical Nutrition 2011;93(4):851-60.
Kingma EM, de Jonge P, van der Harst P, Ormel J, Rosmalen JGM. The Association
between Intelligence and Telomere Length: A Longitudinal Population Based Study. Plos
One 2012;7(11).
Kirchhof P, Lip GYH, Van Gelder IC, Bax J, Hylek E, Kaab S, et al. Comprehensive risk
reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
Executive summary* of the report from the 3rd AFNET/EHRA consensus conference.
Thrombosis and Haemostasis 2011;106(6):1012-9.
Page 47 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Kirchhof P, Lip GYH, Van Gelder IC, Bax J, Hylek E, Kaab S, et al. Comprehensive risk
reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a
report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm
Association consensus conference. Europace 2012;14(1):8-27.
Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, et al.
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial
Fibrillation competence NETwork/European Heart Rhythm Association consensus
conference. Europace 2013;15(11):1540-56.
Klapholz M, Abraham WT, Ghali JK, Ponikowski P, Anker SD, Knusel B, et al. The
safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic
heart failure. European Journal of Heart Failure 2009;11(11):1071-7.
Kleijn L, Belonje AMS, Voors AA, de Boer RA, Jaarsma T, Ghosh S, et al. Inflammation
and anaemia in a broad spectrum of patients with heart failure. Heart
2012;98(16):1237-41.
Kleijn L, Westenbrink BD, van Deursen VM, Damman K, de Boer RA, Hillege HL, et al.
Anemia is associated with an increased central venous pressure and mortality in a broad
spectrum of cardiovascular patients. Clinical Research in Cardiology
2014;103(6):467-76.
Kleinjan A, Aggarwal A, van de Geer A, Faselis C, Buller HR, Di Nisio M, et al. A
worldwide survey to assess the current approach to the treatment of patients with cancer
and venous thromboembolism. Thrombosis and Haemostasis 2013;110(5):959-65.
Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, et
al. Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability,
D-Dimer Testing, and Ultrasonography for Suspected Upper Extremity Deep Venous
Thrombosis A Prospective Management Study. Annals of Internal Medicine
2014;160(7):451-+.
Kleinjan A, Hutten BA, Di Nisio M, Buller HR, Kamphuisen PW. Anticoagulant treatment
of cancer patients with pulmonary embolism in the real world Actual use of
low-molecular-weight heparin in cancer. Netherlands Journal of Medicine
2014;72(9):467-72.
Klinkenberg TJ, Ahmed S, Ten Hagen A, Wiesfeld ACP, Tan ES, Zijlstra F, et al.
Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation
using minimal invasive surgery and high intensity focused ultrasound. Europace
2009;11(12):1624-31.
Klip IJT, Voors AA, Anker SD, Hillege HL, Struck J, Squire I, et al. Prognostic value of
mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial
infarction. Heart 2011;97(11):892-8.
Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron
deficiency in chronic heart failure: An international pooled analysis. American Heart
Journal 2013;165(4):575-+.
Page 48 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Klip IT, Jankowska EA, Enjuanes C, Voors AA, Banasiak W, Bruguera J, et al. The
additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem
and its consequences. European Journal of Heart Failure 2014;16(6):655-62.
Kneyber MCJ, Grotenhuis F, Berger RFM, Ebels TW, Burgerhof JGM, Albers MJIJ.
Transfusion of Leukocyte-Depleted RBCs Is Independently Associated With Increased
Morbidity After Pediatric Cardiac Surgery. Pediatric Critical Care Medicine
2013;14(3):298-305.
Komhoff M, Roofthooft MT, Westra D, Teertstra TK, Losito A, De Kar NCAJ, et al.
Combined Pulmonary Hypertension and Renal Thrombotic Microangiopathy in
Cobalamin C Deficiency. Pediatrics 2013;132(2):E540-E544.
Koning JP, Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh B, et al. Association of
two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement
disorders in young Caucasian patients. Psychopharmacology 2012;219(3):727-36.
Koonen DPY, Sung MMY, Kao CKC, Dolinsky VW, Koves TR, Ilkayeva O, et al.
Alterations in Skeletal Muscle Fatty Acid Handling Predisposes Middle-Aged Mice to
Diet-Induced Insulin Resistance. Diabetes 2010;59(6):1366-75.
Kortekaas KA, Hoogslag GE, de Boer RA, Dokter MM, Versteegh MIM, Braun J, et al.
Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair.
European Journal of Heart Failure 2013;15(9):1011-8.
Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al.
Genome-wide association analyses identify 18 new loci associated with serum urate
concentrations. Nature Genetics 2013;45(2):145-54.
Koyak Z, de Groot JR, Van Gelder IC, Bouma BJ, van Dessel PFHM, Budts W, et al.
Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease
Who Is at Risk of Shocks? Circulation-Arrhythmia and Electrophysiology
2012;5(1):101-10.
Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, et al. Sudden
Cardiac Death in Adult Congenital Heart Disease. Circulation 2012;126(16):1944-54.
Koyak Z, Kroon B, de Groot JR, Wagenaar LJ, van Dijk AP, Mulder BA, et al. Efficacy of
Antiarrhythmic Drugs in Adults With Congenital Heart Disease and Supraventricular
Tachycardias. American Journal of Cardiology 2013;112(9):1461-7.
Koyak Z, de Groot JR, Bouma BJ, Van Gelder IC, Budts W, Zwinderman AH, et al.
Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated
with appropriate implantable cardioverter therapy in tetralogy of Fallot. International
Journal of Cardiology 2013;167(4):1532-5.
Kraai IH, Luttik MLA, de Jong RM, Jaarsma T, Hillege HL. Heart Failure Patients
Monitored With Telemedicine: Patient Satisfaction, a Review of the Literature. Journal of
Cardiac Failure 2011;17(8):684-90.
Page 49 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Kraai IH, Luttik MLA, Johansson P, de Jong RM, Van Veldhuisen DJ, Hillege HL, et al.
Health-related quality of life and anemia in hospitalized patients with heart failure.
International Journal of Cardiology 2012;161(3):151-5.
Kraai IH, Vermeulen KM, Luttik MLA, Hoekstra T, Jaarsma T, Hillege HL. Preferences of
heart failure patients in daily clinical practice: quality of life or longevity? European
Journal of Heart Failure 2013;15(10):1113-21.
Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, et al. Impaired
Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction.
Journal of the American College of Cardiology 2014;63(5):447-56.
Kraja AT, Chasman DI, North KE, Reiner AP, Yanek LR, Kilpelainen TO, et al.
Pleiotropic genes for metabolic syndrome and inflammation. Molecular Genetics and
Metabolism 2014;112(4):317-38.
Krajewska M, Heijink AM, Bisselink YJWM, Seinstra RI, Sillje HHW, de Vries EGE, et al.
Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination.
Oncogene 2013;32(24):3001-8.
Krikken JA, Gansevoort RT, Dullaart RPF. Lower HDL-C and apolipoprotein A-I are
related to higher glomerular filtration rate in subjects without kidney disease. Journal of
Lipid Research 2010;51(7):1982-90.
Krul SPJ, van der Smagt JJ, van den Berg MP, Sollie KM, Pieper PG, van
Spaendonck-Zwarts KY. Systematic review of pregnancy in women with inherited
cardiomyopathies. European Journal of Heart Failure 2011;13(6):584-94.
Krum H, Van Veldhuisen DJ, Funck-Brentano C, Vanoli E, Silke B, Erdmann E, et al.
Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by
Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial.
Cardiovascular Therapeutics 2011;29(2):89-98.
Kuchenbecker WKH, Groen H, Zijlstra TM, Bolster JHT, Slart RHJ, van der Jagt EJ, et
al. The Subcutaneous Abdominal Fat and Not the Intra-Abdominal Fat Compartment Is
Associated With Anovulation in Women With Obesity and Infertility EDITORIAL
COMMENT. Obstetrical & Gynecological Survey 2010;65(9):567-8.
Kuchenbecker WKH, Groen H, Zijlstra TM, Bolster JHT, Slart RHJ, van der Jagt EJ, et
al. The Subcutaneous Abdominal Fat and Not the Intraabdominal Fat Compartment Is
Associated with Anovulation in Women with Obesity and Infertility. Journal of Clinical
Endocrinology & Metabolism 2010;95(5):2107-12.
Kuchenbecker WKH, Groen H, van Asselt SJ, Bolster JHT, Zwerver J, Slart RHJ, et al.
In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is
associated with resumption of ovulation. Human Reproduction 2011;26(9):2505-12.
Kuipers I, Li JA, Vreeswijk-Baudoin I, Koster J, van der Harst P, Sillje HHW, et al.
Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.
European Journal of Heart Failure 2010;12(10):1042-50.
Page 50 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Kuipers I, van der Harst P, Kuipers F, van Genne L, Goris M, Lehtonen JY, et al.
Activation of liver X receptor-alpha reduces activation of the renal and cardiac
renin-angiotensin-aldosterone system. Laboratory Investigation 2010;90(4):630-6.
Kuivenhoven JA, Hegele RA. Mining the genome for lipid genes. Biochimica et
Biophysica Acta-Molecular Basis of Disease 2014;1842(10):1993-2009.
Kuznetsova T, Codd V, Brouilette S, Thijs L, Gonzalez A, Jin Y, et al. Association
Between Left Ventricular Mass and Telomere Length in a Population Study. American
Journal of Epidemiology 2010;172(4):440-50.
Kwakernaak AJ, Waanders F, Slagman MCJ, Dokter MM, Laverman GD, de Boer RA, et
al. Sodium restriction on top of renin-angiotensin-aldosterone system blockade
increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney
disease patients. Journal of Hypertension 2013;31(12):2425-32.
Lagou V, Liu GF, Zhu HD, Stallmann-Jorgensen IS, Gutin B, Dong YB, et al. Lifestyle
and Socioeconomic-Status Modify the Effects of ADRB2 and NOS3 on Adiposity in
European-American and African-American Adolescents. Obesity 2011;19(3):595-603.
Lainscak M, Blue L, Clark AL, Dahlstrom U, Dickstein K, Ekman I, et al. Self-care
management of heart failure: practical recommendations from the Patient Care
Committee of the Heart Failure Association of the European Society of Cardiology.
European Journal of Heart Failure 2011;13(2):115-26.
Lam MK, Al-Ansari S, van Dam GM, Tio RA, Breek JC, Slart RHJA, et al. Single-Chain
VEGF/Cy5.5 Targeting VEGF Receptors to Indicate Atherosclerotic Plaque Instability.
Molecular Imaging and Biology 2013;15(3):250-61.
Lambeck AJA, Verschuuren EA, Bouwman I, Jongsma T, Roozendaal C, Bungener LB,
et al. Successful lung transplantation in the presence of pre-existing donor-specific
cytotoxic HLA Class II antibodies. Journal of Heart and Lung Transplantation
2012;31(12):1301-6.
Lambers Heerspink HJ, Nauta FL, van der Zee CP, Brinkman JW, Gansevoort RT, de
Zeeuw D, et al. Alkalinization of urine samples preserves albumin concentrations during
prolonged frozen storage in patients with diabetes mellitus. Diabetic Medicine
2009;26(5):556-9.
Lambers Heerspink HJ, Gansevoort RT, Brenner BM, Cooper ME, Parving HH,
Shahinfar S, et al. Comparison of Different Measures of Urinary Protein Excretion for
Prediction of Renal Events. Journal of the American Society of Nephrology
2010;21(8):1355-60.
Landman GWD, van Vliet-Ostaptchouk JV, Kleefstra N, van Hateren KJJ, Drion I,
Groenier KH, et al. Association between 9p21 genetic variants and mortality risk in a
prospective cohort of patients with type 2 diabetes (ZODIAC-15). Cardiovascular
Diabetology 2012;11.
Lansink AO, Fahrentholz S, Nijsten MWN. Risk of severe hypernatremia depends on
underlying cause in critically ill patients. Journal of Critical Care 2013;28(2):213.
Page 51 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Lau CP, Gbadebo TD, Connolly SJ, Van Gelder IC, Capucci A, Gold MR, et al. Ethnic
Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices. Journal of
Cardiovascular Electrophysiology 2013;24(4):381-7.
Lazarenko SV, van der Vleuten PA, Tio RA, Willemsen ATM, Paans AMJ, Douma JE, et
al. Left ventricular volume assessment by planar radionuclide ventriculography
evaluated by MRI. Nuclear Medicine Communications 2009;30(9):727-35.
Leclercq C, Padeletti L, Cihak R, Ritter P, Milasinovic G, Gras D, et al. Incidence of
paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy
and continuously monitored by device diagnostics. Europace 2010;12(1):71-7.
Lee AYY, Kamphuisen PW. Epidemiology and prevention of catheter-related thrombosis
in patients with cancer. Journal of Thrombosis and Haemostasis 2012;10(8):1491-9.
Lee AYY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, et al.
CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for
treatment of acute venous thromboembolism in cancer patients. Bmc Cancer 2013;13.
Lee D, Wilson K, Akehurst R, Cowie MR, Zannad F, Krum H, et al. Cost-effectiveness of
eplerenone in patients with systolic heart failure and mild symptoms. Heart
2014;100(21):1681-7.
Lee J, Chen L, Snieder H, Chen DF, Lee LM, Liu GF, et al. Heritability of Obesity-related
Phenotypes and Association with Adiponectin Gene Polymorphisms in the Chinese
National Twin Registry. Annals of Human Genetics 2010;74:146-54.
Leizorovicz A, Becker F, Buchmuller A, Quere I, Prandoni P, Decousus H. Clinical
relevance of symptomatic superficial-vein thrombosis extension: lessons from the
CALISTO study. Blood 2013;122(10):1724-9.
Leonhard WN, van der Wal A, Novalic Z, Kunnen SJ, Gansevoort RT, Breuning MH, et
al. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling
pathways: in vivo evidence from a Pkd1-deletion model. American Journal of
Physiology-Renal Physiology 2011;300(5):F1193-F1202.
Lesman-Leegte I, Van Veldhuisen DJ, Hillege HL, Moser D, Sanderman R, Jaarsma T.
Depressive symptoms and outcomes in patients with heart failure: data from the COACH
study dagger. European Journal of Heart Failure 2009;11(12):1202-7.
Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R.
Quality of Life and Depressive Symptoms in the Elderly: A Comparison Between
Patients With Heart Failure and Age- and Gender-Matched Community Controls. Journal
of Cardiac Failure 2009;15(1):17-23.
Leusink M, Onland-Moret NC, Asselbergs FW, Ding B, Kotti S, van Zuydam NR, et al.
Cholesteryl Ester Transfer Protein Polymorphisms, Statin Use, and Their Impact on
Cholesterol Levels and Cardiovascular Events. Clinical Pharmacology & Therapeutics
2014;95(3):314-20.
Page 52 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The
definition, classification, and prognosis of chronic kidney disease: a KDIGO
Controversies Conference report. Kidney International 2011;80(1):17-28.
Levi M, de Peuter OR, Kamphuisen PW. Management Strategies for Optimal Control of
Anticoagulation in Patients with Atrial Fibrillation. Seminars in Thrombosis and
Hemostasis 2009;35(6):560-7.
Levi MM, Eerenberg E, Lowenberg E, Kamphuisen PW. Bleeding in patients using new
anticoagulants or antiplatelet agents: risk factors and management. Netherlands Journal
of Medicine 2010;68(2):68-76.
Lexis CPH, Rahel BM, Meeder JG, Zijlstra F, van derHorst ICC. The role of glucose
lowering agents on restenosis after percutaneous coronary intervention in patients with
diabetes mellitus. Cardiovascular Diabetology 2009;8.
Lexis CPH, van der Horst ICC, Rahel BM, Lexis MAS, Kampinga MA, Gu YLL, et al.
Impact of Chronic Total Occlusions on Markers of Reperfusion, Infarct Size, and
Long-Term Mortality: A Substudy from the TAPAS-Trial. Catheterization and
Cardiovascular Interventions 2011;77(4):484-91.
Lexis CPH, van der Horst ICC, Lipsic E. Effects of metformin on insulin resistance in
heart failure. Which came first: the chicken or the egg? European Journal of Heart
Failure 2012;14(11):1197-8.
Lexis CPH, van der Horst ICC, Lipsic E, van der Harst P, van der Horst-Schrivers A,
Wolffenbuttel BHR, et al. Metformin in non-Diabetic Patients Presenting with ST
Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention
as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction
(GIPS)-III Trial. Cardiovascular Drugs and Therapy 2012;26(5):417-26.
Lexis CPH, van der Horst ICC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel
AFM, et al. Effect of Metformin on Left Ventricular Function After Acute Myocardial
Infarction in Patients Without Diabetes The GIPS-III Randomized Clinical Trial.
Jama-Journal of the American Medical Association 2014;311(15):1526-35.
Lexis CPH, Wieringa WG, Hiemstra B, van Deursen VM, Lipsic E, van der Harst P, et al.
Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in
Diabetic Patients with ST-segment Elevation Myocardial Infarction. Cardiovascular
Drugs and Therapy 2014;28(2):163-71.
Lexis CPH, van der Horst ICC. Metformin for cardiovascular disease: promise still
unproven. Lancet Diabetes & Endocrinology 2014;2(2):94-5.
Li NS, van der Sijde MR, Bakker SJL, Dullaart RPF, van der Harst P, Gansevoort RT, et
al. Pleiotropic Effects of Lipid Genes on Plasma Glucose, HbA(1c), and HOMA-IR
Levels. Diabetes 2014;63(9):3149-58.
Li NS, Fu JY, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are
hypertriglyceridemia and low HDL causal factors in the development of insulin
resistance? Atherosclerosis 2014;233(1):130-8.
Page 53 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Li ZB, Snieder H, Su SY, Ding XH, Thayer JF, Treiber FA, et al. A longitudinal study in
youth of heart rate variability at rest and in response to stress. International Journal of
Psychophysiology 2009;73(3):212-7.
Li ZB, Snieder H, Harshfield GA, Treiber FA, Wang XL. A 15-year longitudinal study on
ambulatory blood pressure tracking from childhood to early adulthood. Hypertension
Research 2009;32(5):404-10.
Li ZB, Snieder H, Su SY, Harshfield GA, Treiber FA, Wang XL. A longitudinal study of
blood pressure variability in African-American and European American youth. Journal of
Hypertension 2010;28(4):715-22.
Liem A, van de Woestijne AP, Bruijns E, van Lennep HWOR, De Boo JAJ, van Halteren
HK, et al. Effect of EPO administration on myocardial infarct size in patients with
non-STE acute coronary syndromes; results from a pilot study. International Journal of
Cardiology 2009;131(2):285-7.
Liem ET, Vonk JM, Sauer PJJ, van der Steege G, Oosterom E, Stolk RP, et al. Influence
of common variants near INSIG2, in FTO, and near MC4R genes on overweight and the
metabolic profile in adolescence: the TRAILS (TRacking Adolescents' Individual Lives
Survey) Study. American Journal of Clinical Nutrition 2010;91(2):321-8.
Limantoro I, De Vos CB, Delhaas T, Marcos E, Blaauw Y, Weijs B, et al. Tissue velocity
imaging of the left atrium predicts response to flecainide in patients with acute atrial
fibrillation. Heart Rhythm 2014;11(3):478-84.
Lin HH, Sinner MF, Brody JA, Arking DE, Lunetta KL, Rienstra M, et al. Targeted
sequencing in candidate genes for atrial fibrillation: The Cohorts for Heart and Aging
Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study. Heart
Rhythm 2014;11(3):452-7.
Linssen GCM, Damman K, Hillege HL, Navis G, Van Veldhuisen DJ, Voors AA. Urinary
N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic
Heart Failure. Circulation 2009;120(1):35-41.
Linssen GCM, Damman K, Hillege HL, Van Veldhuisen DJ, Voors AA, Navis G. Letter by
van Kimmenade et al Regarding Article, "Urinary N-Terminal Prohormone Brain
Natriuretic Peptide Excretion in Patients With Chronic Heart Failure" Response.
Circulation 2010;121(10):E243.
Linssen GCM, Bakker SJL, Voors AA, Gansevoort RT, Hillege HL, de Jong PE, et al.
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular
morbidity and mortality in the general population. European Heart Journal
2010;31(1):120-7.
Linssen GCM, Rienstra M, Jaarsma T, Voors AA, Van Gelder IC, Hillege HL, et al.
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced
and preserved left ventricular ejection fraction. European Journal of Heart Failure
2011;13(10):1111-20.
Page 54 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Lipsic E, Van Veldhuisen DJ. Nebivolol in chronic heart failure: current evidence and
future perspectives. Expert Opinion on Pharmacotherapy 2010;11(6):983-92.
Lipsic E, van der Meer P, Van Veldhuisen DJ. Erythropoiesis-Stimulating Agents and
Heart Failure. Cardiovascular Therapeutics 2011;29(4):E52-E59.
Lipsic E, Kamphuisen PW. To dilate or to denervate? What is the future of renal artery
interventions in heart failure? European Journal of Heart Failure 2012;14(7):716-7.
Lisman T, Kamphuisen PW, Northup PG, Porte RJ. Established and new-generation
antithrombotic drugs in patients with cirrhosis - Possibilities and caveats. Journal of
Hepatology 2013;59(2):358-66.
Liu GF, Riese H, Spector TD, Mangino M, O'Dell SD, Stolk RP, et al. Bivariate genetic
modelling of the response to an oral glucose tolerance challenge: A gene x environment
interaction approach. Diabetologia 2009;52(6):1048-55.
Liu GF, Zhu HD, Lagou V, Gutin B, Stallmann-Jorgensen IS, Treiber FA, et al. FTO
variant rs9939609 is associated with body mass index and waist circumference, but not
with energy intake or physical activity in European- and African-American youth. Bmc
Medical Genetics 2010;11.
Liu GF, Zhu HD, Dong YB, Podolsky RH, Treiber FA, Snieder H. Influence of common
variants in FTO and near INSIG2 and MC4R on growth curves for adiposity in Africanand European-American youth. European Journal of Epidemiology 2011;26(6):463-73.
Liu H, Luiten PGM, Eisel ULM, Dejongste MJL, Schoemaker RG. Depression after
myocardial infarction: TNF-alpha-induced alterations of the blood-brain barrier and its
putative therapeutic implications. Neuroscience and Biobehavioral Reviews
2013;37(4):561-72.
Liu LCY, Voors AA, Van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, et
al. Vitamin D status and outcomes in heart failure patients. European Journal of Heart
Failure 2011;13(6):619-25.
Liu LCY, Voors AA, Valente MAE, van der Meer P. A Novel Approach to Drug
Development in Heart Failure: Towards Personalized Medicine. Canadian Journal of
Cardiology 2014;30(3):288-95.
Liu LCY, Damman K, Lipsic E, Maass AH, Rienstra M, Westenbrink BD. Heart failure
highlights in 2012-2013. European Journal of Heart Failure 2014;16(2):122-32.
Ljunggren S, Levels JHM, Turkina MV, Sundberg S, Bochem AE, Hovingh K, et al.
ApoA-I mutations, L202P and K131del, in HDL from heterozygotes with low HDL-C.
Proteomics Clinical Applications 2014;8(3-4):241-50.
Lok A, Bockting CLH, Koeter MWJ, Snieder H, Assies J, Mocking RJT, et al. Interaction
between the MTHFR C677T polymorphism and traumatic childhood events predicts
depression. Translational Psychiatry 2013;3.
Page 55 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Lok DJ, Lok SI, de la Porte PWBA, Badings E, Lipsic E, van Wijngaarden J, et al.
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients
with chronic heart failure. Clinical Research in Cardiology 2013;102(2):103-10.
Lok DJ, Klip IT, Lok SI, de la Porte PWBA, Badings E, van Wijngaarden J, et al.
Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15,
High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in
Patients With Advanced Chronic Heart Failure. American Journal of Cardiology
2013;112(6):831-7.
Lok DJ, Klip IT, Voors AA, Lok SI, de la Porte PWBA, Hillege HL, et al. Prognostic value
of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and
reduced ejection fraction. European Journal of Heart Failure 2014;16(9):958-66.
Lok DJA, van der Meer P, Bruggink-Andre de la Porte P, Lipsic E, van Wijngaarden J,
Hillege HL, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients
with chronic heart failure: data from the DEAL-HF study. Clinical Research in Cardiology
2010;99(5):323-8.
Lok SI, Lok DJ, van der Weide P, Winkens B, de la Porte PWBA, Doevendans PA, et al.
Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart
failure, but are of limited prognostic value. Netherlands Heart Journal 2014;22(9):391-5.
Lorgelly PK, Briggs AH, Wedel H, Dunselman P, Hjalmarson A, Kjekshus J, et al. An
economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the
CORONA trial. European Journal of Heart Failure 2010;12(1):66-74.
Lu B, Mahmud H, Maass AH, Yu B, van Gilst WH, de Boer RA, et al. The Plk1 Inhibitor
BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates
Aneuploidy In Vitro. Plos One 2010;5(9).
Lu B, Yu HJ, Zwartbol M, Ruifrok WP, van Gilst WH, de Boer RA, et al. Identification of
hypertrophy- and heart failure-associated genes by combining in vitro and in vivo
models. Physiological Genomics 2012;44(8):443-54.
Lu B, Tigchelaar W, Ruifrok WPT, van Gilst WH, de Boer RA, Sillje HHW. DHRS7c, a
novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation
and in heart failure. European Journal of Heart Failure 2012;14(1):5-13.
Lubitz SA, Yin XY, Fontes JD, Magnani JW, Rienstra M, Pai M, et al. Association
Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation.
Jama-Journal of the American Medical Association 2010;304(20):2263-9.
Lubitz SA, Moser C, Sullivan L, Rienstra M, Fontes JD, Villalon ML, et al. Atrial
Fibrillation Patterns and Risks of Subsequent Stroke, Heart Failure, or Death in the
Community. Journal of the American Heart Association 2013;2(5).
Luijendijk P, Bouma BJ, Vriend JWJ, Groenink M, Vliegen HW, de Groot E, et al.
Rationale and design of a trial on the effect of high dose statins on cardiovascular risk in
adults after successful coarctation repair. Contemporary Clinical Trials 2012;33(2):410-6.
Page 56 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Luijendijk P, Bouma BJ, Vriend JWJ, Groenink M, Vliegen HW, de Groot E, et al.
Beneficial effect of high dose statins on the vascular wall in patients with repaired aortic
coarctation? International Journal of Cardiology 2014;176(1):40-7.
Lundby A, Rossin EJ, Steffensen AB, Acha MR, Newton-Cheh C, Pfeufer A, et al.
Annotation of loci from genome-wide association studies using tissue-specific
quantitative interaction proteomics. Nature Methods 2014;11(8):868-74.
Luscher TF, Ruschitzka F, Landmesser U, Voors AA, van Gilst WH, Van Veldhuisen DJ.
The European Heart Journal and the European Journal of Heart Failure: partners in
scientific publishing. European Journal of Heart Failure 2012;14(10):1075-82.
Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Buller HR, Cattaneo M. Association
of V617F Jak2 mutation with the risk of thrombosis among patients with essential
thrombocythaemia or idiopathic myelofibrosis: A systematic review. Thrombosis
Research 2009;124(4):409-17.
Luttik ML, Jaarsma T, Lesman I, Sanderman R, Hagedoorn M. Quality of life in partners
of people with congestive heart failure: gender and involvement in care. Journal of
Advanced Nursing 2009;65(7):1442-51.
Luttik ML, Lesman-Leegte I, Jaarsma T. Quality of Life and Depressive Symptoms in
Heart Failure Patients and Their Partners: The Impact of Role and Gender. Journal of
Cardiac Failure 2009;15(7):580-5.
Luttik MLA, Jaarsma T, Sanderman R, Fleer J. The advisory brought to practice Routine
screening on depression (and anxiety) in coronary heart disease; consequences and
implications. European Journal of Cardiovascular Nursing 2011;10(4):228-33.
Luttik MLA, Brons M, Jaarsma T, Hillege HL, Hoes A, de Jong R, et al. Design and
methodology of the COACH-2 (Comparative study on guideline adherence and patient
compliance in heart failure patients) study: HF clinics versus primary care in stable
patients on optimal therapy. Netherlands Heart Journal 2012;20(7-8):307-12.
Luttik MLA, Jaarsma T, Van Geel PP, Brons M, Hillege HL, Hoes AW, et al. Long-term
follow-up in optimally treated and stable heart failure patients: primary care vs. heart
failure clinic. Results of the COACH-2 study. European Journal of Heart Failure
2014;16(11):1241-8.
Maass AH, Buck S, Nieuwland W, Brugemann J, Van Veldhuisen DJ, Van Gelder IC.
Importance of Heart Rate During Exercise for Response to Cardiac Resynchronization
Therapy. Journal of Cardiovascular Electrophysiology 2009;20(7):773-80.
Maass AH, Waterbolk TW, Van Gelder IC. Pitfalls of internal cardioverter defibrillator
implantation: Part I. Europace 2009;11(2):237-8.
Maass AH, Waterbolk TW, Van Gelder IC. Pitfalls of internal cardioverter defibrillator
implantation: Part II. Europace 2009;11(2):268-70.
Page 57 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Maass AH, Van Veldhuisen DJ. Device therapy in patients with heart failure and
preserved ejection fraction (HFPEF): a new frontier? European Journal of Heart Failure
2010;12(6):527-9.
Maass AH, Maier SKG. Letter by Maass and Maier Regarding Article, "Cardiac
Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training".
Circulation 2011;124(9):E249.
Maass AH, Van Gelder IC. Atrial resynchronization therapy: a new concept for treatment
of heart failure with preserved ejection fraction and prevention of atrial fibrillation?
European Journal of Heart Failure 2012;14(3):227-9.
Maass AH, Van Gelder IC. Post-shock oversensing by a subcutaneous defibrillator
resulting in inappropriate withholding of post-shock bradycardia pacing. Europace
2014;16(7):1032.
Maass AH. Diagnostic tests to predict outcome in patients with implantable cardioverter
defibrillators: it is not that simple! Netherlands Heart Journal 2014;22(10):438-9.
Macdougall IC, Canaud B, de Francisco ALM, Filippatos G, Ponikowski P, Silverberg D,
et al. Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency.
European Journal of Heart Failure 2012;14(8):882-6.
Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al.
EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF
Pilot). European Journal of Heart Failure 2010;12(10):1076-84.
Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al.
EURObservational Research Programme: regional differences and 1-year follow-up
results of the Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart
Failure 2013;15(7):808-17.
Magnani JW, Rienstra M, Lin H, Sinner MF, Lubitz SA, McManus DD, et al. Atrial
Fibrillation Current Knowledge and Future Directions in Epidemiology and Genomics.
Circulation 2011;124(18):1982-U170.
Mahida S, Lubitz SA, Rienstra M, Milan DJ, Ellinor PT. Monogenic atrial fibrillation as
pathophysiological paradigms. Cardiovascular Research 2011;89(4):692-700.
Mahmoodi BK, Gansevoort RT, Kluin-Nelemans HC. Antiphospholipid Syndrome,
Microalbuminuria, and Risk of Venous Thromboembolism Reply. Jama-Journal of the
American Medical Association 2009;302(9):945-6.
Mahmoodi BK, Gansevoort RT, Veeger NJGM, Matthews AG, Navis G, Hillege HL, et al.
Microalbuminuria and Risk of Venous Thromboembolism. Jama-Journal of the American
Medical Association 2009;301(17):1790-7.
Mahmoodi BK, Nijsten M, Wijsman J, Matthews AG, van der Laan L. ABO-blood groups
and risk of abdominal aortic aneurysm and peripheral obstructive artery disease: Two
sides of the same coin. Thrombosis Research 2012;129(1):89-90.
Page 58 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Mahmoodi BK, Gansevoort RT, Naess IA, Lutsey PL, Braekkan SK, Veeger NJGM, et al.
Association of Mild to Moderate Chronic Kidney Disease With Venous
Thromboembolism Pooled Analysis of Five Prospective General Population Cohorts.
Circulation 2012;126(16):1964-+.
Mahmoodi BK, Yatsuya H, Matsushita K, Sang YY, Gottesman RF, Astor BC, et al.
Association of Kidney Disease Measures With Ischemic Versus Hemorrhagic Strokes
Pooled Analyses of 4 Prospective Community-Based Cohorts. Stroke
2014;45(7):1925-31.
Mahmoud KD, De Smet BJGL, Zijlstra F, Rihal CS, Holmes DR. Sudden Cardiac Death:
Epidemiology, Circadian Variation, and Triggers. Current Problems in Cardiology
2011;36(2):56-80.
Mahmoud KD, Vlaar PJ, van den Heuvel AFM, Hillege HL, Zijlstra F, De Smet BJGL.
Usefulness of Thrombus Aspiration for the Treatment of Coronary Stent Thrombosis.
American Journal of Cardiology 2011;108(12):1721-7.
Mahmoud KD, Hillege HL, Lennon RJ, Gersh BJ, Holmes DR. Timing of intervention and
outcome in non-ST-elevation acute coronary syndromes: There is risk on both sides of
the curve. International Journal of Cardiology 2014;177(1):23-4.
Mahmud H, Sillje HHW, Cannon MV, van Gilst WH, de Boer RA. Regulation of the
(pro)renin-renin receptor in cardiac remodelling. Journal of Cellular and Molecular
Medicine 2012;16(4):722-9.
Mahmud H, Ruifrok WPT, Westenbrink BD, Cannon MV, Vreeswijk-Baudoin I, van Gilst
WH, et al. Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart
failure-associated anaemia. Cardiovascular Research 2013;98(1):37-46.
Mahmud H, Candido WM, van Genne L, Vreeswijk-Baudoin I, Yu HJ, van de Sluis B, et
al. Cardiac Function and Architecture Are Maintained in a Model of Cardiorestricted
Overexpression of the Prorenin-Renin Receptor. Plos One 2014;9(2).
Maisel A, Xue Y, Van Veldhuisen DJ, Voors AA, Jaarsma T, Pang PS, et al. Effect of
Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH
Study). American Journal of Cardiology 2014;114(5):737-42.
Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, et al. Prognostic
utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart
failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely
decompensated heart failure (GALLANT) trial. European Journal of Heart Failure
2011;13(8):846-51.
Maisel AS, Katz N, Hillege HL, Shaw A, Zanco P, Bellomo R, et al. Biomarkers in kidney
and heart disease. Nephrology Dialysis Transplantation 2011;26(1):62-74.
Majoor CJ, Kamphuisen PW, Zwinderman AH, ten Brinke A, Amelink M,
Rijssenbeek-Nouwens L, et al. Risk of deep vein thrombosis and pulmonary embolism in
asthma. European Respiratory Journal 2013;42(3):655-61.
Page 59 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Majoor CJ, De Pol MAV, Kamphuisen PW, Meijers JCM, Molenkamp R, Wolthers KC, et
al. Evaluation of coagulation activation after Rhinovirus infection in patients with asthma
and healthy control subjects: an observational study. Respiratory Research 2014;15.
Manhenke C, Orn S, von Haehling S, Wollert KC, Ueland T, Aukrust P, et al. Clustering
of 37 circulating biomarkers by exploratory factor analysis in patients following
complicated acute myocardial infarction. International Journal of Cardiology
2013;166(3):729-35.
Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S, et al. Predictors of
clinical outcomes in elderly patients with heart failure. European Journal of Heart Failure
2011;13(5):528-36.
Masteling MG, Zeebregts CJ, Tio RA, Breek JC, Tietge UJF, de Boer JF, et al.
High-resolution imaging of human atherosclerotic carotid plaques with micro(18)F-FDG
PET scanning exploring plaque vulnerability. Journal of Nuclear Cardiology
2011;18(6):1066-75.
Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al.
Association of estimated glomerular filtration rate and albuminuria with all-cause and
cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Lancet 2010;375(9731):2073-81.
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al.
Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study
Equation for Estimated Glomerular Filtration Rate. Jama-Journal of the American
Medical Association 2012;307(18):1941-51.
Matsushita K, Ballew SH, Astor BC, de Jong PE, Gansevoort RT, Hemmelgarn BR, et al.
Cohort Profile: The Chronic Kidney Disease Prognosis Consortium. International Journal
of Epidemiology 2013;42(6):1660-8.
McCullough PA, Haapio M, Mankad S, Zamperetti N, Massie B, Bellomo R, et al.
Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI
Consensus Conference. Nephrology Dialysis Transplantation 2010;25(6):1777-84.
McDonagh TA, Blue L, Clark AL, Dahlstrom U, Ekman I, Lainscak M, et al. European
Society of Cardiology Heart Failure Association Standards for delivering heart failure
care. European Journal of Heart Failure 2011;13(3):235-41.
McManus DD, Rienstra M, Benjamin EJ. An Update on the Prognosis of Patients With
Atrial Fibrillation. Circulation 2012;126(10):E143-E146.
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, et al. Design of
the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III,
anaemia correction, morbidity-mortality trial. European Journal of Heart Failure
2009;11(8):795-801.
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, et al. Baseline
characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart
Failure trial (RED-HF). European Journal of Heart Failure 2013;15(3):334-41.
Page 60 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
McMurray JJV, Van Veldhuisen DJ. beta blockers, atrial fibrillation, and heart failure.
Lancet 2014;384(9961):2181-3.
Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, et
al. The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients
Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular
Tachycardia or Genotype Negative, Exercise-Induced Long QT Syndrome A
Comprehensive Open Reading Frame Mutational Analysis. Journal of the American
College of Cardiology 2009;54(22):2065-74.
Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, et
al. The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients
Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular
Tachycardia or Genotype Negative, Exercise-Induced Long QT Syndrome A
Comprehensive Open Reading Frame Mutational Analysis. Journal of the American
College of Cardiology 2009;54(22):2065-74.
Meems LMG, van der Harst P, van Gilst WH, de Boer RA. Vitamin D Biology in Heart
Failure: Molecular Mechanisms and Systematic Review. Current Drug Targets
2011;12(1):29-41.
Meems LMG, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Sillje HHW, et al. The
vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a
murine model of pressure overload. Journal of Steroid Biochemistry and Molecular
Biology 2012;132(3-5):282-9.
Meerwaldt R, Slart RHJA, van Dam GM, Luijckx GJ, Tio RA, Zeebregts CJ. PET/SPECT
imaging: From carotid vulnerability to brain viability. European Journal of Radiology
2010;74(1):104-9.
Meijer E, Bakker SJL, de Jong PE, van der Heide JJH, van Son WJ, Struck J, et al.
Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal
Function Decline in Renal Transplant Recipients. Transplantation 2009;88(4):561-7.
Meijer E, Boertien WE, Nauta FL, Bakker SJL, van Oeveren W, Rook M, et al.
Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal
Dominant Polycystic Kidney Disease: A Cross-sectional Analysis. American Journal of
Kidney Diseases 2010;56(5):883-95.
Meijer E, Rook M, Tent H, Navis G, van der Jagt EJ, de Jong PE, et al. Early Renal
Abnormalities in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the
American Society of Nephrology 2010;5(6):1091-8.
Meijer E, de Jong PE, Gansevoort RT. Vasopressin and microalbuminuria: is it
vasopressin per se or is it salt intake? Kidney International 2010;77(9):832-3.
Meijer E, Gansevoort RT, de Jong PE, van der Wal AM, Leonhard WN, de Krey SR, et
al. Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for
autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug.
Nephrology Dialysis Transplantation 2011;26(8):2445-U39.
Page 61 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Meijer E, Bakker SJL, van der Jagt EJ, Navis G, de Jong PE, Struck J, et al. Copeptin, a
Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal
Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of
Nephrology 2011;6(2):361-8.
Meijer E, Boertien WE, Zietse R, Gansevoort RT. Potential Deleterious Effects of
Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic
Kidney Disease. Kidney & Blood Pressure Research 2011;34(4):235-44.
Meijer E, Drenth JPH, d'Agnolo H, Casteleijn NF, de Fijter JW, Gevers TJ, et al.
Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial
Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal
Dominant Polycystic Kidney Disease. American Journal of Kidney Diseases
2014;63(3):446-55.
Meijers WC, van der Velde AR, Ruifrok WP, Schroten NF, Dokter MM, Damman K, et al.
Renal Handling of Galectin-3 in the General Population, Chronic Heart Failure, and
Hemodialysis. Journal of the American Heart Association 2014;3(5).
Meijers WC, Januzzi JL, deFilippi C, Adourian AS, Shah SJ, Van Veldhuisen DJ, et al.
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure:
A pooled analysis of 3 clinical trials. American Heart Journal 2014;167(6):853-U117.
Meijers WC, van der Velde AR, de Boer RA. The ARCHITECT galectin-3 assay:
comparison with other automated and manual assays for the measurement of circulating
galectin-3 levels in heart failure. Expert Review of Molecular Diagnostics
2014;14(3):257-66.
Meissner M, Wolters H, de Boer RA, Havinga R, Boverhof R, Bloks VW, et al. Bile acid
sequestration normalizes plasma cholesterol and reduces atherosclerosis in
hypercholesterolemic mice. No additional effect of physical activity. Atherosclerosis
2013;228(1):117-23.
Menni C, Mangino M, Zhang F, Clement G, Snieder H, Padmanabhan S, et al.
Heritability analyses show visit-to-visit blood pressure variability reflects different
pathological phenotypes in younger and older adults: evidence from UK twins. Journal of
Hypertension 2013;31(12):2356-61.
Mentz RJ, Cotter G, Cleland JGF, Stevens SR, Chiswell K, Davison BA, et al.
International differences in clinical characteristics, management, and outcomes in acute
heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe
and Russia in the PROTECT trial. European Journal of Heart Failure 2014;16(6):614-24.
Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JGF, Anker SD, et al. Decongestion
in acute heart failure. European Journal of Heart Failure 2014;16(5):471-82.
Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CSP, Cowie MR, et al. Noncardiac
Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction.
Journal of the American College of Cardiology 2014;64(21):2281-93.
Page 62 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Metra M, Teerlink JR, Voors AA, Felker GM, Milo-Cotter O, Weatherley B, et al.
Vasodilators in the treatment of acute heart failure: what we know, what we don't. Heart
Failure Reviews 2009;14(4):299-307.
Metra M, Felker GM, Zaca V, Bugatti S, Lombardi C, Bettari L, et al. Acute heart failure:
Multiple clinical profiles and mechanisms require tailored therapy. International Journal
of Cardiology 2010;144(2):175-9.
Metra M, Teerlink JR, Felker GM, Greenberg BH, Filippatos G, Ponikowski P, et al.
Dyspnoea and worsening heart failure in patients with acute heart failure: results from
the Pre-RELAX-AHF study. European Journal of Heart Failure 2010;12(10):1130-9.
Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie BM, et al.
Dyspnoea in patients with acute heart failure: an analysis of its clinical course,
determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
European Journal of Heart Failure 2010;12(5):499-507.
Metra M, O'Connor CM, Davison BA, Cleland JGF, Ponikowski P, Teerlink JR, et al.
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and
effect of rolofylline in the PROTECT Study. European Heart Journal
2011;32(12):1519-34.
Metra M, Voors AA. The puzzle of kidney dysfunction in heart failure: an introduction.
Heart Failure Reviews 2012;17(2):129-31.
Metra M, Cotter G, Gheorghiade M, Cas LD, Voors AA. The role of the kidney in heart
failure. European Heart Journal 2012;33(17):2135-+.
Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, et al. Effect of
Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart
Failure (RELAX-AHF) Development Program Correlation With Outcomes. Journal of the
American College of Cardiology 2013;61(2):196-206.
Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, et al. Effects of
serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF.
European Heart Journal 2013;34(40):3128-36.
Meyer S, van der Meer P, Massie BM, O'Connor CM, Metra M, Ponikowski P, et al.
Sex-specific acute heart failure phenotypes and outcomes from PROTECT. European
Journal of Heart Failure 2013;15(12):1374-81.
Meyer S, van der Meer P, van Deursen VM, Jaarsma T, Van Veldhuisen DJ, Van der
Wal MHL, et al. Neurohormonal and clinical sex differences in heart failure. European
Heart Journal 2013;34(32):2538-+.
Meyer S, van der Meer P, van Tintelen JP, van den Berg MP. Sex differences in
cardiomyopathies. European Journal of Heart Failure 2014;16(3):238-47.
Milo-Cotter O, Bettari L, Kleijn L, Bugatti S, Lombardi C, Rund M, et al. The
management of acute heart failure. Panminerva Medica 2010;52(1):53-66.
Page 63 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Mirkovic K, Doorenbos CRC, Dam WA, Heerspink HJL, Slagman MCJ, Nauta FL, et al.
Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial
Inflammation and Fibrosis. Plos One 2013;8(2).
Mohamed R, Ranganathan P, Jayakumar C, Nauta FL, Gansevoort RT, Weintraub NL,
et al. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic
nephropathy and associated inflammation in mice. Journal of Molecular Medicine-Jmm
2014;92(12):1245-56.
Montero-Perez-Barquero M, Flather M, Roughton M, Coats A, Bohm M, Van Veldhuisen
DJ, et al. Influence of systolic blood pressure on clinical outcomes in elderly heart failure
patients treated with nebivolol: data from the SENIORS trial. European Journal of Heart
Failure 2014;16(9):1009-15.
Moons P, Fleck D, Jaarsma T, Norekval TM, Smith K, Stromberg A, et al. What do
cardiovascular nurses know about the hematological management of patients with
Eisenmenger syndrome? European Journal of Cardiovascular Nursing
2009;8(4):246-50.
Mos ICM, Douma RA, Erkens PMG, Kruip MJHA, Hovens MM, van Houten AA, et al.
Diagnostic outcome management study in patients with clinically suspected recurrent
acute pulmonary embolism with a structured algorithm. Thrombosis Research
2014;133(6):1039-44.
Motazacker MM, Peter J, Treskes M, Shoulders CC, Kuivenhoven JA, Hovingh GK.
Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol
Levels-Brief Report. Arteriosclerosis Thrombosis and Vascular Biology
2013;33(7):1521-8.
Mulder BA, Kamphuisen PW, Van Gelder IC. Stroke aetiology in heart failure: towards
patient-tailored prevention of stroke. European Journal of Heart Failure
2012;14(3):230-1.
Mulder BA, Van Veldhuisen DJ, Crijns HJGM, Bohm M, Cohen-Solal A, Babalis D, et al.
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation:
insights from SENIORS. European Journal of Heart Failure 2012;14(10):1171-8.
Mulder BA, Van Veldhuisen DJ, Crijns HJGM, Tijssen JGP, Hillege HL, Alings M, et al.
Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc
analysis of the RACE II study. European Journal of Heart Failure 2013;15(11):1311-8.
Mulder BA, Van Veldhuisen DJ, Crijns HJGM, Tijssen JGP, Hillege HL, Alings M, et al.
Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study. Heart
Rhythm 2014;11(9):1543-50.
Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Skin autofluorescence
is elevated in acute myocardial infarction and is associated with the one-year incidence
of major adverse cardiac events. Netherlands Heart Journal 2009;17(4):162-8.
Page 64 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Muller M, de Jong M, Jaarsma T, Koops A, Voors AA, Nieuwenhuis JA, et al. Central
sleep apnoea syndrome in chronic heart failure: an underestimated and treatable
comorbidity. Netherlands Heart Journal 2010;18(5):260-3.
Munneke AJ, Rakhorst G, Petersen AH, van Oeveren W, Prop J, Erasmus ME. Flush at
room temperature followed by storage on ice creates the best lung graft preservation in
rats. Transplant International 2013;26(7):751-60.
Muntinghe FLH, Gross S, Bakker SJL, Landman GWD, van der Harst P, Bilo HJG, et al.
CCR5 Delta 32 genotype is associated with outcome in type 2 diabetes mellitus.
Diabetes Research and Clinical Practice 2009;86(2):140-5.
Murabito JM, White CC, Kavousi M, Sun YV, Feitosa MF, Nambi V, et al. Association
Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a
Meta-Analysis of 21 Genome-Wide Association Studies. Circulation-Cardiovascular
Genetics 2012;5(1):100-12.
Nannenberg EA, Michels M, Christiaans I, Majoor-Krakauer D, Hoedemaekers YM, van
Tintelen JP, et al. Mortality Risk of Untreated Myosin-Binding Protein C-Related
Hypertrophic Cardiomyopathy Insight Into the Natural History. Journal of the American
College of Cardiology 2011;58(23):2406-14.
Nannenberg EA, Sijbrands EJG, Dijksman LM, Alders M, van Tintelen JP, Birnie M, et
al. Mortality of Inherited Arrhythmia Syndromes Insight Into Their Natural History.
Circulation-Cardiovascular Genetics 2012;5(2):183-9.
Naude PJW, Mommersteeg PMC, Zijlstra WP, Gouweleeuw L, Kupper N, Eisel ULM, et
al. Neutrophil Gelatinase-Associated Lipocalin and depression in patients with chronic
heart failure. Brain Behavior and Immunity 2014;38:59-65.
Nauta FL, Bakker SJL, van Oeveren W, Navis G, van der Heide JJH, van Goor H, et al.
Albuminuria, Proteinuria, and Novel Urine Biomarkers as Predictors of Long-term
Allograft Outcomes in Kidney Transplant Recipients. American Journal of Kidney
Diseases 2011;57(5):733-43.
Nauta FL, Boertien WE, Bakker SJL, van Goor H, van Oeveren W, de Jong PE, et al.
Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes.
Diabetes Care 2011;34(4):975-81.
Nauta FL, Bakker SJL, Gansevoort RT. In Reply to 'Albuminuria, Proteinuria, and Graft
Survival in Kidney Transplantation'. American Journal of Kidney Diseases
2011;58(6):1037-8.
Nauta FL, Bakker SJL, Heerspink HL, de Zeeuw D, van Oeveren W, Bilo H, et al. Effect
of Frozen Storage on Urinary Concentration of Kidney Damage Markers. American
Journal of Kidney Diseases 2012;59(4):586-9.
Nauta FL, Scheven L, Meijer E, van Oeveren W, de Jong PE, Bakker SJL, et al.
Glomerular and Tubular Damage Markers in Individuals with Progressive Albuminuria.
Clinical Journal of the American Society of Nephrology 2013;8(7):1106-14.
Page 65 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Navis G, Bakker SJL, van der Harst P. Dissecting the genetics of complex traits: lessons
from hypertension(*). Nephrology Dialysis Transplantation 2010;25(5):1382-5.
Nawrot TS, van der Harst P, Staessen JA. Online journals: paying or delaying? Lancet
2010;375(9719):984.
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al.
Genome-wide association study identifies eight loci associated with blood pressure.
Nature Genetics 2009;41(6):666-76.
Neyt M, Van den Bruel A, Smit Y, de Jonge N, Erasmus M, Van Dijk D, et al.
Cost-Effectiveness of Continuous-Flow Left Ventricular Assist Devices. International
Journal of Technology Assessment in Health Care 2013;29(3):254-60.
Ngo K, Kotecha D, Walters JAE, Manzano L, Palazzuoli A, Van Veldhuisen DJ, et al.
Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane
Database of Systematic Reviews 2010;(1).
Nieuwenhuis MMW, Jaarsma T, Van Veldhuisen DJ, Van der Wal MHL. Factors
Associated With Patient Delay in Seeking Care After Worsening Symptoms in Heart
Failure Patients. Journal of Cardiac Failure 2011;17(8):657-63.
Nieuwenhuis MMW, Van der Wal MHL, Jaarsma T. The Body of Knowledge on
Compliance in Heart Failure Patients We Are Not There Yet. Journal of Cardiovascular
Nursing 2011;26(1):21-8.
Nieuwenhuis MMW, Jaarsma T, Van Veldhuisen DJ, Postmus D, Van der Wal MHL.
Long-Term Compliance With Nonpharmacologic Treatment of Patients With Heart
Failure. American Journal of Cardiology 2012;110(3):392-7.
Nieuwenhuis MMW, Jaarsma T, Van Veldhuisen DJ, Van der Wal MHL. Self-reported
versus 'true' adherence in heart failure patients: a study using the Medication Event
Monitoring System. Netherlands Heart Journal 2012;20(7-8):313-9.
Nijenhuis T, Sloan AJ, Hoenderop JGJ, Flesche J, van Goor H, Kistler AD, et al.
Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an
NFAT-Mediated Positive Feedback Signaling Pathway. American Journal of Pathology
2011;179(4):1719-32.
Nijsten MWN, van Dam GM. Hypothesis: Using the Warburg effect against cancer by
reducing glucose and providing lactate. Medical Hypotheses 2009;73(1):48-51.
Nilsson L, Wieringa WG, Pundziute G, Gjerde M, Engvall J, Swahn E, et al.
Neutrophil/Lymphocyte Ratio Is Associated with Non-Calcified Plaque Burden in Patients
with Coronary Artery Disease. Plos One 2014;9(9).
Noordzij W, Glaudemans AWJM, Slart RHJA, Dierckx RA, Hazenberg BPC. Clinical use
of differential nuclear medicine modalities in patients with ATTR amyloidosis.
Amyloid-Journal of Protein Folding Disorders 2012;19(4):208-11.
Page 66 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Noordzij W, Glaudemans AWJM, van Rheenen RWJ, Hazenberg BPC, Tio RA, Dierckx
RAJO, et al. I-123-Labelled metaiodobenzylguanidine for the evaluation of cardiac
sympathetic denervation in early stage amyloidosis. European Journal of Nuclear
Medicine and Molecular Imaging 2012;39(10):1609-17.
Noordzij W, Glaudemans AWJM, Dierckx RA, Slart RHJA, Boerboom AL, Hazenberg
BPC. Fluorine-18 labeled fluorodeoxyglucose PET useful for therapy monitoring in
localized AL amyloidosis? Amyloid-Journal of Protein Folding Disorders
2013;20(2):135-7.
Noordzij W, Slart RHJA, Zeebregts CJ, Glaudemans AWJM. Gastrocolocutaneous
fistula detected by [F-18]fluorodeoxyglucose positron emission tomography with
low-dose computed tomography: a rare iatrogenic complication of colonoscopy.
Endoscopy 2013;45:E67-E68.
Noordzij W, Glaudemans AWJM, Slart RHJA, Hazenberg BPC. Cardiac diphosphonate
uptake. Heart 2014;100(15):1192-U63.
Noordzij W, Glaudemans AWJM, van Rheenen RWJ, Dierckx RA, Slart RHJA,
Hazenberg BPC. Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled
serum amyloid P component scintigraphy in a patient with pulmonary nodular
amyloidosis. Amyloid-Journal of Protein Folding Disorders 2014;21(2):131-3.
Noordzij W, van Beek AP, Tio RA, van der Horst-Schrivers A, de Vries EG, van Ginkel
B, et al. Myocardial Metastases on 6-[F-18] fluoro-L-DOPA PET/CT: A Retrospective
Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients. Plos One
2014;9(11).
Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al.
Lipoprotein(a) as a cardiovascular risk factor: current status. European Heart Journal
2010;31(23):2844-U14.
Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps
OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the
general population: guidance for clinicians to prevent coronary heart disease. European
Heart Journal 2013;34(45):3478-+.
Nordkamp LRAO, Knops RE, Bardy GH, Blaauw Y, Boersma LVA, Bos JS, et al.
Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd
comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator
therapy. American Heart Journal 2012;163(5):753-+.
Nordkamp LRAO, Abkenari LD, Boersma LVA, Maass AH, de Groot JR, van Oostrom
AJHH, et al. The Entirely Subcutaneous Implantable Cardioverter-Defibrillator Initial
Clinical Experience in a Large Dutch Cohort. Journal of the American College of
Cardiology 2012;60(19):1933-9.
Nurnberg ST, Rendon A, Smethurst PA, Paul DS, Voss K, Thon JN, et al. A GWAS
sequence variant for platelet volume marks an alternative DNM3 promoter in
megakaryocytes near a MEIS1 binding site. Blood 2012;120(24):4859-68.
Page 67 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, et al. The association
between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart
failure: results from CORONA. Journal of Internal Medicine 2012;271(5):436-43.
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, et
al. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure. New
England Journal of Medicine 2011;365(1):32-43.
O'Connor CM, Fiuzat M, Lombardi C, Fujita K, Jia G, Davison BA, et al. Impact of Serial
Troponin Release on Outcomes in Patients With Acute Heart Failure Analysis From the
PROTECT Pilot Study. Circulation-Heart Failure 2011;4(6):724-32.
O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, et al. The
PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute
heart failure and renal dysfunction. European Journal of Heart Failure
2012;14(6):605-12.
Ocak G, Verduijn M, Vossen CY, Lijfering WM, Dekker FW, Rosendaal FR, et al.
Chronic kidney disease stages 1-3 increase the risk of venous thrombosis. Journal of
Thrombosis and Haemostasis 2010;8(11):2428-35.
Odden MC, Tager IB, Gansevoort RT, Bakker SJL, Katz R, Fried LF, et al. Age and
cystatin C in healthy adults: a collaborative study. Nephrology Dialysis Transplantation
2010;25(2):463-9.
Odden MC, Tager IB, Gansevoort RT, Bakker SJL, Fried LF, Newman AB, et al.
Hypertension and low HDL cholesterol were associated with reduced kidney function
across the age spectrum: a collaborative study. Annals of Epidemiology
2013;23(3):106-11.
Oeseburg H, Iusuf D, van der Harst P, van Gilst WH, Henning RH, Roks AJM.
Bradykinin Protects Against Oxidative Stress-Induced Endothelial Cell Senescence.
Hypertension 2009;53(2):417-22.
Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HHW.
Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species-Induced Endothelial Cell
Senescence Through the Activation of Protein Kinase A. Arteriosclerosis Thrombosis
and Vascular Biology 2010;30(7):1407-U356.
Oeseburg H, de Boer RA, van Gilst WH, van der Harst P. Telomere biology in healthy
aging and disease. Pflugers Archiv-European Journal of Physiology 2010;459(2):259-68.
Oldenbeuving G, McDonald JR, Goodwin ML, Sayilir R, Reijngoud DJ, Gladden LB, et
al. A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who
was not in coma: causes and consequences of lactate-protected hypoglycaemia.
Anaesthesia and Intensive Care 2014;42(4):507-11.
Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations
in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400
Emergency Department Patients in 46 Countries The RE-LY Atrial Fibrillation Registry.
Circulation 2014;129(15):1568-76.
Page 68 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Oldoni F, Sinke RJ, Kuivenhoven JA. Mendelian Disorders of High-Density Lipoprotein
Metabolism. Circulation Research 2014;114(1):124-42.
Onuta G, Groenewegen HC, Klatter FA, Boer MW, Goris M, van Goor H, et al.
Long-Term Type 1 Diabetes Enhances In-Stent Restenosis after Aortic Stenting in
Diabetes-Prone BB Rats. Journal of Biomedicine and Biotechnology 2011.
op den Dries S, Karimian N, Sutton ME, Westerkamp AC, Nijsten MWN, Gouw ASH, et
al. Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human
Donor Livers. American Journal of Transplantation 2013;13(5):1327-35.
Oterdoom LH, de Vries APJ, van Ree RM, Gansevoort RT, van Son WJ, van der Heide
JJH, et al. N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant
Recipients Versus the General Population. Transplantation 2009;87(10):1562-70.
Oterdoom LH, de Vries APJ, Gansevoort RT, de Jong PE, Gans ROB, Bakker SJL.
Fasting insulin is a stronger cardiovascular risk factor in women than in men.
Atherosclerosis 2009;203(2):640-6.
Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans ROB, Bakker SJL.
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent
predictor of cardiovascular disease and mortality in the general population.
Atherosclerosis 2009;207(2):534-40.
Otten E, Deprez RHLD, Weiss MM, van Slegtenhorst M, Joosten M, van der Smagt JJ,
et al. Recurrent and founder mutations in the Netherlands: mutation p.K217del in
troponin T2, causing dilated cardiomyopathy. Netherlands Heart Journal
2010;18(10):478-85.
Otten E, Asimaki A, Maass A, van Langen IM, van der Wal A, de Jonge N, et al. Desmin
mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart
Rhythm 2010;7(8):1058-64.
Otterman ML, Nijboer JM, van der Horst ICC, van Meurs M, ten Duis HJ, Nijsten MWN.
Reticulocyte Counts and Their Relation to Hemoglobin Levels in Trauma Patients.
Journal of Trauma-Injury Infection and Critical Care 2009;67(1):121-4.
Ozyilmaz A, Bakker SJL, de Zeeuw D, de Jong PE, Gansevoort RT. Selection on
albuminuria enhances the efficacy of screening for cardiovascular risk factors.
Nephrology Dialysis Transplantation 2010;25(11):3560-8.
Ozyilmaz A, de Jong PE, Gansevoort RT. Screening for chronic kidney disease can be
of help to prevent atherosclerotic end organ damage. Nephrology Dialysis
Transplantation 2012;27(11):4046-52.
Ozyilmaz A, Bakker SJL, de Zeeuw D, de Jong PE, Gansevoort RT. Screening for
albuminuria with subsequent screening for hypertension and hypercholesterolaemia
identifies subjects in whom treatment is warranted to prevent cardiovascular events.
Nephrology Dialysis Transplantation 2013;28(11):2805-15.
Page 69 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Navis G, et al.
Genome Wide Association Study of Blood Pressure Extremes Identifies Variant in Umod
Associated with Hypertension. Journal of Hypertension 2010;28:E237.
Panday PVN, Vischjager P, Rodgers MGG, Maurer JM, Sturkenboom MGG, Nijsten
MWN. Rifampicin treatment of persistently elevated benzodiazepine metabolites in a
comatose patient. Intensive Care Medicine 2009;35(9):1647-8.
paricio-Vergara M, Shiri-Sverdlov R, Koonen DPY, Hofker MH. Bone marrow
transplantation as an established approach for understanding the role of macrophages in
atherosclerosis and the metabolic syndrome. Current Opinion in Lipidology
2012;23(2):111-21.
paricio-Vergara M, Hommelberg PPH, Schreurs M, Gruben N, Stienstra R,
Shiri-Sverdlov R, et al. Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation
Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in
a Murine Model. Hepatology 2013;57(2):566-76.
Paukku K, Backlund M, de Boer RA, Kalkkinen N, Kontula KK, Lehtonen JYA.
Regulation of AT1R expression through HuR by insulin. Nucleic Acids Research
2012;40(12):5250-61.
Paul DS, Albers CA, Rendon A, Voss K, Stephens J, van der Harst P, et al. Maps of
open chromatin highlight cell type-restricted patterns of regulatory sequence variation at
hematological trait loci. Genome Research 2013;23(7):1130-41.
Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after
surgery in Europe: a 7 day cohort study. Lancet 2012;380(9847):1059-65.
Peels JOJ, Hautvast RWM, de Swart JBRM, Huybregts MAJM, Umans VAWM, Arnold
AER, et al. Percutaneous coronary intervention without on site surgical back-up;
two-years registry of a large Dutch community hospital. International Journal of
Cardiology 2009;132(1):59-65.
Pena MJ, Heerspink HJL, Hellemons ME, Friedrich T, Dallmann G, Lajer M, et al. Urine
and plasma metabolites predict the development of diabetic nephropathy in individuals
with Type 2 diabetes mellitus. Diabetic Medicine 2014;31(9):1138-47.
Pera T, Zuidhof A, Valadas J, Smit M, Schoemaker RG, Gosens R, et al. Tiotropium
inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD.
European Respiratory Journal 2011;38(4):789-96.
Perrin MJ, Adler A, Green S, Al-Zoughool F, Doroshenko P, Orr N, et al. Evaluation of
Genes Encoding for the Transient Outward Current (Ito) Identifies the KCND2 Gene as a
Cause of J-Wave Syndrome Associated With Sudden Cardiac Death.
Circulation-Cardiovascular Genetics 2014;7(6):782-U123.
Perry JRB, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, et al.
Parent-of-origin-specific allelic associations among 106 genomic loci for age at
menarche. Nature 2014;514(7520):92-+.
Page 70 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Petrie CJ, Voors AA, Van Veldhuisen DJ. Low pulse pressure is an independent
predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced
heart failure patients. International Journal of Cardiology 2009;131(3):336-44.
Petrie CJ, Voors AA, Robertson M, Van Veldhuisen DJ, Dargie HJ. A low pulse pressure
predicts mortality in subjects with heart failure after an acute myocardial infarction: a
post-hoc analysis of the CAPRICORN study. Clinical Research in Cardiology
2012;101(1):29-35.
Petrie CJ, Damman K, Jhund PS, Hillege HL, Van Veldhuisen DJ, Voors AA. Low pulse
pressure as a poor-man's indicator of a low cardiac index in patients with severe cardiac
dysfunction. Journal of Cardiovascular Medicine 2014;15(4):315-21.
Petzold K, Gansevoort RT, Ong ACM, Devuyst O, Rotar L, Eckardt KU, et al. Building a
network of ADPKD reference centres across Europe: the EuroCYST initiative.
Nephrology Dialysis Transplantation 2014;29:26-32.
Pieper PG, Silversides CK. Assessment of severity of pulmonary regurgitation.
European Journal of Echocardiography 2011;12(2).
Pieper PG, Hoendermis ES. Pregnancy in women with pulmonary hypertension.
Netherlands Heart Journal 2011;19(12):504-8.
Pieper PG. Pre-pregnancy risk assessment and counselling of the cardiac patient.
Netherlands Heart Journal 2011;19(11):477-81.
Pieper PG, Hoendermis ES, Drijver YN. Cardiac surgery and percutaneous intervention
in pregnant women with heart disease. Netherlands Heart Journal 2012;20(3):125-8.
Pieper PG. The pregnant woman with heart disease: management of pregnancy and
delivery. Netherlands Heart Journal 2012;20(1):33-7.
Pieper PG, Walker F. Pregnancy in women with hypertrophic cardiomyopathy.
Netherlands Heart Journal 2013;21(1):14-8.
Pieper PG, Balci A, Aarnoudse JG, Kampman MAM, Sollie KM, Groen H, et al.
Uteroplacental Blood Flow, Cardiac Function, and Pregnancy Outcome in Women With
Congenital Heart Disease. Circulation 2013;128(23):2478-87.
Pieper PG, Lameijer H, Hoendermis ES. Pregnancy and pulmonary hypertension. Best
Practice & Research Clinical Obstetrics & Gynaecology 2014;28(4):579-91.
Piers LH, Touw HRW, Gansevoort R, Franssen CFM, Oudkerk M, Zijlstra F, et al.
Relation of Aortic Valve and Coronary Artery Calcium in Patients With Chronic Kidney
Disease to the Stage and Etiology of the Renal Disease. American Journal of Cardiology
2009;103(10):1473-7.
Ploegstra MJ, Douwes JM, Roofthooft MTR, Zijlstra WMH, Hillege HL, Berger RMF.
Identification of treatment goals in paediatric pulmonary arterial hypertension. European
Respiratory Journal 2014;44(6):1616-26.
Page 71 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Poelman JE, van der Werf RW, Douglas YL, van den Heuvel AFM, De Smet BJGL,
Mariani MA. Percutaneous Aortic Valve Replacement Using a Subclavian Artery Graft.
Annals of Thoracic Surgery 2012;94(4):E95-E96.
Polinder-Bos HA, Emmelot-Vonk MH, Gansevoort RT, Diepenbroek A, Gaillard CAJM.
High fall incidence and fracture rate in elderly dialysis patients. Netherlands Journal of
Medicine 2014;72(10):509-15.
Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, et al.
Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
American Journal of Emergency Medicine 2014;32(11):1433-4.
Ponikowski P, Metra M, Teerlink JR, Unemori E, Felker GM, Voors AA, et al. Design of
the RELAXin in Acute Heart Failure Study. American Heart Journal
2012;163(2):149-U234.
Ponikowski P, Mitrovic V, Ruda M, Fernandez A, Voors AA, Vishnevsky A, et al. A
randomized, double-blind, placebo-controlled, multicentre study to assess
haemodynamic effects of serelaxin in patients with acute heart failure. European Heart
Journal 2014;35(7):431-41.
Pose PN, Kuijpers M, Ebels T, Zijlstra F. The relation between volume and outcome of
coronary interventions: a systematic review and meta-analysis. European Heart Journal
2010;31(16):1985-92.
Postema PG, van den Berg MP, van Tintelen JP, van den Heuvel F, Grundeken M,
Hofman N, et al. Founder mutations in the Netherlands SCN5a 1795insD, the first
described arrhythmia overlap syndrome and one of the largest and best characterised
families worldwide. Netherlands Heart Journal 2009;17(11):422-8.
Postmus D, Pari AAA, Jaarsma T, Luttik ML, Van Veldhuisen DJ, Hillege HL, et al. A
trial-based economic evaluation of 2 nurse-led disease management programs in heart
failure. American Heart Journal 2011;162(6):1096-104.
Postmus D, Van Veldhuisen DJ, Jaarsma T, Luttik ML, Lassus J, Mebazaa A, et al. The
COACH risk engine: a multistate model for predicting survival and hospitalization in
patients with heart failure. European Journal of Heart Failure 2012;14(2):168-75.
Postmus D, de Graaf G, Hillege HL, Steyerberg EW, Buskens E. A method for the early
health technology assessment of novel biomarker measurement in primary prevention
programs. Statistics in Medicine 2012;31(23):2733-44.
Postmus D, Tervonen T, van Valkenhoef G, Hillege HL, Buskens E. A multi-criteria
decision analysis perspective on the health economic evaluation of medical
interventions. European Journal of Health Economics 2014;15(7):709-16.
Pot LM, Alizadeh BZ, Ahrenberg D, Coenraads PJ, Snieder H, Blomeke B. No major role
for glutathione S-transferase gene polymorphisms in sensitization to
para-phenylenediamine and other xenobiotics: a study of association and a
meta-analysis. British Journal of Dermatology 2011;164(4):890-2.
Page 72 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Pot LM, Alizadeh BZ, Ahrenberg D, Coenraads PJ, Snieder H, Blomeke B. Comment on
'No major role for glutathione S-transferase gene polymorphisms in sensitization to
para-phenylenediamine and other xenobiotics: a study of association and a
meta-analysis': reply from authors. British Journal of Dermatology 2011;165(3):693-4.
Pozzoli A, De Maat GE, Hillege HL, Boogaard JJA, Natour E, Mariani MA. Severe
Thrombocytopenia and Its Clinical Impact After Implant of the Stentless Freedom Solo
Bioprosthesis. Annals of Thoracic Surgery 2013;96(5):1581-6.
Preiss D, Van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H, et al. Eplerenone
and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in
Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
European Journal of Heart Failure 2012;14(8):909-15.
Prins BP, Lagou V, Asselbergs FW, Snieder H, Fu JY. Genetics of coronary artery
disease: Genome-wide association studies and beyond. Atherosclerosis
2012;225(1):1-10.
Procter M, Suter TM, de Azambuja E, Dafni U, van Dooren V, Muehlbauer S, et al.
Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the
Herceptin Adjuvant (HERA) Trial. Journal of Clinical Oncology 2010;28(21):3422-8.
Pultrum BB, Bosch DJ, Nijsten MWN, Rodgers MGG, Groen H, Slaets JPJ, et al.
Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of
Age Alone in Determining the Postoperative Course and Survival. Annals of Surgical
Oncology 2010;17(6):1572-80.
Pundziute G, Schuijf JD, van Werkhoven JM, Nucifora G, van der Wall EE, Jukema JW,
et al. Head-to-head comparison between bicycle exercise testing and coronary calcium
score and coronary stenoses on multislice computed tomography. Coronary Artery
Disease 2009;20(4):281-7.
Pundziute G, Schuijf JD, Jukema JW, van Werkhoven JM, Nucifora G, Decramer I, et al.
Type 2 diabetes is associated with more advanced coronary atherosclerosis on
multislice computed tomography and virtual histology intravascular ultrasound. Journal
of Nuclear Cardiology 2009;16(3):376-83.
Pundziute G, Schuijf JD, van Velzen JLE, Jukema JW, van Werkhoven JM, Nucifora G,
et al. Assessment With Multi-Slice Computed Tomography and Gray-Scale and Virtual
Histology Intravascular Ultrasound of Gender-Specific Differences in Extent and
Composition of Coronary Atherosclerotic Plaques in Relation to Age. American Journal
of Cardiology 2010;105(4):480-6.
Qi X, Yeh YH, Chartier D, Xiao L, Tsuji Y, Brundel BJJM, et al. The
Calcium/Calmodulin/Kinase System and Arrhythmogenic Afterdepolarizations in
Bradycardia-Related Acquired Long-QT Syndrome. Circulation-Arrhythmia and
Electrophysiology 2009;2(3):295-304.
Qi XY, Diness JG, Brundel BJJM, Zhou XB, Naud P, Wu CT, et al. Role of
Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology
and Fibrillation in the Dog. Circulation 2014;129(4):430-40.
Page 73 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Qian C, Schoemaker RG, van Gilst WH, Roks AJM. The role of the
renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. Clinical
Science 2009;116(3-4):301-14.
Queiroz KCS, Tio RA, Zeebregts CJ, Bijlsma MF, Zijlstra F, Badlou B, et al. Human
Plasma Very Low Density Lipoprotein Carries Indian Hedgehog. Journal of Proteome
Research 2010;9(11):6052-9.
Radonic T, de Witte P, Groenink M, de Bruin-Bon RACM, Timmermans J, Scholte AJH,
et al. Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome.
Clinical Genetics 2011;80(4):346-53.
Radonic T, de Witte P, Groenink M, de Waard V, Lutter R, van Eijk M, et al.
Inflammation Aggravates Disease Severity in Marfan Syndrome Patients. Plos One
2012;7(3).
Rafi S, van Doormaal FF, Kamphuisen RW, Gerdes VEA, van Lienden KP, Gerdes VEA,
et al. Venous thrombo-embolism and aortic calcifications; more evidence on the link
between venous and arterial thrombosis. Thrombosis Research 2009;124(3):381-2.
Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, et al. Effect of
Statins on Venous Thromboembolic Events: A Meta-analysis of Published and
Unpublished Evidence from Randomised Controlled Trials. Plos Medicine 2012;9(9).
Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, et al.
Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show
Sexual Dimorphism in Genetic Loci for Anthropometric Traits. Plos Genetics 2013;9(6).
Rapsomaniki E, White IR, Wood AM, Thompson SG. A framework for quantifying net
benefits of alternative prognostic models. Statistics in Medicine 2012;31(2):114-30.
Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JHE, Hoorntje JCA, Gosselink ATM, et
al. Predictors of 30-day and 1-year mortality after primary percutaneous coronary
intervention for ST-elevation myocardial infarction. Coronary Artery Disease
2009;20(6):415-21.
Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JHE, Hoorntje JCA, Gosselink ATM, et
al. Primary percutaneous coronary intervention for ST-elevation myocardial infarction:
From clinical trial to clinical practice. International Journal of Cardiology
2009;134(1):104-9.
Raum MR, Nijsten MWN, Vogelzang M, Schuring F, Lefering R, Bouillon B, et al.
Emergency trauma score: An instrument for early estimation of trauma severity. Critical
Care Medicine 2009;37(6):1972-7.
Reznichenko A, Boger CA, Snieder H, van den Born J, de Borst MH, Damman J, et al.
UMOD as a susceptibility gene for end-stage renal disease. Bmc Medical Genetics
2012;13.
Page 74 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MCRF, et
al. CUBN as a Novel Locus for End-Stage Renal Disease: Insights from Renal
Transplantation. Plos One 2012;7(5).
Reznichenko A, Sinkeler SJ, Snieder H, van den Born J, de Borst MH, Damman J, et al.
SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in
renal transplantation. Physiological Genomics 2013;45(6):201-9.
Rienstra M, Cheng S, Larson MG, Mccabe EL, Booth SL, Jacques PF, et al. Vitamin D
status is not related to development of atrial fibrillation in the community. American Heart
Journal 2011;162(3):538-41.
Rienstra M. Atrial fibrillation and cardiac resynchronization therapy: how should rate be
controlled? European Journal of Heart Failure 2012;14(6):569-70.
Rienstra M, Sun JX, Magnani JW, Sinner MF, Lubitz SA, Sullivan LM, et al. White Blood
Cell Count and Risk of Incident Atrial Fibrillation (From the Framingham Heart Study).
American Journal of Cardiology 2012;109(4):533-7.
Rienstra M, Sun JX, Lubitz SA, Frankel DS, Vasan RS, Levy D, et al. Plasma resistin,
adiponectin, and risk of incident atrial fibrillation: The Framingham Offspring Study.
American Heart Journal 2012;163(1):119-U151.
Rienstra M, Lubitz SA, Mahida S, Sinner MF, Ellinor PT, Van Gelder IC, et al. Response
to Letter Regarding Article, "Symptoms and Functional Status of Patients With Atrial
Fibrillation: State of the Art and Future Research Opportunities". Circulation
2012;126(24):E350.
Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, et al. Symptoms
and Functional Status of Patients With Atrial Fibrillation State of the Art and Future
Research Opportunities. Circulation 2012;125(23):2933-43.
Rienstra M, McManus DD, Benjamin EJ. Novel Risk Factors for Atrial Fibrillation Useful
for Risk Prediction and Clinical Decision Making? Circulation 2012;125(20):E941-E946.
Rienstra M, Van Gelder IC. Ventricular Rate Control of Atrial Fibrillation in Heart Failure.
Heart Failure Clinics 2013;9(4):397-+.
Rienstra M, Lyass A, Murabito JM, Magnani JW, Lubitz SA, Massaro JM, et al.
Reciprocal relations between physical disability, subjective health, and atrial fibrillation:
The Framingham Heart Study. American Heart Journal 2013;166(1):171-+.
Rienstra M, Yin XY, Larson MG, Fontes JD, Magnani JW, McManus DD, et al. Relation
between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and
incident atrial fibrillation. American Heart Journal 2014;167(1):109-+.
Rienstra M, Vermond RA, Crijns HJGM, Tijssen JGP, Van Gelder IC. Asymptomatic
persistent atrial fibrillation and outcome: Results of the RACE study. Heart Rhythm
2014;11(6):939-45.
Page 75 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Riese H, Rijsdijk FV, Rosmalen JGM, Snieder H, Ormel J. Neuroticism and Morning
Cortisol Secretion: Both Heritable, But No Shared Genetic Influences. Journal of
Personality 2009;77(5):1561-76.
Riese H, Rijsdijk FV, Snieder H, Ormel J. The Twin Interdisciplinary Neuroticism Study.
Twin Research and Human Genetics 2013;16(1):268-70.
Riese H, van den Heuvel ER, Snieder H, den Dunnen WF, Plosch T, Kema IP, et al.
Association Between Methylation of the Slc6A4 Promoter Region in Peripheral Blood
Leukocytes and Methylation in Amygdala Tissue. Psychosomatic Medicine
2014;76(3):244-6.
Riese H, Snieder H, Jeronimus BF, Korhonen T, Rose RJ, Kaprio J, et al. Timing of
Stressful Life Events Affects Stability and Change of Neuroticism. European Journal of
Personality 2014;28(2):193-200.
Riese H, Munoz LM, Hartman CA, Ding XH, Su SY, Oldehinkel AJ, et al. Identifying
Genetic Variants for Heart Rate Variability in the Acetylcholine Pathway. Plos One
2014;9(11).
Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW, et al. GWAS of
126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment.
Science 2013;340(6139):1467-71.
Righini M, Kamphuisen PW, Le Gal G. Age-Adjusted D-Dimer Cutoff Levels and
Pulmonary Embolism Reply. Jama-Journal of the American Medical Association
2014;312(5):557-8.
Righini M, van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, et al.
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism The ADJUST-PE
Study. Jama-Journal of the American Medical Association 2014;311(11):1117-24.
Rijnbeek PR, van Herpen G, Bots ML, Man S, Verweij N, Hofman A, et al. Normal values
of the electrocardiogram for ages 16-90 years. Journal of Electrocardiology
2014;47(6):914-21.
Rijsdijk FV, Riese H, Tops M, Snieder H, Brouwer WH, Smid HGOM, et al. Neuroticism,
recall bias and attention bias for valenced probes: a twin study. Psychological Medicine
2009;39(1):45-54.
Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, et al.
Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With
Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31).
Diabetes Care 2013;36(10):3201-7.
Roberts JD, Herkert JC, Rutberg J, Nikkel SM, Wiesfeld ACP, Dooijes D, et al. Detection
of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathy.
Clinical Genetics 2013;83(5):452-6.
Page 76 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Rogers JK, McMurray JJV, Pocock SJ, Zannad F, Krum H, Van Veldhuisen DJ, et al.
Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms Analysis of
Repeat Hospitalizations. Circulation 2012;126(19):2317-23.
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al.
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis
Quality Initiative. European Heart Journal 2010;31(6):703-711C.
Roofthooft MTR, Douwes JM, Vrijlandt EJLE, Berger RMF. Frequency and Prognostic
Significance of Hemoptysis in Pediatric Pulmonary Arterial Hypertension. American
Journal of Cardiology 2013;112(9):1505-9.
Roolvink V, Rasoul S, Ottervanger JP, Dambrink JHE, Lipsic E, van der Horst ICC, et al.
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled
clinical trial of early administration of intravenous beta-blockers in patients with
ST-elevation myocardial infarction before primary percutaneous coronary intervention:
EARLY beta-blocker Administration before primary PCI in patients with ST-elevation
Myocardial Infarction trial. American Heart Journal 2014;168(5):661-6.
Roscioni SS, de Zeeuw D, Hellemons ME, Mischak H, Zurbig P, Bakker SJL, et al. A
urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes
mellitus. Diabetologia 2013;56(2):259-67.
Rosmalen JGM, Kema IP, Wust S, van der Ley C, Visser ST, Snieder H, et al. 24 h
urinary free cortisol in large-scale epidemiological studies: Short-term and long-term
stability and sources of variability. Psychoneuroendocrinology 2014;47:10-6.
Rossignol P, Dobre D, McMurray JJV, Swedberg K, Krum H, Van Veldhuisen DJ, et al.
Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening
Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor
Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy Results From
the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure
(EMPHASIS-HF). Circulation-Heart Failure 2014;7(1):51-8.
Ruifrok WPT, de Boer RA, Iwakura A, Silver M, Kusano K, Tio RA, et al.
Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice
with hind-limb ischemia. Vascular Medicine 2009;14(1):29-36.
Ruifrok WPT, Qian C, Sillje HHW, van Goor H, Van Veldhuisen DJ, van Gilst WH, et al.
Heart failure-associated anemia: bone marrow dysfunction and response to
erythropoietin. Journal of Molecular Medicine-Jmm 2011;89(4):377-87.
Ruifrok WT, Westenbrink BD, de Boer RA, den Hamer IJ, Erasmus ME, Mungroop HE,
et al. Apoptosis during CABG surgery with the use of cardiopulmonary bypass is
prominent in ventricular but not in atrial myocardium. Netherlands Heart Journal
2010;18(5):236-42.
Ruiter JS, Berkenbosch-Nieuwhof K, van den Berg MP, van Dijk R, Middel B, van
Tintelen JP. The Importance of the Family History in Caring for Families With Long QT
Syndrome and Dilated Cardiomyopathy. American Journal of Medical Genetics Part A
2010;152A(3):607-12.
Page 77 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Rump P, Jongbloed JDH, Sikkema-Raddatz B, Mundlos S, Klopocki E, van der Luijt RB.
Madelung Deformity in a Girl With a Novel and De Novo Mutation in the GNAS Gene.
American Journal of Medical Genetics Part A 2011;155A(10):2566-70.
Ruys TPE, Roos-Hesselink JW, Hall R, Subirana-Domenech MT, Grando-Ting J,
Estensen M, et al. Heart failure in pregnant women with cardiac disease: data from the
ROPAC. Heart 2014;100(3):231-U116.
Said SAM, Nijhuis RLG, op den Akker JW, Kimman GP, Van Houwelingen KG, Gerrits
D, et al. Diagnostic and therapeutic approach of congenital solitary coronary artery
fistulas in adults: Dutch case series and review of literature. Netherlands Heart Journal
2011;19(4):183-91.
Said SAM, Oortman RM, Hofstra JH, Verhorst PMJ, Slart RHJA, de Haan MW, et al.
Coronary artery-bronchial artery fistulas: report of two Dutch cases with a review of the
literature. Netherlands Heart Journal 2014;22(4):139-47.
Said SAM, Nijhuis RLG, op den Akker JW, Takechi M, Slart RHJA, Bos JS, et al.
Unilateral and Multilateral Congenital Coronary-Pulmonary Fistulas in Adults: Clinical
Presentation, Diagnostic Modalities, and Management With a Brief Review of the
Literature. Clinical Cardiology 2014;37(9):536-45.
Saleem BR, Pol RA, Slart RHJA, Reijnen MMPJ, Zeebregts CJ.
F-18-Fluorodeoxyglucose Positron Emission Tomography/CT Scanning in Diagnosing
Vascular Prosthetic Graft Infection. Biomed Research International 2014.
Saltzherr TP, Wendt KW, Nieboer P, Nijsten MWN, Valk JP, Luitse JSK, et al.
Preventability of trauma deaths in a Dutch Level-1 trauma centre. Injury-International
Journal of the Care of the Injured 2011;42(9):870-3.
Sanders YV, Eikenboom J, de Wee EM, van der Bom JG, Cnossen MH,
genaar-Dujardin MEL, et al. Reduced prevalence of arterial thrombosis in von Willebrand
disease. Journal of Thrombosis and Haemostasis 2013;11(5):845-54.
Sanfilippo PG, Hammond CJ, Staffieri SE, Kearns LS, Liew SHM, Barbour JM, et al.
Heritability of Strabismus: Genetic Influence Is Specific to Eso-Deviation and
Independent of Refractive Error. Twin Research and Human Genetics
2012;15(5):624-30.
Sani MU, Davison BA, Cotter G, Sliwa K, Edwards C, Liu L, et al. Renal dysfunction in
African patients with acute heart failure. European Journal of Heart Failure
2014;16(7):718-28.
Santos ABS, Kraigher-Krainer E, Bello N, Claggett B, Zile MR, Pieske B, et al. Left
ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
European Heart Journal 2014;35(1):42-7.
Santos ABS, Kraigher-Krainer E, Gupta DK, Claggett B, Zile MR, Pieske B, et al.
Impaired left atrial function in heart failure with preserved ejection fraction. European
Journal of Heart Failure 2014;16(10):1096-103.
Page 78 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Sas AA, Snieder H, Korf J. Gompertz' survivorship law as an intrinsic principle of aging.
Medical Hypotheses 2012;78(5):659-63.
Sas AA, Jamshidi Y, Zheng DL, Wu T, Korf J, Alizadeh BZ, et al. The age-dependency
of genetic and environmental influences on serum cytokine levels: A twin study. Cytokine
2012;60(1):108-13.
Sas AA, Rijsdijk FV, Ormel J, Snieder H, Riese H. The Relationship Between
Neuroticism and Inflammatory Markers: A Twin Study. Twin Research and Human
Genetics 2014;17(3):177-82.
Saxena R, Elbers CC, Guo YR, Peter I, Gaunt TR, Mega JL, et al. Large-Scale
Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci.
American Journal of Human Genetics 2012;90(3):410-25.
Scheer MLJ, Pol RA, Haveman JW, Tielliu IFJ, Verhoeven ELG, Van den Dungen JJAM,
et al. Effectiveness of treatment for octogenarians with acute abdominal aortic
aneurysm. Journal of Vascular Surgery 2011;53(4):918-25.
Scheven L, de Jong PE, Hillege HL, Lambers Heerspink HJ, van Pelt LJ, Kootstra JE, et
al. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated
with cardiovascular events despite the cross-sectional association with albuminuria and
glomerular filtration rate. European Heart Journal 2012;33(18):2272-81.
Scheven L, van der Velde M, Heerspink HJL, de Jong PE, Gansevoort RT. Isolated
microalbuminuria indicates a poor medical prognosis. Nephrology Dialysis
Transplantation 2013;28(7):1794-801.
Scheven L, Halbesma N, de Jong PE, de Zeeuw D, Bakker SJL, Gansevoort RT.
Predictors of Progression in Albuminuria in the General Population: Results from the
PREVEND Cohort. Plos One 2013;8(5).
Scheven L, Joosten MM, de Jong PE, Bakker SJL, Gansevoort RT. The Association of
Albuminuria With Tubular Reabsorption of Uric Acid: Results From a General Population
Cohort. Journal of the American Heart Association 2014;3(2).
Schierenbeck F, Nijsten MWN, Franco-Cereceda A, Liska J. Introducing intravascular
microdialysis for continuous lactate monitoring in patients undergoing cardiac surgery: a
prospective observational study. Critical Care 2014;18(2).
Schirmer SH, Baumhakel M, Neuberger HR, Hohnloser SH, Van Gelder IC, Lip GYH, et
al. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Current Clinical
Evidence and Future Developments. Journal of the American College of Cardiology
2010;56(25):2067-76.
Schmitter D, Cotter G, Voors AA. Clinical use of novel biomarkers in heart failure:
towards personalized medicine. Heart Failure Reviews 2014;19(3):369-81.
Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, et al. Risk
assessment for incident heart failure in individuals with atrial fibrillation. European
Journal of Heart Failure 2013;15(8):843-9.
Page 79 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Scholtens AM, Tio RA, Willemsen A, Dierckx RAJO, Boersma HH, Zeebregts CJ, et al.
Myocardial perfusion reserve compared with peripheral perfusion reserve: A
[13N]ammonia PET study. Journal of Nuclear Cardiology 2011;18(2):238-46.
Schoormans D, Sprangers MAG, Pieper PG, van Melle JP, van Dijk APJ, Sieswerda GT,
et al. The Perspective of Patients with Congenital Heart Disease: Does Health Care
Meet Their Needs? Congenital Heart Disease 2011;6(3):219-27.
Schoormans D, Mulder BJM, van Melle JP, Pieper EG, van Dijk APJ, Sieswerda GJTJ,
et al. Patients with a congenital heart defect and Type D personality feel functionally
more impaired, report a poorer health status and quality of life, but use less healthcare.
European Journal of Cardiovascular Nursing 2012;11(3):349-55.
Schoormans D, Mulder BJM, van Melle JP, Pieper PG, van Dijk APJ, Sieswerda GT, et
al. Illness perceptions of adults with congenital heart disease and their predictive value
for quality of life two years later. European Journal of Cardiovascular Nursing
2014;13(1):86-94.
Schouwenburg JJ, Klinkenberg TJ, Maass AH, Mariani MA. Video-Assisted Thoracic
Placement of Epicardial Leads. Journal of Cardiac Surgery 2014;29(2):286-9.
Schroten NF, Gaillard CAJM, Van Veldhuisen DJ, Szymanski MK, Hillege HL, de Boer
RA. New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart
Failure Reviews 2012;17(2):191-201.
Schroten NF, Ruifrok WPT, Kleijn L, Dokter MM, Sillje HH, Heerspink HJL, et al.
Short-term vitamin D3 supplementation lowers plasma renin activity in patients with
stable chronic heart failure: An open-label, blinded end point, randomized prospective
trial (VitD-CHF trial). American Heart Journal 2013;166(2):357-+.
Schumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D, et al.
Genome-wide association and genetic functional studies identify autism susceptibility
candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proceedings of the
National Academy of Sciences of the United States of America 2011;108(17):7119-24.
Schuuring MJ, Vis JC, Bouma BJ, van Dijk APJ, van Melle JP, Pieper PG, et al.
Rationale and design of a trial on the role of bosentan in Fontan patients: Improvement
of exercise capacity? Contemporary Clinical Trials 2011;32(4):586-91.
Schuuring MJ, Vis JC, van Dijk APJ, van Melle JP, Vliegen HW, Pieper PG, et al. Impact
of bosentan on exercise capacity in adults after the Fontan procedure: a randomized
controlled trial. European Journal of Heart Failure 2013;15(6):690-8.
Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan JA, et al. Large-scale
association analyses identify new loci influencing glycemic traits and provide insight into
the underlying biological pathways. Nature Genetics 2012;44(9):991-+.
Sechterberger MK, Hutten BA, Hermanides J, Cohn DM, Hoekstra JBL, Kamphuisen
PW, et al. The incidence of diabetes mellitus following pulmonary embolism: a
retrospective cohort study. Journal of Thrombosis and Haemostasis
2012;10(12):2628-30.
Page 80 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Seferovic PM, Stoerk S, Filippatos G, Mareev V, Kavoliuniene A, Ristic AD, et al.
Organization of heart failure management in European Society of Cardiology member
countries: survey of the Heart Failure Association of the European Society of Cardiology
in collaboration with the Heart Failure National Societies/Working Groups. European
Journal of Heart Failure 2013;15(9):947-59.
Seshasai SRK, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. New England
Journal of Medicine 2011;364(9):829-41.
Shah S, Nelson CP, Gaunt TR, van der Harst P, Barnes T, Braund PS, et al. Four
Genetic Loci Influencing Electrocardiographic Indices of Left Ventricular Hypertrophy.
Circulation-Cardiovascular Genetics 2011;4(6):626-U314.
Shantsila E, Kamphuisen PW, Lip GYH. Circulating microparticles in cardiovascular
disease: implications for atherogenesis and atherothrombosis. Journal of Thrombosis
and Haemostasis 2010;8(11):2358-68.
Sheedfar F, Di Biase S, Koonen D, Vinciguerra M. Liver diseases and aging: friends or
foes? Aging Cell 2013;12(6):950-4.
Sheedfar F, Sung MMY, paricio-Vergara M, Kloosterhuis NJ, Miquilena-Colina ME,
Vargas-Castrillon J, et al. Increased hepatic CD36 expression with age is associated
with enhanced susceptibility to nonalcoholic fatty liver disease. Aging-Us
2014;6(4):281-95.
Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C
versus Creatinine in Determining Risk Based on Kidney Function. New England Journal
of Medicine 2013;369(10):932-43.
Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus Creatinine for Kidney
Function-Based Risk. New England Journal of Medicine 2013;369(25):2459.
Sikkema-Raddatz B, Johansson LF, de Boer EN, Almomani R, Boven LG, van den Berg
MP, et al. Targeted Next-Generation Sequencing can Replace Sanger Sequencing in
Clinical Diagnostics. Human Mutation 2013;34(7):1035-42.
Simino J, Shi G, Bis JC, Chasman DI, Ehret GB, Gu XJ, et al. Gene-Age Interactions in
Blood Pressure Regulation: A Large-Scale Investigation with the CHARGE, Global
BPgen, and ICBP Consortia. American Journal of Human Genetics 2014;95(1):24-38.
Sinkeler SJ, Damman K, Van Veldhuisen DJ, Hillege H, Navis G. A re-appraisal of
volume status and renal function impairment in chronic heart failure: combined effects of
pre-renal failure and venous congestion on renal function. Heart Failure Reviews
2012;17(2):263-70.
Sinner MF, Wang N, Fox CS, Fontes JD, Rienstra M, Magnani JW, et al. Relation of
Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation.
American Journal of Cardiology 2013;111(2):219-24.
Page 81 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Slart RHJA, Tio RA, Zijlstra F, Dierckx RA. Diagnostic pathway of integrated SPECT/CT
for coronary artery disease. European Journal of Nuclear Medicine and Molecular
Imaging 2009;36(11):1829-34.
Slart RHJA, Tio RA, van der Vleuten PA, Willems TP, Lubbers DD, Dierckx RA, et al.
Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in
patients with idiopathic dilated cardiomyopathy. Journal of Nuclear Cardiology
2010;17(3):479-85.
Slart RHJA, Zeebregts CJ, Hillege HL, de Sutter J, Dierckx RAJO, Van Veldhuisen DJ,
et al. Myocardial Perfusion Reserve After a PET-Driven Revascularization Procedure: A
Strong Prognostic Factor. Journal of Nuclear Medicine 2011;52(6):873-9.
Slart RHJA, Glauche J, Golestani R, Zeebregts CJ, Jansen JW, Dierckx RAJO, et al.
PET and MRI for the evaluation of regional myocardial perfusion and wall thickening
after myocardial infarction. European Journal of Nuclear Medicine and Molecular
Imaging 2012;39(6):1065-9.
Slebos DJ, Klooster K, Erasmus M. Emphysema! American Journal of Respiratory and
Critical Care Medicine 2012;186(2):197.
Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current
state of knowledge on aetiology, diagnosis, management, and therapy of peripartum
cardiomyopathy: a position statement from the Heart Failure Association of the
European Society of Cardiology Working Group on peripartum cardiomyopathy.
European Journal of Heart Failure 2010;12(8):767-78.
Sliwa K, Hilfiker-Kleiner D, Mebazaa A, Petrie MC, Maggioni AP, Regitz-Zagrosek V, et
al. EURObservational Research Programme: a worldwide registry on peripartum
cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the
European Society of Cardiology Working Group on PPCM. European Journal of Heart
Failure 2014;16(5):583-91.
Smilde TDJ, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, et al.
Differential associations between renal function and "modifiable" risk factors in patients
with chronic heart failure. Clinical Research in Cardiology 2009;98(2):121-9.
Smilde TDJ, Van Veldhuisen DJ, van den Berg MP. Prognostic value of heart rate
variability and ventricular arrhythmias during 13-year follow-up in patients with mild to
moderate heart failure. Clinical Research in Cardiology 2009;98(4):233-9.
Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker
SJL, et al. Albuminuria, Estimated GFR, Traditional Risk Factors, and Incident
Cardiovascular Disease: The PREVEND (Prevention of Renal and Vascular Endstage
Disease) Study. American Journal of Kidney Diseases 2012;60(5):804-11.
Smit JJJ, van Oeveren W, Ottervanger JP, Slingerland RJ, Remijn JA, Zijlstra F, et al.
Iron-induced platelet aggregation measurement: a novel method to measure platelet
function in stenting for ST segment elevation myocardial infarction. European Journal of
Clinical Investigation 2009;39(2):103-9.
Page 82 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Smit MD, Van Gelder IC. Valsartan and Recurrent Atrial Fibrillation. New England
Journal of Medicine 2009;361(5):532.
Smit MD, Van Veldhuisen DJ, Van Gelder IC. Guidelines for Atrial Fibrillation in Heart
Failure Need To Be Clarified. Journal of the American College of Cardiology
2010;55(2):167.
Smit MD, Maass AH, Hillege HL, Wiesfeld ACP, Van Veldhuisen DJ, Van Gelder IC.
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving
cardiac resynchronization therapy. European Journal of Heart Failure
2011;13(5):543-50.
Smit MD, Van Gelder IC. New treatment options for atrial fibrillation: towards patient
tailored therapy. Heart 2011;97(21):1796-802.
Smit MD, Crijns HJGM, Tijssen JGP, Hillege HL, Alings M, Tuininga YS, et al. Effect of
Lenient Versus Strict Rate Control on Cardiac Remodeling in Patients With Atrial
Fibrillation. Journal of the American College of Cardiology 2011;58(9):942-9.
Smit MD, Maass AH, De Jong AM, Kobold ACM, Van Veldhuisen DJ, Van Gelder IC.
Role of inflammation in early atrial fibrillation recurrence. Europace 2012;14(6):810-7.
Smit MD, Moes ML, Van Gelder IC. Antiarrhythmic drug treatment after cardioversion of
atrial fibrillation. Lancet 2012;380(9852):1467.
Smit MD, Moes ML, Maass AH, Achekar ID, Van Geel PP, Hillege HL, et al. The
importance of whether atrial fibrillation or heart failure develops first. European Journal
of Heart Failure 2012;14(9):1030-40.
Snijder PM, de Boer RA, Bos EM, van den Born JC, Ruifrok WPT, Vreeswijk-Baudoin I,
et al. Gaseous Hydrogen Sulfide Protects against Myocardial Ischemia-Reperfusion
Injury in Mice Partially Independent from Hypometabolism. Plos One 2013;8(5).
Sochalski J, Jaarsma T, Krumholz HM, Laramee A, McMurray JJV, Naylor MD, et al.
What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs
2009;28(1):179-89.
Sofat R, Hingorani AD, Smeeth L, Humphries SE, Talmud PJ, Cooper J, et al.
Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer
Protein Inhibitors With CETP Gene Polymorphisms. Circulation 2010;121(1):52-62.
Solomon SD, Zile M, Pieske B, Voors AA, Shah A, Kraigher-Krainer E, et al. The
angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection
fraction: a phase 2 double-blind randomised controlled trial. Lancet
2012;380(9851):1387-95.
Sotoodehnia N, Isaacs A, de Bakker PIW, Dorr M, Newton-Cheh C, Nolte IM, et al.
Common variants in 22 loci are associated with QRS duration and cardiac ventricular
conduction. Nature Genetics 2010;42(12):1068-U62.
Page 83 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Spithoven EM, Bakker SJL, Kootstra-Ros JE, de Jong PE, Gansevoort RT. Stability of
creatinine and cystatin C in whole blood. Clinical Biochemistry 2013;46(15):1611-4.
Spithoven EM, Meijer E, Boertien WE, Sinkeler SJ, Tent H, de Jong PE, et al. Tubular
Secretion of Creatinine in Autosomal Dominant Polycystic Kidney Disease:
Consequences for Cross-sectional and Longitudinal Performance of Kidney Function
Estimating Equations. American Journal of Kidney Diseases 2013;62(3):531-40.
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, et al. Analysis of
data from the ERA-EDTA Registry indicates that conventional treatments for chronic
kidney disease do not reduce the need for renal replacement therapy in autosomal
dominant polycystic kidney disease. Kidney International 2014;86(6):1244-52.
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, et al. Renal
replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in
Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry.
Nephrology Dialysis Transplantation 2014;29:15-25.
Spronk HMH, De Jong AM, Crijns HJ, Schotten U, Van Gelder IC, Ten Cate H.
Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.
Cardiovascular Research 2014;101(3):344-51.
Squizzato A, Galli M, Romualdi E, Dentali F, Kamphuisen PW, Guasti L, et al. Statins,
fibrates, and venous thromboembolism: a meta-analysis. European Heart Journal
2010;31(10):1248-56.
ssink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A.
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective
multicenter investigator-initiated trial to analyse whether daily measurements of
procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration
in intensive care unit patients - calculated sample size: 1816 patients. Bmc Infectious
Diseases 2013;13.
Steggerda R, Balt J, Damman K, van den Berg MP, ten Berg JM. Predictors of outcome
after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Special interest for the septal coronary anatomy. Netherlands Heart Journal
2013;21(11):504-9.
Steggerda RC, Damman K, Balt JC, Liebregts M, ten Berg JM, van den Berg MP.
Periprocedural Complications and Long-Term Outcome After Alcohol Septal Ablation
Versus Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy A Single-Center
Experience. Jacc-Cardiovascular Interventions 2014;7(11):1227-34.
Stoel MG, von Birgelen C, Zijlstra F. Aspiration of Embolized Thrombus During Primary
Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions
2009;73(6):781-6.
Stolk L, Perry JRB, Chasman DI, He CY, Mangino M, Sulem P, et al. Meta-analyses
identify 13 loci associated with age at menopause and highlight DNA repair and immune
pathways. Nature Genetics 2012;44(3):260-U55.
Page 84 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Stomp W, Fidler V, ten Duis HJ, Nijsten MWN. Relation of the Weather and the Lunar
Cycle With the Incidence of Trauma in the Groningen Region Over a 36-Year Period.
Journal of Trauma-Injury Infection and Critical Care 2009;67(5):1103-8.
Su SY, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, et al. Common Genetic
Contributions to Depressive Symptoms and Inflammatory Markers in Middle-Aged Men:
The Twins Heart Study. Psychosomatic Medicine 2009;71(2):152-8.
Su SY, Lampert R, Zhao JY, Bremner JD, Miller A, Snieder H, et al. Pleiotropy of
C-Reactive Protein Gene Polymorphisms With C-Reactive Protein Levels and Heart
Rate Variability in Healthy Male Twins. American Journal of Cardiology
2009;104(12):1748-54.
Su SY, Zhao JY, Bremner JD, Miller AH, Tang WN, Bouzyk M, et al. Serotonin
Transporter Gene, Depressive Symptoms, and Interleukin-6. Circulation-Cardiovascular
Genetics 2009;2(6):614-U205.
Su SY, Lampert R, Lee F, Bremner JD, Snieder H, Jones L, et al. Common Genes
Contribute to Depressive Symptoms and Heart Rate Variability: The Twins Heart Study.
Twin Research and Human Genetics 2010;13(1):1-9.
Su SY, Zhu HD, Xu XJ, Wang X, Dong YB, Kapuku G, et al. DNA Methylation of the
LY86 Gene is Associated With Obesity, Insulin Resistance, and Inflammation. Twin
Research and Human Genetics 2014;17(3):183-91.
Sung MMY, Koonen DPY, Soltys CLM, Jacobs RL, Febbraio M, Dyck JRB. Increased
CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy
in the absence of cardiac dysfunction. Journal of Molecular Medicine-Jmm
2011;89(5):459-69.
Surakka I, Isaacs A, Karssen LC, Laurila PPP, Middelberg RPS, Tikkanen E, et al. A
Genome-Wide Screen for Interactions Reveals a New Locus on 4p15 Modifying the
Effect of Waist-to-Hip Ratio on Total Cholesterol. Plos Genetics 2011;7(10).
Swedberg K, Zannad F, McMurray JJV, Krum H, Van Veldhuisen DJ, Shi H, et al.
Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure Results From the
EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart
Failure) Study. Journal of the American College of Cardiology 2012;59(18):1598-603.
Swedberg K, Young JB, Anand IS, Cheng SF, Desai AS, Diaz R, et al. Treatment of
Anemia with Darbepoetin Alfa in Systolic Heart Failure. New England Journal of
Medicine 2013;368(13):1210-9.
Szymanski MK, Damman K, Van Veldhuisen DJ, van Gilst WH, Hillege HL, de Boer RA.
Prognostic value of renin and prorenin in heart failure patients with decreased kidney
function. American Heart Journal 2011;162(3):487-93.
Szymanski MK, de Boer RA, Navis GJ, van Gilst WH, Hillege HL. Animal models of
cardiorenal syndrome: a review. Heart Failure Reviews 2012;17(3):411-20.
Page 85 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Szymanski MK, Buikema JH, Van Veldhuisen DJ, Koster J, van der Velden J, Hamdani
N, et al. Increased cardiovascular risk in rats with primary renal dysfunction; mediating
role for vascular endothelial function. Basic Research in Cardiology 2012;107(2).
Szymanski MK, Kruizinga S, Tio RA, Willemsen ATM, Schafers MA, Stegger L, et al.
Use of gated N-13-NH3 micro-PET to examine left ventricular function in rats. Nuclear
Medicine and Biology 2012;39(5):724-9.
Szymanski MK, Hillege HL, Danser AHJ, Garrelds IM, Schoemaker RG. Elevated
sensitivity to cardiac ischemia in proteinuric rats is independent of adverse cardiac
remodeling. Journal of Hypertension 2013;31(5):966-74.
Tahara N, Zandbergen HR, de Haas HJ, Petrov A, Pandurangi R, Yamaki T, et al.
Noninvasive Molecular Imaging of Cell Death in Myocardial Infarction using
In-111-GSAO. Scientific Reports 2014;4.
Tan ES, Mulder BA, Rienstra M, Wiesfeld ACP, Ahmed S, Zijlstra F, et al. Pulmonary
vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation A
single centre and single operator experience in the Netherlands. Netherlands Heart
Journal 2009;17(10):366-72.
Tan ES, Jessurun GAJ, Anthonio RL, Slart RHJA, Zijlstra F, Tio RA. Electromechanical
mapping of the left ventricle: possible tool for online decision making in the
catheterization laboratory. Journal of Cardiovascular Medicine 2009;10(5):415-9.
Tan ES, van der Vleuten PA, Jessurun GAJ, Tio RA, Zijlstra F, Van Gelder IC.
Evaluation of global left ventricular function assessment of non-fluorescent
electromechanical endocardial mapping compared with biplane left ventricular contrast
angiography. Netherlands Heart Journal 2010;18(2):72-7.
te Rijdt WP, Jongbloed JDH, de Boer RA, Thiene G, Basso C, van den Berg MP, et al.
Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC).
European Journal of Human Genetics 2014;22(2).
Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, et al.
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a
multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb
study. Lancet 2009;373(9673):1429-39.
Teerlink JR, Iragui VJ, Mohr JP, Carson PE, Hauptman PJ, Lovett DH, et al. The Safety
of an Adenosine A(1)-Receptor Antagonist, Rolofylline, in Patients with Acute Heart
Failure and Renal Impairment Findings from PROTECT. Drug Safety 2012;35(3):233-44.
Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, et al.
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure
(RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013;381(9860):29-39.
Teichman SL, Unemori E, Dschietzig T, Conrad K, Voors AA, Teerlink JR, et al. Relaxin,
a pleiotropic vasodilator for the treatment of heart failure. Heart Failure Reviews
2009;14(4):321-9.
Page 86 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Tengborn L, Baudo F, Huth-Kuhne A, Knoebl P, Levesque H, Marco P, et al.
Pregnancy-associated acquired haemophilia A: results from the European Acquired
Haemophilia (EACH2) registry. Bjog-An International Journal of Obstetrics and
Gynaecology 2012;119(12):1529-37.
ter Avest E, Patist FM, ter Maaten JC, Nijsten MWN. Elevated lactate during
psychogenic hyperventilation. Emergency Medicine Journal 2011;28(4):269-73.
ter Maaten JM, Damman K, Hillege HL, Bakker SJ, Anker SD, Navis G, et al. Creatinine
excretion rate, a marker of muscle mass, is related to clinical outcome in patients with
chronic systolic heart failure. Clinical Research in Cardiology 2014;103(12):976-83.
Tervonen T, van Valkenhoef G, Buskens E, Hillege HL, Postmus D. A stochastic
multicriteria model for evidence-based decision making in drug benefit-risk analysis.
Statistics in Medicine 2011;30(12):1419-28.
Tielemans SMAJ, Geleijnse JM, van Baak MA, Engberink MF, Brink EJ, de Jong PE, et
al. Twenty-four hour urinary urea excretion and 9-year risk of hypertension: the
PREVEND study. Journal of Hypertension 2013;31(8):1564-9.
Timmer JR, Breet N, Svilaas T, Haaksma J, Van Gelder IC, Zijlstra F. Predictors of
ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with
primary coronary intervention. Netherlands Heart Journal 2010;18(3):122-8.
Timmer JR, Hoekstra M, Nijsten MWN, van der Horst ICC, Ottervanger JP, Slingerland
RJ, et al. Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in
Nondiabetic Patients With ST-Segment-Elevation Myocardial Infarction Treated With
Percutaneous Coronary Intervention. Circulation 2011;124(6):704-11.
Tio RA, Dabeshlim A, Siebelink HMJ, de Sutter J, Hillege HL, Zeebregts CJ, et al.
Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial
Perfusion Reserve in Patients with Ischemic Heart Disease. Journal of Nuclear Medicine
2009;50(2):214-9.
Tio RA, Slart RHJA, de Boer RA, van der Vleuten PA, de Jong RM, van Wijk LM, et al.
Reduced regional myocardial perfusion reserve is associated with impaired contractile
performance in idiopathic dilated cardiomyopathy. Netherlands Heart Journal
2009;17(12):470-4.
Tolani S, Pagler TA, Murphy AJ, Bochem AE, Abramowicz S, Welch C, et al.
Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation
and monocytosis: Studies in mice and FH children. Atherosclerosis 2013;229(1):79-85.
Tomaszewski M, Debiec R, Braund PS, Nelson CP, Hardwick R, Christofidou P, et al.
Genetic Architecture of Ambulatory Blood Pressure in the General Population Insights
From Cardiovascular Gene-Centric Array. Hypertension 2010;56(6):1069-U146.
Tomaszewski M, Charchar FJ, Nelson CP, Barnes T, Denniff M, Kaiser M, et al.
Pathway Analysis Shows Association between FGFBP1 and Hypertension. Journal of
the American Society of Nephrology 2011;22(5):947-55.
Page 87 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Torres VE, Meijer E, Bae KT, Chapman AB, Devuyst O, Gansevoort RT, et al. Rationale
and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal
Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study. American Journal of
Kidney Diseases 2011;57(5):692-9.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et
al. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease. New
England Journal of Medicine 2012;367(25):2407-18.
Torres VE, Gansevoort RT, Czerwiec FS. Tolvaptan in Autosomal Dominant Polycystic
Kidney Disease Reply. New England Journal of Medicine 2013;368(13):1259.
Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N, et al.
Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies
Multiple Blood-Pressure-Related Loci. American Journal of Human Genetics
2014;94(3):349-60.
Tromp J, van der Pol A, Klip IT, de Boer RA, Jaarsma T, van Gilst WH, et al. Fibrosis
Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and
Preserved Ejection Fraction. Circulation-Heart Failure 2014;7(3):457-U119.
Ukena C, Mahfoud F, Kindermann M, Kindermann I, Bals R, Voors AA, et al. The
cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung
disease. International Journal of Cardiology 2010;145(2):172-6.
Ulu N, Schoemaker RG, Henning RH, Buikema H, Teerlink T, Zijlstra FJ, et al.
Proteinuria-Associated Endothelial Dysfunction Is Strain Dependent. American Journal
of Nephrology 2009;30(3):209-17.
Vaduganathan M, Greene SJ, Fonarow GC, Voors AA, Butler J, Gheorghiade M.
Hemoconcentration-guided Diuresis in Heart Failure. American Journal of Medicine
2014;127(12):1154-9.
Vaessen SFC, Veldman RJ, Comijn EM, Snapper J, Sierts JA, van den Oever K, et al.
AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density
lipoprotein-choteslerol levels: correction of murine ApoA-I deficiency. Journal of Gene
Medicine 2009;11(8):697-707.
Vaessen SFC, linga-Thie GM, Ross CJD, Splint LJ, Castellani LW, Rensen PCN, et al.
Plasma apolipoprotein AV levels in mice are positively associated with plasma
triglyceride levels. Journal of Lipid Research 2009;50(5):880-4.
Vaessen SFC, Sierts JA, Kuivenhoven JA, Schaap FG. Efficient lowering of triglyceride
levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
Biochemical and Biophysical Research Communications 2009;379(2):542-6.
Valente MAE, Damman K, Dunselman PHJM, Hillege HL, Voors AA. Urinary Proteins in
Heart Failure. Progress in Cardiovascular Diseases 2012;55(1):44-55.
Page 88 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Valente MAE, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O'Connor CM, et
al. Diuretic response in acute heart failure: clinical characteristics and prognostic
significance. European Heart Journal 2014;35(19):1284-+.
Valente MAE, Hillege HL, Navis G, Voors AA, Dunselman PHJM, Van Veldhuisen DJ, et
al. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the
Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in
chronic systolic heart failure. European Journal of Heart Failure 2014;16(1):86-94.
van Albada ME, Bartelds B, Wijnberg H, Mohaupt S, Dickinson MG, Schoemaker RG, et
al. Gene expression profile in flow-associated pulmonary arterial hypertension with
neointimal lesions. American Journal of Physiology-Lung Cellular and Molecular
Physiology 2010;298(4):L483-L491.
van Ark J, Moser J, Lexis CPH, Bekkema F, Pop I, van der Horst ICC, et al. Type 2
diabetes mellitus is associated with an imbalance in circulating endothelial and smooth
muscle progenitor cell numbers. Diabetologia 2012;55(9):2501-12.
van Bockel EAP, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, van den Berg MP, et al.
Cardiac assessment of patients with late stage Duchenne muscular dystrophy.
Netherlands Heart Journal 2009;17(6):232-7.
van de Ven LLM, Van Veldhuisen DJ, Goulder M, Zilahi Z, Meyer WR, Willenheimer R.
The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and
function in heart failure. International Journal of Cardiology 2010;144(1):59-63.
Van De Wauwer C, Verschuuren EAM, van der Bij W, Nossent GD, Erasmus ME. The
use of non-heart-beating lung donors category III can increase the donor pool. European
Journal of Cardio-Thoracic Surgery 2011;39(6):E175-E180.
Van De Wauwer C, Munneke AJ, Engels GE, Berga FM, Rakhorst G, Nijsten MW, et al.
In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory
death donors category III. Transplant International 2013;26(5):485-92.
van den Berg MP, de Boer RA, van Tintelen JP. Brugada Syndrome or Brugada
Electrocardiogram? Journal of the American College of Cardiology 2009;53(17):1569.
van den Berg MP, van Spaendonck-Zwarts KY, Van Veldhuisen DJ, Gietema JA,
Postma A, van Tintelen JP. Familial dilated cardiomyopathy: another risk factor for
anthracycline-induced cardiotoxicity? European Journal of Heart Failure
2010;12(12):1297-9.
van den Berg MP, van Spaendonck-Zwarts KY, Van Veldhuisen DJ. Dilated
Cardiomyopathy Complicates Pregnancy Outcome: But How? Journal of the American
College of Cardiology 2010;55(20):2291.
van den Berg MP, van den Heuvel F, van Tintelen JP, Volders PGA, Van Gelder IC.
Successful treatment of a patient with symptomatic long QT syndrome type 3 using
ranolazine combined with a beta-blocker. International Journal of Cardiology
2014;171(1):90-2.
Page 89 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
van den Bogaard B, Holleboom AG, Duivenvoorden R, Hutten BA, Kastelein JJP,
Hovingh GK, et al. Patients with low HDL-cholesterol caused by mutations in LCAT have
increased arterial stiffness. Atherosclerosis 2012;225(2):481-5.
van den Wijngaard A, Volders P, van Tintelen JP, Jongbloed JDH, van den Berg MP,
Deprez RHL, et al. Recurrent and founder mutations in the Netherlands: cardiac
Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and
restrictive cardiomyopathy. Netherlands Heart Journal 2011;19(7-8):344-51.
van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, et al.
Rationale and design of a trial on the effect of angiotensin II receptor blockers on the
function of the systemic right ventricle. American Heart Journal 2010;160(5):812-8.
van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, et al.
Effect of Valsartan on Systemic Right Ventricular Function A Double-Blind, Randomized,
Placebo-Controlled Pilot Trial. Circulation 2013;127(3):322-+.
van der Bom T, Winter MM, Groenink M, Vliegen HW, Pieper PG, van Dijk APJ, et al.
Right Ventricular End-Diastolic Volume Combined With Peak Systolic Blood Pressure
During Exercise Identifies Patients at Risk for Complications in Adults With a Systemic
Right Ventricle. Journal of the American College of Cardiology 2013;62(10):926-36.
van der Harst P, Slart RHJA, Tio RA, Dunselman PHJM, Willemsen ATM, van den
Heuvel AFM, et al. Effects of Rosuvastatin on Coronary Flow Reserve and Metabolic
Mismatch in Patients With Heart Failure (from the CORONA Study). American Journal of
Cardiology 2010;105(4):517-21.
van der Harst P, Bakker SJL, de Boer RA, Wolffenbuttel BHR, Johnson T, Caulfield MJ,
et al. Replication of the five novel loci for uric acid concentrations and potential
mediating mechanisms. Human Molecular Genetics 2010;19(2):387-95.
van der Harst P, de Boer RA, Samani NJ, Wong LSM, Huzen J, Codd V, et al. Telomere
length and outcome in heart failure. Annals of Medicine 2010;42(1):36-44.
van der Harst P, Zhang WH, Leach IM, Rendon A, Verweij N, Sehmi J, et al.
Seventy-five genetic loci influencing the human red blood cell. Nature
2012;492(7429):369-+.
van der Horst ICC, de Boer RA, Hillege HL, Boomsma F, Voors AA, Van Veldhuisen DJ.
Neurohormonal profile of patients with heart failure and diabetes. Netherlands Heart
Journal 2010;18(4):190-6.
van der Horst ICC, Nijsten MWN. Is admission to and surviving the intensive care unit an
outcome measure of optimal treatment for patients with diabetes? Critical Care Medicine
2012;40(6):1981-3.
van der Horst ICC. Acute Coronary Syndromes Early Metabolic Modulation-A Solution
for Mi? Nature Reviews Cardiology 2012;9(7):377-8.
Page 90 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Van der Hulle T, Den Exter PL, Erkens PGM, van Es J, Mos ICM, Ten Cate H, et al.
Variable D-dimer thresholds for diagnosis of clinically suspected acute pulmonary
embolism. Journal of Thrombosis and Haemostasis 2013;11(11):1986-92.
Van der Hulle T, Den Exter PL, Mos ICM, Kamphuisen PW, Hovens MMC, Kruip MJHA,
et al. Optimization of the diagnostic management of clinically suspected pulmonary
embolism in hospitalized patients. British Journal of Haematology 2014;167(5):681-6.
van der Laan AM, Hirsch A, Haeck JDE, Nijveldt R, Delewi R, Biemond BJ, et al.
Recovery of Microcirculation After Intracoronary Infusion of Bone Marrow Mononuclear
Cells or Peripheral Blood Mononuclear Cells in Patients Treated by Primary
Percutaneous Coronary Intervention The Doppler Substudy of the Hebe Trial.
Jacc-Cardiovascular Interventions 2011;4(8):913-20.
van der Laan ME, Verhagen EA, Bos AF, Berger RMF, Kooi EMW. Effect of balloon
atrial septostomy on cerebral oxygenation in neonates with transposition of the great
arteries. Pediatric Research 2013;73(1):62-7.
van der Linde D, Yap SC, van Dijk APJ, Budts W, Pieper PG, van der Burgh PH, et al.
Effects of Rosuvastatin on Progression of Stenosis in Adult Patients With Congenital
Aortic Stenosis (PROCAS Trial). American Journal of Cardiology 2011;108(2):265-71.
van der Linde D, Andrinopoulou ER, Oechslin EN, Budts W, van Dijk APJ, Pieper PG, et
al. Congenital valvular aortic stenosis in young adults: Predictors for rate of progression
of stenosis and aortic dilatation. International Journal of Cardiology 2013;168(2):863-70.
van der Meer P, Van Veldhuisen DJ. Anaemia and renal dysfunction in chronic heart
failure. Heart 2009;95(21):1808-12.
van der Meer P, Groenveld HF, Januzzi JL, Van Veldhuisen DJ. Erythropoietin treatment
in patients with chronic heart failure: a meta-analysis. Heart 2009;95(16):1309-14.
van der Meer P, Van Veldhuisen DJ. Risk of bias in meta-analysis on
erythropoietin-stimulating agents in heart failure Reply. Heart 2009;95(15):1279.
van der Meer P, Lipsic E, Van Veldhuisen DJ. Asialoerythropoietin to Protect the Failing
Heart Is it Possible to Run With the Hare and Hunt With the Hounds? Journal of the
American College of Cardiology 2010;56(23):1959-60.
van der Meer P, Van Veldhuisen DJ. The unfulfilled promise of erythropoietin in patients
with MI. Nature Reviews Cardiology 2011;8(8):425-6.
van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, et al.
The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients
Presenting With Acute Decompensated Heart Failure. Journal of the American College
of Cardiology 2013;61(19):1973-81.
van der Most PJ, Vaez A, Prins BP, Munoz ML, Snieder H, Alizadeh BZ, et al.
QCGWAS: A flexible R package for automated quality control of genome-wide
association results. Bioinformatics 2014;30(8):1185-6.
Page 91 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
van der Pol A, Domian I, van der Meer P. Cardiac regeneration in left ventricular
dysfunction: are we asking the right questions? European Journal of Heart Failure
2012;14(1):1-4.
van der Roest WP, Pennings JM, Bakker M, van den Berg MP, van Tintelen JP. Family
Letters Are an Effective Way to Inform Relatives About Inherited Cardiac Disease.
American Journal of Medical Genetics Part A 2009;149A(3):357-63.
van der Smagt JJ, van der Zwaag PA, van Tintelen JP, Cox MGPJ, Wilde AAM, van
Langen IM, et al. Clinical and Genetic Characterization of Patients with Arrhythmogenic
Right Ventricular Dysplasia/Cardiomyopathy Caused by a Plakophilin-2 Splice Mutation.
Cardiology 2012;123(3):181-9.
van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, et al.
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart
Failure Data From CORONA and COACH. Circulation-Heart Failure 2013;6(2):219-+.
van der Velde M, Halbesma N, de Charro FT, Bakker SJL, de Zeeuw D, de Jong PE, et
al. Screening for Albuminuria Identifies Individuals at Increased Renal Risk. Journal of
the American Society of Nephrology 2009;20(4):852-62.
van der Velde M, de Jong PE, Gansevoort RT. Comparison of the yield of different
screening approaches to detect chronic kidney disease. Nephrology Dialysis
Transplantation 2010;25(10):3222-30.
van der Velde M, Bakker SJL, de Jong PE, Gansevoort RT. Influence of Age and
Measure of eGFR on the Association between Renal Function and Cardiovascular
Events. Clinical Journal of the American Society of Nephrology 2010;5(11):2053-9.
van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, et al.
Lower estimated glomerular filtration rate and higher albuminuria are associated with
all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk
population cohorts. Kidney International 2011;79(12):1341-52.
van der Velde M, Bello AK, Brantsma AH, El Nahas M, Bakker SJL, de Jong PE, et al.
Do albuminuria and hs-CRP add to the International Diabetes Federation definition of
the metabolic syndrome in predicting outcome? Nephrology Dialysis Transplantation
2012;27(6):2275-83.
van der Vleuten PA, Vogelzang M, Svilaas T, van der Horst ICC, Tio RA, Zijlstra F.
Predictive value of Q waves on the 12-lead electrocardiogram after reperfusion therapy
for ST elevation myocardial infarction. Journal of Electrocardiology 2009;42(4):310-8.
van der Vleuten PA, de Jonge GJ, Lubbers DD, Tio RA, Willems TP, Oudkerk M, et al.
Evaluation of global left ventricular function assessment by dual-source computed
tomography compared with MRI. European Radiology 2009;19(2):271-7.
Van der Wal MHL, Van Veldhuisen DJ, Veeger NJGM, Rutten FH, Jaarsma T.
Compliance with non-pharmacological recommendations and outcome in heart failure
patients. European Heart Journal 2010;31(12):1486-93.
Page 92 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Van der Wal MHL, Jaarsma T, Moser DK, van Gilst WH, Van Veldhuisen DJ. Qualitative
examination of compliance in heart failure patients in The Netherlands. Heart & Lung
2010;39(2):121-30.
van der Wall EE, de Boer MJ, Doevendans PA, Wilde AA, Zijlstra F. Major achievements
in cardiology in the past century: influence on Dutch cardiovascular medicine.
Netherlands Heart Journal 2009;17(4):136-9.
van der Werf C, Nederend I, Hofman N, van Geloven N, Ebink C, Frohn-Mulder IME, et
al. Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia
Disease Penetrance and Expression in Cardiac Ryanodine Receptor Mutation-Carrying
Relatives. Circulation-Arrhythmia and Electrophysiology 2012;5(4):748-56.
van der Zwaag PA, Jongbloed JDH, van den Berg MP, van der Smagt JJ, Jongbloed R,
Bikker H, et al. A Genetic Variants Database for Arrhythmogenic Right Ventricular
Dysplasia/Cardiomyopathy. Human Mutation 2009;30(9):1278-83.
van der Zwaag PA, Jongbloed JDH, van den Berg MP, Jonkman MF, van Tintelen JP.
Letter regarding the article: "R298Q mutation of p63 gene in autosomal dominant
ectodermal dysplasia associated with arrhythmogenic right ventricular cardiomyopathy"
by Valenzise et al. European Journal of Medical Genetics 2009;52(4):277.
van der Zwaag PA, Jongbloed JDH, van den Berg MP, Jonkman MF, van Tintelen JP.
Letter regarding the article: "R298Q mutation of p63 gene in autosomal dominant
ectodermal dysplasia associated with arrhythmogenic right ventricular cardiomyopathy"
by Valenzise et al. European Journal of Medical Genetics 2009;52(4):277.
van der Zwaag PA, Cox MGPJ, van der Werf C, Wiesfeld ACP, Jongbloed JDH, Dooijes
D, et al. Recurrent and founder mutations in the Netherlands Plakophilin-2 p.Arg79X
mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Netherlands Heart Journal 2010;18(12):583-91.
van der Zwaag PA, van Tintelen JP, Gerbens F, Jongbloed JDH, Boven LG, van der
Smagt JJ, et al. Haplotype sharing test maps genes for familial cardiomyopathies.
Clinical Genetics 2011;79(5):459-67.
van der Zwaag PA, van Tintelen JP. Counsel the genotype, treat the phenotype.
European Journal of Heart Failure 2011;13(11):1159-60.
van der Zwaag PA, van Rijsingen IAW, Asimaki A, Jongbloed JDH, Van Veldhuisen DJ,
Wiesfeld ACP, et al. Phospholamban R14del mutation in patients diagnosed with dilated
cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence
supporting the concept of arrhythmogenic cardiomyopathy. European Journal of Heart
Failure 2012;14(11):1199-207.
van der Zwaag PA, van Rijsingen IAW, de Ruiter R, Nannenberg EA, Groeneweg JA,
Post JG, et al. Recurrent and founder mutations in the Netherlands-Phospholamban
p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Netherlands Heart Journal
2013;21(6):286-93.
Page 93 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
van der Zwaag PA, Jongbloed JDH, van Tintelen JP. Genetic Diagnosis through
Whole-Exome Sequencing. New England Journal of Medicine 2014;370(11):1067.
van Deursen VM, Damman K, Hillege HL, van Beek AP, Van Veldhuisen DJ, Voors AA.
Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients.
Journal of Cardiac Failure 2010;16(1):84-90.
van Deursen VM, Edwards C, Cotter G, Davison BA, Damman K, Teerlink JR, et al.
Liver Function, In-Hospital, and Post-Discharge Clinical Outcome in Patients With Acute
Heart Failure-Results From the Relaxin for the Treatment of Patients With Acute Heart
Failure Study. Journal of Cardiac Failure 2014;20(6):407-13.
van Deursen VM, Damman K, van der Meer P, Wijkstra P, Luijckx GJ, van Beek A, et al.
Co-morbidities in heart failure. Heart Failure Reviews 2014;19(2):163-72.
van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, Van Veldhuisen
DJ, et al. Prognostic Value of Plasma Neutrophil Gelatinase-Associated Lipocalin for
Mortality in Patients With Heart Failure. Circulation-Heart Failure 2014;7(1):35-42.
van Deursen VM, Urso R, Laroche C, Damman K, Dahlstrom U, Tavazzi L, et al.
Co-morbidities in patients with heart failure: an analysis of the European Heart Failure
Pilot Survey. European Journal of Heart Failure 2014;16(1):103-11.
van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, et
al. Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for
Acute Decompensated Heart Failure Results From the Acute Study of Clinical
Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation
2014;130(12):958-+.
van Eersel MEA, Joosten H, Gansevoort RT, Dullaart RPF, Slaets JPJ, Izaks GJ. The
Interaction of Age and Type 2 Diabetes on Executive Function and Memory in Persons
Aged 35 Years or Older. Plos One 2013;8(12).
van Es J, Douma RA, Gerdes VEA, Kamphuisen PW, Buller HR. Acute pulmonary
embolism. Part 2: treatment. Nature Reviews Cardiology 2010;7(11):613-22.
van Es J, Douma RA, Schreuder SM, Middeldorp S, Kamphuisen PW, Gerdes VEA, et
al. Clinical Impact of Findings Supporting an Alternative Diagnosis on CT Pulmonary
Angiography in Patients With Suspected Pulmonary Embolism. Chest
2013;144(6):1893-9.
van Es J, Den Exter PL, Kaptein AA, Andela CD, Erkens PMG, Klok FA, et al. Quality of
life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. Thrombosis
Research 2013;132(5):500-5.
van Es J, Biere-Rafi S, Ahdi M, Kamphuisen PW, Meijers JCM, Gerdes VEA. Urinary
prothrombin fragment 1+2 in patients with venous thrombosis and myocardial infarction.
Journal of Thrombosis and Thrombolysis 2013;36(1):47-9.
Van Gelder IC, Crijns HJGM, van den Berg MP. Lenient versus Strict Rate Control in
Atrial Fibrillation REPLY. New England Journal of Medicine 2010;363(4):393-4.
Page 94 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Van Gelder IC, Groenveld HF, Crijns HJGM, Tuininga YS, Tijssen JGP, Alings AM, et al.
Lenient versus Strict Rate Control in Patients with Atrial Fibrillation. New England
Journal of Medicine 2010;362(15):1363-73.
Van Gelder IC, Haegeli LM, Brandes A, Heidbuchel H, Aliot E, Kautzner J, et al.
Rationale and current perspective for early rhythm control therapy in atrial fibrillation.
Europace 2011;13(11):1517-25.
Van Gelder IC, Phan HM, Wilkoff BL, Brown ML, Rogers T, Peterson BJ, et al.
Prognostic Significance of Atrial Arrhythmias in a Primary Prevention ICD Population.
Pace-Pacing and Clinical Electrophysiology 2011;34(9):1070-9.
van Hateren KJJ, Alkhalaf A, Kleefstra N, Groenier KH, de Jong PE, de Zeeuw D, et al.
Comparison of Midregional Pro-A-Type Natriuretic Peptide and the N-Terminal
Pro-B-Type Natriuretic Peptide for Predicting Mortality and Cardiovascular Events.
Clinical Chemistry 2012;58(1):293-7.
van Herk-Sukel MPP, Shantakumar S, Penning-van Beest FJA, Kamphuisen PW,
Majoor CJ, Overbeek LIH, et al. Pulmonary Embolism, Myocardial Infarction, and
Ischemic Stroke in Lung Cancer Patients: Results from a Longitudinal Study. Lung
2013;191(5):501-9.
van Huysduynen BH, Rienstra M. Atrial fibrillation: is there evidence to support an early
ablation strategy? Europace 2012;14(5):613-4.
van Langen IM, Arens Y, Baars H, Bokenkamp R, Delhaas T, Dooijes D, et al. Genetic
diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM).
Netherlands Heart Journal 2010;18(3):144-+.
Van Leuven SI, Birjmohun RS, Franssen R, Bisoendial RJ, De Kort H, Levels JHM, et al.
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of
C-reactive protein in humans. Journal of Thrombosis and Haemostasis
2009;7(2):347-54.
van Loon RLE, Roofthooft MTR, van Osch-Gevers M, Delhaas T, Strengers JLM, Blom
NA, et al. Clinical Characterization of Pediatric Pulmonary Hypertension: Complex
Presentation and Diagnosis. Journal of Pediatrics 2009;155(2):176-82.
van Loon RLE, Roofthooft MTR, Delhaas T, van Osch-Gevers M, ten Harkel ADJ,
Strengers JLM, et al. Outcome of Pediatric Patients With Pulmonary Arterial
Hypertension in the Era of New Medical Therapies. American Journal of Cardiology
2010;106(1):117-24.
van Loon RLE, Roofthooft MTR, Hillege HL, ten Harkel ADJ, van Osch-Gevers M,
Delhaas T, et al. Pediatric Pulmonary Hypertension in the Netherlands Epidemiology
and Characterization During the Period 1991 to 2005. Circulation
2011;124(16):1755-U136.
van Melle JP, Bot M, de Jonge P, de Boer RA, Van Veldhuisen DJ, Whooley MA.
Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable
Page 95 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Coronary Artery Disease Data from the Heart and Soul Study. Diabetes Care
2010;33(9):2084-9.
van Melle JP, van der Vleuten PA, Hummel YM, Nijveldt R, Tio RA, Voors AA, et al.
Predictive value of tissue Doppler imaging for left ventricular ejection fraction,
remodelling, and infarct size after percutaneous coronary intervention for acute
myocardial infarction. European Journal of Echocardiography 2010;11(7):596-601.
van Ockenburg SL, de Jonge P, van der Harst P, Ormel J, Rosmalen JGM. Does
neuroticism make you old? Prospective associations between neuroticism and leukocyte
telomere length. Psychological Medicine 2014;44(4):723-9.
van Oort RJ, Brown JH, Westenbrink BD. CaMKII confirms its promise in ischaemic
heart disease. European Journal of Heart Failure 2014;16(12):1268-9.
van Ree RM, de Vries APJ, Oterdoom LH, Seelen MA, Gansevoort RT, Schouten JP, et
al. Plasma Procalcitonin Is an Independent Predictor of Graft Failure Late After Renal
Transplantation. Transplantation 2009;88(2):279-87.
van Rheenen RWJ, Glaudemans AWJM, Plasschaert SLA, Noordzij W, Slart RHJA.
Cushingoid facies on F-18-FDG PET/CT. European Journal of Nuclear Medicine and
Molecular Imaging 2014;41(7):1460.
van Rijsingen IAW, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der
Kooi AJ, et al. Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation
Carriers A European Cohort Study. Journal of the American College of Cardiology
2012;59(5):493-500.
van Rijsingen IAW, Bakker A, Azim D, Hermans-van Ast JF, van der Kooi AJ, van
Tintelen JP, et al. Lamin A/C mutation is independently associated with an increased risk
of arterial and venous thromboembolic complications. International Journal of Cardiology
2013;168(1):472-7.
van Rijsingen IAW, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Hermans-van
Ast JF, et al. Gender-specific differences in major cardiac events and mortality in lamin
A/C mutation carriers. European Journal of Heart Failure 2013;15(4):376-84.
van Rijsingen IAW, van der Zwaag PA, Groeneweg JA, Nannenberg EA, Jongbloed
JDH, Zwinderman AH, et al. Outcome in Phospholamban R14del Carriers Results of a
Large Multicentre Cohort Study. Circulation-Cardiovascular Genetics
2014;7(4):455-U191.
Van Schouwenburg IM, Mahmoodi BK, Veeger NJGM, Bakker SJL, Kluin-Nelemans HC,
Meijer K, et al. Insulin resistance and risk of venous thromboembolism: results of a
population-based cohort study. Journal of Thrombosis and Haemostasis
2012;10(6):1012-8.
Van Schouwenburg IM, Mahmoodi BK, Veeger NJGM, Kluin-Nelemans HC, Gansevoort
RT, Meijer K. Elevated albuminuria associated with increased risk of recurrent venous
thromboembolism: results of a population-based cohort study. British Journal of
Haematology 2012;156(5):667-71.
Page 96 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, Muntinghe FLH, Dullaart RPF,
Kluin-Nelemans HC, et al. Lipid levels do not influence the risk of venous
thromboembolism Results of a population-based cohort study. Thrombosis and
Haemostasis 2012;108(5):923-9.
Van Schouwenburg IM, Gansevoort RT, Mahmoodi BK, Visser MM, Kluin-Nelemans HC,
Lijfering WM, et al. Increased risk of arterial thromboembolism after a prior episode of
venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage
Disease (PREVEND) Study. British Journal of Haematology 2012;159(2):216-22.
van Slooten YJ, Elzenga NJ, Waterbolk TW, van Melle JP, Berger RMF, Ebels T. The
Effect of Additional Pulmonary Blood Flow on Timing of the Total Cavopulmonary
Connection. Annals of Thoracic Surgery 2012;93(6):2028-34.
van Slooten YJ, Freling HG, van Melle JP, Mulder BJM, Jongbloed MRM, Ebels T, et al.
Long-term tricuspid valve prosthesis-related complications in patients with congenital
heart disease. European Journal of Cardio-Thoracic Surgery 2014;45(1):83-9.
van Sluis GL, Nieuwdorp M, Kamphuisen PW, van der Vlag J, Van Noorden CJF, Spek
CA. A Low Molecular Weight Heparin Inhibits Experimental Metastasis in Mice
Independently of the Endothelial Glycocalyx. Plos One 2010;5(6).
van Spaendonck-Zwarts KY, van Tintelen JP, Van Veldhuisen DJ, van der Werf R,
Jongbloed JDH, Paulus WJ, et al. Peripartum Cardiomyopathy as a Part of Familial
Dilated Cardiomyopathy. Circulation 2010;121(20):2169-75.
van Spaendonck-Zwarts KY, van Tintelen JP, Jongbloed JDH, Van Veldhuisen DJ, van
der Werf R, van den Berg MP, et al. Response to Letter Regarding Article, "Peripartum
Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy". Circulation
2011;123(2):E9.
van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JDH, de Walle HEK, Capetanaki
Y, van der Kooi AJ, et al. Desmin-related myopathy. Clinical Genetics
2011;80(4):354-66.
van Spaendonck-Zwarts KY, van der Kooi AJ, van den Berg MP, Ippel EF, Boven LG,
Yee WC, et al. Recurrent and founder mutations in the Netherlands: the cardiac
phenotype of founder mutations p.S13F and p.N342D. Netherlands Heart Journal
2012;20(5):219-28.
van Spaendonck-Zwarts KY, van Rijsingen IAW, van den Berg MP, Deprez RHL, Post
JG, van Mil AM, et al. Genetic analysis in 418 index patients with idiopathic dilated
cardiomyopathy: overview of 10 years' experience. European Journal of Heart Failure
2013;15(6):628-36.
van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen
IAE, Sliwa K, et al. Titin gene mutations are common in families with both peripartum
cardiomyopathy and dilated cardiomyopathy. European Heart Journal
2014;35(32):2165-73.
Page 97 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
van Tintelen JP, Van Gelder IC, Asimaki A, Suurmijer AJH, Wiesfeld ACP, Jongbloed
JDH, et al. Severe cardiac phenotype with right ventricular predominance in a large
cohort of patients with a single missense mutation in the DES gene. Heart Rhythm
2009;6(11):1574-83.
van Tintelen JP, Wilde AAM, Jongbloed JDH. Recurrent and founder mutations in
inherited cardiac diseases in the Netherlands. Netherlands Heart Journal
2009;17(11):407-8.
van Tintelen JP, Hauer RNW. New test for arrhythmogenic right ventricular
cardiomyopathy. Nature Reviews Cardiology 2009;6(7):450-1.
van Tintelen JP, van Spaendonck-Zwarts KY, van den Berg MP. Lamin A/C-related
cardiac disease and pregnancy. European Journal of Heart Failure 2010;12(6):532-4.
van Tintelen JP, Pieper PG, van Spaendonck-Zwarts KY, van den Berg MP. Pregnancy,
cardiomyopathies, and genetics. Cardiovascular Research 2014;101(4):571-8.
van Valkenhoef G, Tervonen T, Zhao J, de Brock B, Hillege HL, Postmus D. Multicriteria
benefit-risk assessment using network meta-analysis. Journal of Clinical Epidemiology
2012;65(4):394-403.
van Valkenhoef G, Tervonen T, de Brock B, Hillege H. Deficiencies in the transfer and
availability of clinical trials evidence: a review of existing systems and standards. Bmc
Medical Informatics and Decision Making 2012;12.
van Valkenhoef G, Tervonen T, Zwinkels T, de Brock B, Hillege H. ADDIS: A decision
support system for evidence-based medicine. Decision Support Systems
2013;55(2):459-75.
van Veen T, Goeman JJ, Monajemi R, Wardenaar KJ, Hartman CA, Snieder H, et al.
Different gene sets contribute to different symptom dimensions of depression and
anxiety. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics
2012;159B(5):519-28.
Van Veldhuisen DJ, Cohen-Solal A, Bohm M, Anker SD, Babalis D, Roughton M, et al.
Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and
Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of
Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart
Failure). Journal of the American College of Cardiology 2009;53(23):2150-8.
Van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, Van Gelder IC, Dickstein K, et al.
Implementation of device therapy (cardiac resynchronization therapy and implantable
cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to
2008. European Journal of Heart Failure 2009;11(12):1143-51.
Van Veldhuisen DJ, de Boer RA. Low-dose digoxin in heart failure. International Journal
of Cardiology 2009;136(1):90-1.
Page 98 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Van Veldhuisen DJ, Swedberg K. Treatment of chronic heart failure with
aldosterone-blocking agents. European Heart Journal Supplements
2011;13(B):B43-B45.
Van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, et al.
Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients
With Heart Failure. Circulation 2011;124(16):1719-U82.
Van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron
deficiency in heart failure: mechanisms and therapeutic approaches. Nature Reviews
Cardiology 2011;8(9):485-93.
Van Veldhuisen DJ, Maass AH. Telemonitoring of Outpatients With Heart Failure A
Search for the Holy Grail? Circulation 2012;125(24):2965-7.
Van Veldhuisen DJ, McMurray JJV. Pharmacological treatment of heart failure with
preserved ejection fraction: a glimpse of light at the end of the tunnel? European Journal
of Heart Failure 2013;15(1):5-8.
Van Veldhuisen DJ, Jaarsma T, Hillege HL. B-Type Natriuretic Peptide Levels in Heart
Failure Patients With Preserved and Reduced Ejection Fraction Reply. Journal of the
American College of Cardiology 2013;62(6):567-8.
Van Veldhuisen DJ, Van Gelder IC, Ahmed A, Gheorghiade M. Digoxin for patients with
atrial fibrillation and heart failure: paradise lost or not? European Heart Journal
2013;34(20):1468-70.
Van Veldhuisen DJ, Linssen GCM, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JGP, et
al. B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved
and Reduced Ejection Fraction. Journal of the American College of Cardiology
2013;61(14):1498-506.
Van Veldhuisen DJ. The European Journal of Heart Failure from 2010 to 2015 A farewell
and a move of the Editorial Team from Groningen to Brescia. European Journal of Heart
Failure 2014;16(12):1259-62.
van Velzen JE, Schuijf JD, de Graaf FR, Nucifora G, Pundziute G, Jukema JW, et al.
Plaque type and composition as evaluated non-invasively by MSCT angiography and
invasively by VH IVUS in relation to the degree of stenosis. Heart 2009;95(24):1990-6.
van Vliet-Ostaptchouk JV, den Hoed M, Luan J, Zhao JH, Ong KK, van der Most PJ, et
al. Pleiotropic effects of obesity-susceptibility loci on metabolic traits: a meta-analysis of
up to 37,874 individuals. Diabetologia 2013;56(10):2134-46.
van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al.
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a
collaborative analysis of ten large cohort studies. Bmc Endocrine Disorders 2014;14.
van Werkhoven JM, Schuijf JD, Jukema JW, Pundziute G, de Roos A, Schalij MJ, et al.
Comparison of Non-Invasive Multi-Slice Computed Tomography Coronary Angiography
Versus Invasive Coronary Angiography and Fractional Flow Reserve for the Evaluation
Page 99 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
of Men With Known Coronary Artery Disease. American Journal of Cardiology
2009;104(5):653-6.
van Werkhoven JM, Gaemperli O, Schuijf JD, Jukema JW, Kroft LJ, Leschka S, et al.
Multislice computed tomography coronary angiography for risk stratification in patients
with an intermediate pretest likelihood. Heart 2009;95(19):1607-11.
van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Boersma E, Wijns W, et al.
Prognostic Value of Multislice Computed Tomography and Gated Single-Photon
Emission Computed Tomography in Patients With Suspected Coronary Artery Disease.
Journal of the American College of Cardiology 2009;53(7):623-32.
Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bultmann U. Socioeconomic
Measures and CKD in the United States and The Netherlands. Clinical Journal of the
American Society of Nephrology 2013;8(10):1685-93.
Vedovati MC, Becattini C, Agnelli G, Kamphuisen PW, Masotti L, Pruszczyk P, et al.
Multidetector CT Scan for Acute Pulmonary Embolism Embolic Burden and Clinical
Outcome. Chest 2012;142(6):1417-24.
Veeger NJGM, Zijlstra F, Hillege HL, van der Meer J. Fourteen-Year Follow-Up From
CABADAS: Vitamin K Antagonists or Dipyridamole Not Superior to Aspirin. Annals of
Thoracic Surgery 2010;90(5):1515-U527.
Veeger NJGM, Piersma-Wichers M, Meijer K, Hillege HL. Minor bleeds alert for
subsequent major bleeding in patients using vitamin K antagonists. British Journal of
Haematology 2011;153(4):508-14.
Vehof J, Al Hadithy AFY, Burger H, Snieder H, Risselada AJ, Wilffert B, et al.
Association between the ROBO1 gene and body mass index in patients using
antipsychotics. Psychiatric Genetics 2011;21(4):202-7.
Vehof J, Risselada AJ, Al Hadithy AFY, Burger H, Snieder H, Wilffert B, et al.
Association of genetic variants of the histamine H1 and muscarinic M3 receptors with
BMI and HbA1c values in patients on antipsychotic medication. Psychopharmacology
2011;216(2):257-65.
Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh BZ, Snieder H. Clinical response to
antipsychotic drug treatment: Association study of polymorphisms in six candidate
genes. European Neuropsychopharmacology 2012;22(9):625-31.
Vehof J, Bin W, Kozareva D, Hysi PG, Snieder H, Hammond CJ. The Heritability of Dry
Eye Disease in a Female Twin Cohort. Investigative Ophthalmology & Visual Science
2014;55(11):7278-83.
Verbeek DEP, van Riezen J, de Boer RA, van Melle JP, de Jonge P. A Review on the
Putative Association Between Beta-Blockers and Depression. Heart Failure Clinics
2011;7(1):89-+.
Page 100 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Vergeer M, Cohn DM, Boekholdt SM, Sandhu MS, Prins HM, Ricketts SL, et al. Lack of
association between common genetic variation in endothelial lipase (LIPG) and the risk
for CAD and DVT. Atherosclerosis 2010;211(2):558-64.
Vergeer M, Holleboom AG, Kastelein JJP, Kuivenhoven JA. The HDL hypothesis: does
high-density lipoprotein protect from atherosclerosis? Journal of Lipid Research
2010;51(8):2058-73.
Verheugt CL, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk
APJ, et al. Mortality in adult congenital heart disease. European Heart Journal
2010;31(10):1220-9.
Verheugt CL, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda
GT, et al. The emerging burden of hospital admissions of adults with congenital heart
disease. Heart 2010;96(11):872-8.
Verheugt CL, Uiterwaal CSPM, van der Velde ET, Meijboom FJ, Pieper PG, Veen G, et
al. Turning 18 with congenital heart disease: prediction of infective endocarditis based
on a large population. European Heart Journal 2011;32(15):1926-34.
Vermeijden JW, Zijlstra JG, Erasmus ME, Bij WD, Verschuuren EA. Lung
Transplantation for Ventilator-Dependent Respiratory Failure. Journal of Heart and Lung
Transplantation 2009;28(4):347-51.
Vermeltfoort IAC, Raijmakers PGHM, Kamphuisen PW. Improved myocardial perfusion
preceding clinical response on bosentan treatment for coronary vasospasm. Acta
Cardiologica 2009;64(3):415-7.
Vermeulen RP, Hoekstra M, Nijsten MWN, van der Horst IC, van Pelt LJ, Jessurun GA,
et al. Clinical correlates of arterial lactate levels in patients with ST-segment elevation
myocardial infarction at admission: a descriptive study. Critical Care 2010;14(5).
Vermond RA, Crijns HJGM, Tijssen JGP, Alings AM, van den Berg MP, Hillege HL, et al.
Symptom severity is associated with cardiovascular outcome in patients with permanent
atrial fibrillation in the RACE II study. Europace 2014;16(10):1417-25.
Verweij N, Mahmud H, Leach IM, de Boer RA, Brouwers FP, Yu HJ, et al. Genome-Wide
Association Study on Plasma Levels of Midregional-Proadrenomedullin and
C-Terminal-Pro-Endothelin-1. Hypertension 2013;61(3):602-+.
Verweij N, Mateo Leach I, van den Boogaard M, Van Veldhuisen DJ, Christoffels VM,
Hillege HL, et al. Genetic Determinants of P Wave Duration and PR Segment.
Circulation-Cardiovascular Genetics 2014;7(4):475-U243.
Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, Dieffenbach AK, Lu C, et al.
Association of vitamin D status with arterial blood pressure and hypertension risk: a
mendelian randomisation study. Lancet Diabetes & Endocrinology 2014;2(9):719-29.
Vis JC, Thoonsen H, Duffels MG, de Bruin-Bon RA, Huisman SA, van Dijk AP, et al.
Six-Minute Walk Test in Patients With Down Syndrome: Validity and Reproducibility.
Archives of Physical Medicine and Rehabilitation 2009;90(8):1423-7.
Page 101 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Vis JC, Duffels MG, Mulder P, de Bruin-Bon RHAC, Bouma BJ, Berger RMF, et al.
Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult
patients with pulmonary arterial hypertension associated with congenital heart disease.
International Journal of Cardiology 2013;164(1):64-9.
Visser A, Noordzij M, Gansevoort RT, Van Biesen W, Reijneveld SA, Jager KJ, et al.
Exploration of the difference in incidence of renal replacement therapy between Flanders
and the Netherlands-investigation of explanatory variables. Nephrology Dialysis
Transplantation 2012;27(2):803-9.
Visser A, Sunaert P, Franssen CFM, Van Biesen W, Reijneveld SA, Jager KJ, et al.
Exploration of the difference in incidence of renal replacement therapy in elderly patients
in Flanders and the Netherlands-a comparison of referral policy. Nephrology Dialysis
Transplantation 2012;27(1):338-44.
Vlaar PJ, Svilaas T, Damman K, De Smet BJGL, Hillege HL, Zijlstra F, et al. Response
to Letter Regarding Article, "Impact of Pretreatment With Clopidogrel on Initial Patency
and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for
ST-Segment Elevation Myocardial Infarction: A Systematic Review. Circulation
2009;120(4):E27.
Vlaar PJ, Mahmoud KD, Holmes DR, van Valkenhoef G, Hillege HL, van der Horst ICC,
et al. Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary
Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation
Myocardial Infarction A Pairwise and Network Meta-Analysis. Journal of the American
College of Cardiology 2011;58(7):692-703.
Vlaar PJ, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, et al.
Operator dependence of outcome after primary percutaneous coronary intervention.
Eurointervention 2011;6(6):760-7.
Vogelzang M, Vlaar PJ, Svilaas T, Amo D, Nijsten MWN, Zijlstra F. Computer-assisted
myocardial blush quantification after percutaneous coronary angioplasty for acute
myocardial infarction: a substudy from the TAPAS trial. European Heart Journal
2009;30(5):594-9.
Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et
al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation
study. Lancet 2012;380(9841):572-80.
von Haehling S, Van Veldhuisen DJ, Roughton M, Babalis D, de Boer RA, Coats AJS, et
al. Anaemia among patients with heart failure and preserved or reduced ejection
fraction: results from the SENIORS study. European Journal of Heart Failure
2011;13(6):656-63.
Vonk WIM, Bartuzi P, de Bie P, Kloosterhuis N, Wichers CGK, Berger R, et al.
Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper
Accumulation. Plos One 2011;6(12).
Voors AA, von Haehling S, Anker SD, Hillege HL, Struck J, Hartmann O, et al.
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart
Page 102 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
failure after an acute myocardial infarction: results from the OPTIMAAL study. European
Heart Journal 2009;30(10):1187-94.
Voors AA, Belonje AMS, Zijlstra F, Hillege HL, Anker SD, Slart RHJA, et al. A single
dose of erythropoietin in ST-elevation myocardial infarction. European Heart Journal
2010;31(21):2593-600.
Voors AA, Van Veldhuisen DJ. Cardiorenal Effects of Recombinant Human Natriuretic
Peptides. Journal of the American College of Cardiology 2010;55(17):1852-3.
Voors AA, van de Wal RM, Hartog JWL, Vijn RG, Hummel YM, Plokker TWM, et al.
Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with
Hypertension and Diastolic Dysfunction. Cardiovascular Drugs and Therapy
2010;24(1):33-40.
Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, et al. Effects of
the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With
Acute Heart Failure and Renal Dysfunction Results From PROTECT
(Placebo-Controlled Randomized Study of the Selective A(1) Adenosine Receptor
Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart
Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal
Function). Journal of the American College of Cardiology 2011;57(19):1899-907.
Voors AA, van der Horst ICC. Diabetes: a driver for heart failure. Heart
2011;97(9):774-80.
Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, et al. Early drop
in systolic blood pressure and worsening renal function in acute heart failure: renal
results of Pre-RELAX-AHF. European Journal of Heart Failure 2011;13(9):961-7.
Voors AA, Van Veldhuisen DJ. Why do drugs for acute heart failure fail? European
Journal of Heart Failure 2012;14(9):955-6.
Voors AA, Dorhout B, van der Meer P. The potential role of valsartan+AHU377 (LCZ696)
in the treatment of heart failure. Expert Opinion on Investigational Drugs
2013;22(8):1041-7.
Voors AA, Dahlke M, Meyer S, Stepinska J, Gottlieb SS, Jones A, et al. Renal
Hemodynamic Effects of Serelaxin in Patients With Chronic Heart Failure A
Randomized, Placebo-Controlled Study. Circulation-Heart Failure 2014;7(6):994-U205.
Voors AA, Davison BA, Teerlink JR, Felker GM, Cotter G, Filippatos G, et al. Diuretic
response in patients with acute decompensated heart failure: characteristics and clinical
outcome-an analysis from RELAX-AHF. European Journal of Heart Failure
2014;16(11):1230-40.
Voors AA, Van Veldhuisen DJ, Robertson M, Ford I, Borer JS, Bohm M, et al. The effect
of heart rate reduction with ivabradine on renal function in patients with chronic heart
failure: an analysis from SHIFT. European Journal of Heart Failure 2014;16(4):426-34.
Page 103 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, et al. Genome-wide
association study identifies six new loci influencing pulse pressure and mean arterial
pressure. Nature Genetics 2011;43(10):1005-U122.
Waldreus N, Van der Wal MHL, Hahn RG, Van Veldhuisen DJ, Jaarsma T. Thirst
Trajectory and Factors Associated With Persistent Thirst in Patients With Heart Failure.
Journal of Cardiac Failure 2014;20(9):689-95.
Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, et al. Variants near
TERT and TERC influencing telomere length are associated with high-grade glioma risk.
Nature Genetics 2014;46(7):731-5.
Wang X, Ding X, Su S, Spector TD, Mangino M, Iliadou A, et al. Heritability of insulin
sensitivity and lipid profile depend on BMI: evidence for gene-obesity interaction.
Diabetologia 2009;52(12):2578-84.
Wang XL, Ding XH, Su SY, Li ZB, Riese H, Thayer JF, et al. Genetic influences on heart
rate variability at rest and during stress. Psychophysiology 2009;46(3):458-65.
Wang XL, Ding XH, Su SY, Yan WL, Harshfield G, Treiber F, et al. Genetic influences on
daytime and night-time blood pressure: similarities and differences. Journal of
Hypertension 2009;27(12):2358-64.
Wang XL, Zhu HD, Snieder H, Su SY, Munn D, Harshfield G, et al. Obesity related
methylation changes in DNA of peripheral blood leukocytes. Bmc Medicine 2010;8.
Wang XL, Ding XH, Su SY, Harshfield G, Treiber F, Snieder H. Genetic influence on
blood pressure measured in the office, under laboratory stress and during real life.
Hypertension Research 2011;34(2):239-44.
Wang XL, Prins BP, Sober S, Laan M, Snieder H. Beyond Genome-Wide Association
Studies: New Strategies for Identifying Genetic Determinants of Hypertension. Current
Hypertension Reports 2011;13(6):442-51.
Wang XL, Falkner B, Zhu HD, Shi HD, Su SY, Xu XJ, et al. A Genome-Wide Methylation
Study on Essential Hypertension in Young African American Males. Plos One 2013;8(1).
Wang Y, Qian C, Roks AJM, Westermann D, Schumacher SM, Escher F, et al.
Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After
Myocardial Infarction. Circulation-Heart Failure 2010;3(2):286-93.
Wassel CL, Lamina C, Nambi V, Coassin S, Mukamal KJ, Ganesh SK, et al. Genetic
determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate
gene 50K SNP panel in the candidate gene association resource (CARe) consortium.
Atherosclerosis 2012;222(1):138-47.
Weiss MM, Van der Zwaag B, Jongbloed JDH, Vogel MJ, Bruggenwirth HT, Deprez
RHL, et al. Best Practice Guidelines for the Use of Next-Generation Sequencing
Applications in Genome Diagnostics: A National Collaborative Study of Dutch Genome
Diagnostic Laboratories. Human Mutation 2013;34(10):1313-21.
Page 104 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Wellens HJJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, et
al. Risk stratification for sudden cardiac death: current status and challenges for the
future. European Heart Journal 2014;35(25):1642-+.
Wen CP, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, et al. Relative risks of
chronic kidney disease for mortality and end-stage renal disease across races are
similar. Kidney International 2014;86(4):819-27.
Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P,
et al. Bone marrow dysfunction in chronic heart failure patients. European Journal of
Heart Failure 2010;12(7):676-84.
Westenbrink BD, Ruifrok WPT, Voors AA, Tilton RG, Van Veldhuisen DJ, Schoemaker
RG, et al. Vascular endothelial growth factor is crucial for erythropoietin-induced
improvement of cardiac function in heart failure. Cardiovascular Research
2010;87(1):30-9.
Westenbrink BD, Hovinga TKK, Kloppenburg WD, Veeger NJ, Janssen WMT. B-type
natriuretic peptide and interdialytic fluid retention are independent and incremental
predictors of mortality in hemodialysis patients. Clinical Nephrology 2011;76(5):373-9.
Westenbrink BD, Kleijn L, de Boer RA, Tijssen JG, Warnica WJ, Baillot R, et al.
Sustained postoperative anaemia is associated with an impaired outcome after coronary
artery bypass graft surgery: insights from the IMAGINE trial. Heart 2011;97(19):1590-6.
Westenbrink BD, Damman K, Rienstra M, Maass AH, van der Meer P. Heart failure
highlights in 2011. European Journal of Heart Failure 2012;14(10):1090-6.
Westenbrink BD, Kleijn L, van der Meer P. Haemodilution is a mechanism of anaemia in
patients with heart failure: reply. European Journal of Heart Failure 2013;15(9):1074-5.
Westenbrink BD, Edwards AG, Miyamoto S. Conference report from the 2012 AHA
scientific sessions in Los Angeles. Expert Opinion on Therapeutic Targets
2013;17(6):733-7.
Westendorp B, Hamming I, Szymanski MK, Navis G, van Goor H, Buikema H, et al.
Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated
with an ACE inhibitor. European Journal of Pharmacology 2009;602(2-3):373-9.
Weterman MAJ, Barth PG, van Spaendonck-Zwarts KY, Aronica E, Poll-The B, Brouwer
OF, et al. Recessive MYL2 mutations cause infantile type I muscle fibre disease and
cardiomyopathy. Brain 2013;136:282-93.
Wieringa WG, Lexis CPH, Diercks GFH, Lipsic E, Tan ES, Schurer RAJ, et al. The
feasibility of optical coherence tomography guided thrombus aspiration in patients with
non-ST-elevation myocardial infarction after initial conservative therapy - A pilot study.
International Journal of Cardiology 2013;168(5):4981-2.
Wieringa WG, Lexis CPH, Mahmoud KD, Ottervanger JP, Burgerhof JGM, Pundziute G,
et al. Time of symptom onset and value of myocardial blush and infarct size on
Page 105 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
prognosis in patients with ST-elevation myocardial infarction. Chronobiology
International 2014;31(6):797-806.
Willemsen HM, de Jong G, Tio RA, Nieuwland W, Kema IP, van der Horst ICC, et al.
Quick identification of acute chest pain patients study (QICS). Bmc Cardiovascular
Disorders 2009;9.
Willemsen HM, van der Horst ICC, Nieuwland W, Slart RJHA, Zeebregts CJ, de Boef E,
et al. The diagnostic value of soluble CD163 in patients presenting with chest pain.
Clinical Biochemistry 2009;42(16-17):1662-6.
Willemsen S, Hartog JWL, Hummel YM, Posma JL, van Wijk LM, Van Veldhuisen DJ, et
al. Effects of alagebrium, an advanced glycation end-product breaker, in patients with
chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial.
European Journal of Heart Failure 2010;12(3):294-300.
Willemsen S, Hartog JWL, Hummel YM, van Ruijven MHI, van der Horst ICC, Van
Veldhuisen DJ, et al. Tissue advanced glycation end products are associated with
diastolic function and aerobic exercise capacity in diabetic heart failure patients.
European Journal of Heart Failure 2011;13(1):76-82.
Willemsen S, Hartog JWL, Heiner-Fokkema MR, Van Veldhuisen DJ, Voors AA.
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal
syndrome. Heart Failure Reviews 2012;17(2):221-8.
Willemsen S, Hartog JWL, Van Veldhuisen DJ, van der Meer P, Roze JF, Jaarsma T, et
al. The role of advanced glycation end-products and their receptor on outcome in heart
failure patients with preserved and reduced ejection fraction. American Heart Journal
2012;164(5):742-U146.
Winter MM, Bouma BJ, Groenink M, Konings TC, Tijssen JGP, Van Veldhuisen DJ, et al.
Latest insights in therapeutic options for systemic right ventricular failure: a comparison
with left ventricular failure. Heart 2009;95(12):960-3.
Winter MM, Reisma C, Kedde H, Bouma BJ, Vis JC, Luijendijk P, et al. Sexuality in Adult
Patients With Congenital Heart Disease and Their Partners. American Journal of
Cardiology 2010;106(8):1163-8.
Winter MM, van der Bom T, de Vries LCS, Balducci A, Bouma BJ, Pieper PG, et al.
Exercise training improves exercise capacity in adult patients with a systemic right
ventricle: a randomized clinical trial. European Heart Journal 2012;33(11):1378-85.
Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJL, de Jong PE, Gansevoort R.
First Morning Voids Are More Reliable Than Spot Urine Samples to Assess
Microalbuminuria. Journal of the American Society of Nephrology 2009;20(2):436-43.
Wolff D, van Melle JP, Berger RMF, Ebels T. The Fontan Operation Starts With the
Cavopulmonary Shunt. Journal of the American College of Cardiology
2013;61(14):1550-1.
Page 106 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Wolff D, van Melle JP, Ebels T, Hillege H, van Slooten YJ, Berger RMF. Trends in
mortality (1975-2011) after one- and two-stage Fontan surgery, including bidirectional
Glenn through Fontan completion. European Journal of Cardio-Thoracic Surgery
2014;45(4):602-9.
Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder IC. The cost
of illness of atrial fibrillation: a systematic review of the recent literature. Europace
2011;13(10):1375-85.
Wong LS, Windt WA, Roks AJ, van Dokkum RP, Schoemaker RG, de Zeeuw D, et al.
Renal failure induces telomere shortening in the rat heart. Netherlands Heart Journal
2009;17(5):190-4.
Wong LSM, van der Harst P, de Boer RA, Codd V, Huzen J, Samani NJ, et al. Renal
dysfunction is associated with shorter telomere length in heart failure. Clinical Research
in Cardiology 2009;98(10):629-34.
Wong LSM, Oeseburg H, de Boer RA, van Gilst WH, Van Veldhuisen DJ, van der Harst
P. Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart
failure and ageing. Cardiovascular Research 2009;81(2):244-52.
Wong LSM, van der Harst P, de Boer RA, Huzen J, van Gilst WH, Van Veldhuisen DJ.
Aging, telomeres and heart failure. Heart Failure Reviews 2010;15(5):479-86.
Wong LSM, Huzen J, van der Harst P, de Boer RA, Codd V, Westenbrink BD, et al.
Anaemia is associated with shorter leucocyte telomere length in patients with chronic
heart failure. European Journal of Heart Failure 2010;12(4):348-53.
Wong LSM, Huzen J, de Boer RA, van Gilst WH, Van Veldhuisen DJ, van der Harst P.
Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients
with Ischemic Heart Failure and Their Offspring. Plos One 2011;6(8).
Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role
of common variation in the genomic and biological architecture of adult human height.
Nature Genetics 2014;46(11):1173-86.
Woolthuis C, Agool A, Olthof S, Slart RHJA, Huls G, Smid WM, et al. Auto-SCT induces
a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and
enhances in vitro and in vivo cycling activity defined by F-18-FLT PET scanning. Bone
Marrow Transplantation 2011;46(1):110-5.
Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al.
Separate and combined associations of body-mass index and abdominal adiposity with
cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet
2011;377(9771):1085-95.
Wormser D, Di Angelantonio E, Kaptoge S, Wood AM, Gao P, Sun Q, et al. Adult height
and the risk of cause-specific death and vascular morbidity in 1 million people: individual
participant meta-analysis. International Journal of Epidemiology 2012;41(5):1419-33.
Page 107 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Wu T, Snieder H, de Geus E. Genetic influences on cardiovascular stress reactivity.
Neuroscience and Biobehavioral Reviews 2010;35(1):58-68.
Wu T, Boezen HM, Postma DS, Los H, Postmus PE, Snieder H, et al. Genetic and
environmental influences on objective intermediate asthma phenotypes in Dutch twins.
European Respiratory Journal 2010;36(2):261-8.
Wu T, Snieder H, Li LM, Cao WH, Zhan SY, Lv J, et al. Genetic and environmental
influences on blood pressure and body mass index in Han Chinese: a twin study.
Hypertension Research 2011;34(2):173-9.
Wu T, Treiber FA, Snieder H. Genetic Influence on Blood Pressure and Underlying
Hemodynamics Measured at Rest and During Stress. Psychosomatic Medicine
2013;75(4):404-12.
Wyse DG, Van Gelder IC, Ellinor PT, Go AS, Kalman JM, Narayan SM, et al. Lone Atrial
Fibrillation Does it Exist? Journal of the American College of Cardiology
2014;63(17):1715-23.
Xu XJ, Ding XH, Zhang XY, Su SY, Treiber FA, Vlietinck R, et al. Genetic and
environmental influences on blood pressure variability: a study in twins. Journal of
Hypertension 2013;31(4):690-7.
Xu XJ, Su SY, Barnes VA, De Miguel C, Pollock J, Ownby D, et al. A genome-wide
methylation study on obesity Differential variability and differential methylation.
Epigenetics 2013;8(5):522-33.
Yang J, Loos RJF, Powell JE, Medland SE, Speliotes EK, Chasman DI, et al. FTO
genotype is associated with phenotypic variability of body mass index. Nature
2012;490(7419):267-+.
Yap SC, Drenthen W, Meijboom FJ, Moons P, Mulder BJM, Vliegen HW, et al.
Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial
septal defect. Bjog-An International Journal of Obstetrics and Gynaecology
2009;116(12):1593-601.
Yap SC, Drenthen W, Pieper PG, Moons P, Mulder BJM, Vliegen HW, et al. Pregnancy
outcome in women with repaired versus unrepaired isolated ventricular septal defect.
Bjog-An International Journal of Obstetrics and Gynaecology 2010;117(6):683-9.
Yin MM, van der Horst ICC, van Melle JP, Qian C, van Gilst WH, Sillje HHW, et al.
Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
American Journal of Physiology-Heart and Circulatory Physiology
2011;301(2):H459-H468.
Yin MM, Sillje HHW, Meissner M, van Gilst WH, de Boer RA. Early and late effects of the
DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure.
Cardiovascular Diabetology 2011;10.
Yin MM, Westenbrink BD, Meissner M, van Gilst WH, de Boer RA. Variable effects of
anti-diabetic drugs in animal models of myocardial ischemia and remodeling: A
Page 108 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
translational perspective for the cardiologist. International Journal of Cardiology
2013;169(6):385-93.
Yu HJ, Tigchelaar W, Koonen DPY, Patel HH, de Boer RA, van Gilst WH, et al. AKIP1
Expression Modulates Mitochondrial Function in Rat Neonatal Cardiomyocytes. Plos
One 2013;8(11).
Yu HJ, Tigchelaar W, Lu B, van Gilst WH, de Boer RA, Westenbrink BD, et al. AKIP1, a
Cardiac Hypertrophy Induced Protein that Stimulates Cardiomyocyte Growth via the Akt
Pathway. International Journal of Molecular Sciences 2013;14(11):21378-93.
Yu LL, Ruifrok WPT, Meissner M, Bos EM, van Goor H, Sanjabi B, et al. Genetic and
Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering
With Myocardial Fibrogenesis. Circulation-Heart Failure 2013;6(1):107-+.
Zannad F, McMurray JJV, Drexler H, Krum H, Van Veldhuisen DJ, Swedberg K, et al.
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval
Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure
2010;12(6):617-22.
Zannad F, McMurray JJV, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H, et al.
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms. New England
Journal of Medicine 2011;364(1):11-21.
Zannad F, Stough WG, Rossignol P, Bauersachs J, McMurray JJV, Swedberg K, et al.
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction:
integrating evidence into clinical practice. European Heart Journal
2012;33(22):2782-U18.
Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JGF, et al. Clinical
outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure
Association consensus document. European Journal of Heart Failure
2013;15(10):1082-94.
Zhang DL, Ke L, Mackovicova K, Van Der Want JJL, Sibon OCM, Tanguay RM, et al.
Effects of different small HSPB members on contractile dysfunction and structural
changes in a Drosophila melanogaster model for Atrial Fibrillation. Journal of Molecular
and Cellular Cardiology 2011;51(3):381-9.
Zhang DL, Wu CT, Qi XY, Meijering RAM, Hoogstra-Berends F, Tadevosyan A, et al.
Activation of Histone Deacetylase-6 Induces Contractile Dysfunction Through Derailment
of alpha-Tubulin Proteostasis in Experimental and Human Atrial Fibrillation. Circulation
2014;129(3):346-58.
Zhang KX, Huentelman MJ, Rao FW, Sun EI, Corneveaux JJ, Schork AJ, et al. Genetic
Implication of a Novel Thiamine Transporter in Human Hypertension. Journal of the
American College of Cardiology 2014;63(15):1542-55.
Zhu HD, Belcher M, van der Harst P. Healthy aging and disease: role for telomere
biology? Clinical Science 2011;120(9-10):427-40.
Page 109 of 110
PRESERVATION OF CARDIAC FUNCTION OVER TIME
- THE CARDIOVASCULAR CENTER (CVC) -
Zhu HD, Wang XL, Gutin B, Davis CL, Keeton D, Thomas J, et al. Leukocyte Telomere
Length in Healthy Caucasian and African-American Adolescents: Relationships with
Race, Sex, Adiposity, Adipokines, and Physical Activity. Journal of Pediatrics
2011;158(2):215-20.
Zhu HD, Wang XL, Shi HD, Su SY, Harshfield GA, Gutin B, et al. A Genome-Wide
Methylation Study of Severe Vitamin D Deficiency in African American Adolescents.
Journal of Pediatrics 2013;162(5):1004-U165.
Zijlstra WMH, Douwes JM, Rosenzweig EB, Schokker S, Krishnan U, Roofthooft MTR,
et al. Survival Differences in Pediatric Pulmonary Arterial Hypertension Clues to a Better
Understanding of Outcome and Optimal Treatment Strategies. Journal of the American
College of Cardiology 2014;63(20):2159-69.
Zijlstra WMH, Ploegstra MJ, Berger RMF. Current and advancing treatments for
pulmonary arterial hypertension in childhood. Expert Review of Respiratory Medicine
2014;8(5):615-28.
Zittema D, Boertien WE, van Beek AP, Dullaart RPF, Franssen CFM, de Jong PE, et al.
Vasopressin, Copeptin, and Renal Concentrating Capacity in Patients with Autosomal
Dominant Polycystic Kidney Disease without Renal Impairment. Clinical Journal of the
American Society of Nephrology 2012;7(6):906-13.
Zittema D, van den Berg E, Meijer E, Boertien WE, Kobold ACM, Franssen CFM, et al.
Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal
Dominant Polycystic Kidney Disease Patients. Clinical Journal of the American Society
of Nephrology 2014;9(9):1553-62.
Zomer AC, Uiterwaal CSPM, van der Velde ET, Tijssen JGP, Mariman ECM, Verheugt
CL, et al. Mortality in adult congenital heart disease: Are national registries reliable for
cause of death? International Journal of Cardiology 2011;152(2):212-7.
Zomer AC, Vaartjes I, Uiterwaal CSPM, van der Velde ET, van den Merkhof LFM, Baur
LHB, et al. Circumstances of death in adult congenital heart disease. International
Journal of Cardiology 2012;154(2):168-72.
Zwicker JI, Connolly G, Carrier M, Kamphuisen PW, Lee AYY. Catheter-associated deep
vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the
ISTH. Journal of Thrombosis and Haemostasis 2014;12(5):796-800.
Page 110 of 110